Back to GetFilings.com
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
|
|
|
(Mark One) |
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
For the fiscal year ended January 2, 2005 |
|
Or |
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
For the transition period
from to . |
Commission file number: 1-10079
Cypress Semiconductor Corporation
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
94-2885898 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
3901 North First Street, San Jose, California
95134-1599
(Address of principal executive offices and zip code)
Registrants telephone number, including area code:
(408) 943-2600
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of Each Class |
|
Name of Each Exchange on Which Registered |
|
|
|
Common Stock, $.01 par value
|
|
New York Stock Exchange |
1.25% Convertible Subordinated Notes due 2008
|
|
New York Stock Exchange |
Securities registered pursuant to Section 12(g) of the
Act:
None
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. þ Yes o No
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of Regulation S-K is not
contained herein, and will not be contained, to the best of
registrants knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this
Form 10-K or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is an accelerated
filer (as defined in Rule 12b-2 of the
Act). þ Yes o No
At March 1, 2005, 131,017,938 shares of the
registrants common stock were outstanding. The market
value of voting stock held by non-affiliates of the registrant,
based upon the closing sale price of the common stock on
June 27, 2004 as reported on the New York Stock Exchange,
was approximately $1,379,036,358. Shares of common stock held by
each executive officer and director and by each person who owns
5% or more of the outstanding common stock have been excluded
from the foregoing calculation in that such persons may be
deemed affiliates. This determination of affiliate status is not
necessarily a conclusive determination for other purposes.
DOCUMENTS INCORPORATED BY REFERENCE
Parts of the Proxy Statement for registrants 2005 Annual
Meeting of Stockholders are incorporated by reference in
Items 10, 11, 12, 13 and 14 of Part III of this
Annual Report on Form 10-K.
TABLE OF CONTENTS
2
PART I
The discussion in this Annual Report on Form 10-K contains
forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 that
involve risks and uncertainties, including, but not limited to,
statements as to our future financial results, operating
performance and business plans, our prospects and the prospects
of our subsidiaries and the semiconductor industry generally,
and statements as to the utilization of our Philippines factory,
pressure on and trends for average selling prices, entering into
licensing arrangements with third parties, capital expenditures,
future acquisitions, the impact of SunPower Corporation
(SunPower) and our other subsidiaries on our future
financial results, the general economy and its impact to the
market segments we serve, the cycles of the semiconductor
industry, expected inventory corrections and levels of demand in
2005, the rate at which new products are introduced, our outlook
for fiscal 2005, our expected revenue for fiscal 2005, our
expected improvements in gross margin in fiscal 2005, our
expectations to generate positive cash flow from operations in
fiscal 2005, successful integration and achieving the objectives
of the acquired businesses, adequacy of cash and working
capital, our research and development investments and project
timelines, and other liquidity risks. We use words such as
anticipates, believes,
expects, future, intends and
similar expressions to identify forward-looking statements. Our
actual results could differ materially from those projected in
the forward-looking statements for any reason, including the
factors set forth in the Risk Factors and elsewhere
in this Annual Report on Form 10-K. All forward-looking
statements included in this Annual Report on Form 10-K are
based upon information available to Cypress as of the date of
this Annual Report, which may change. In addition, past
financial and/or operating performance is not necessarily a
reliable indicator of future performance and you should not use
our historical performance to anticipate results or trends for
future period. In evaluating these forward-looking statements,
you should specifically consider the risks described below under
Risk Factors which follows our discussion on
critical accounting policies and in other parts of this Annual
Report on Form 10-K. Except as required by law, we assume
no obligation to update any such forward-looking statements to
reflect events or circumstances that arise after the date of
this Annual Report on Form 10-K.
General
Cypress Semiconductor Corporation (the Company or
we) designs, develops, manufactures and markets a
broad line of high-performance digital and mixed-signal
integrated circuits for a broad range of markets including
networking, wireless infrastructure and handsets, computation,
consumer, automotive, and industrial. In addition, we design and
manufacture high-performance silicon solar cells through our
SunPower subsidiary. We have four product divisions and four
subsidiaries organized into three reportable business
segments Memory, Non-Memory and SunPower:
|
|
|
|
|
Memory segment consists of our Memory Product Division; |
|
|
|
Non-Memory segment includes our Data Communication Division,
Timing Technology Division, Personal Communications Division,
and our Silicon Light Machines (SLM), Cypress
MicroSystems (CMS), and Silicon Magnetic Systems
(SMS) subsidiaries; and |
|
|
|
SunPower segment consists of our SunPower subsidiary. |
In addition, we report on our product offerings by market
segments in order to sharpen our focus on serving end markets.
These four market segments are: Wide Area Networks and Storage
Area Networks (WAN/ SAN), which focus on networking
and telecommunications applications; Wireless Infrastructure and
Wireless Terminals (WIN/ WIT), which focus on
wireless base stations and handsets; Computation and Consumer,
which focus on video games, personal computers, and other
consumer applications; and Cypress Subsidiaries, which focus on
emerging technologies and related market developments.
We were incorporated in California in December 1982. The initial
public offering of our common stock occurred in May 1986, at
which time our common stock commenced trading on the Nasdaq
National Market.
3
In February 1987, we were reincorporated in Delaware and in
October 1988, we listed our common stock on the New York Stock
Exchange. Our corporate headquarters are located in 3901 North
First Street, San Jose, California 95134, and our main
telephone number is (408) 943-2600.
Business Segments and Product Overview
We design, manufacture and sell higher-margin, proprietary
products with advanced features and functions, which tend to be
more resistant to market volatility and trends than commodity
type products. We develop proprietary and higher-value products
both in our Memory and Non-Memory businesses. We also design,
manufacture and sell commodity-type products. We sell wireless,
wireline and other products to manufacturers in networking,
wireless infrastructure and handsets, computation, consumer,
automotive, industrial and other business segments. Our SunPower
business designs and manufactures high-performance silicon solar
cells based on an inter-digitated all-back-contact design.
A significant number of the wafers we produce for the Memory
products are manufactured at our eight-inch wafer fabrication
facility in Bloomington, Minnesota. A majority of the wafers we
produce for Non-Memory products are manufactured at our six-inch
production facility in Round Rock, Texas. For non-core
technologies, we purchase wafers from outside facilities, or
foundries. This practice enables us to quickly bring to market
products manufactured with processes that are different than the
high-volume processes needed to maximize the profitability of
our fabrication facilities. These products generally target
markets where fast time-to-market and leading-edge feature sets
are the primary criteria for success. In addition, our SunPower
business manufactures its solar cell products in a facility in
the Philippines.
Please refer to Note 22 of Notes to Consolidated Financial
Statements included under Item 8 of this Annual Report on
Form 10-K for detailed information about our reportable
business segments.
Our Memory business driven by our Memory Products
Division designs and produces static random access
memories (SRAMs). These memories are used to store
and retrieve data in networking, wireless infrastructure and
handsets, computation, consumer, automotive, industrial and
other electronic systems. Manufacturing of many of our SRAMs are
transitioning to the leading-edge 90 nm process technology.
Migrating to advanced processes and reducing manufacturing costs
continue to be important criteria for success in the memory
business, particularly in commodity products.
The SRAM market is characterized by the need for many different
combinations of density (number of bits per memory circuit),
organization (number of bits available to the user in a single
access of the RAM), performance characteristics (number of bits
transferred per cycle) and levels of power consumption
(low-power and ultra-low-power devices required for portable,
battery-operated equipment). We are the worlds second
largest manufacturer of SRAMs, offers a broad selection of SRAM
products, including high-speed synchronous SRAMs,
high-performance
MicroPowertm
SRAMs and fast asynchronous SRAMs. Our memory portfolio
primarily includes the following devices:
Double Data Rate (DDR) SRAMs. DDR SRAMs
target network applications and servers that operate at data
rates up to 400 MHz. We offer a variety of input/output
(I/ O) voltages, bus widths and package options with
product densities up to 72 Mbits, delivering up to
50 percent more system-level bandwidth than competing
products.
Fast Asynchronous SRAMs. We market a wide selection of
fast asynchronous SRAMs with densities ranging from 16 Kbits to
16 Mbits. Our fast asynchronous portfolio includes the
high-performance 16-bit-wide and 24-bit-wide families, which are
optimized for the latest generation of fast digital signal
processors. These memories are available in many combinations of
bus widths, packages and temperature ranges.
More Battery
Lifetm
(MoBL®) and MicroPower SRAMs. Our
More Battery Life SRAMs, the flagship of our low-power memory
product line, significantly increase battery life and talk time
in wireless products such as cellular phones. MoBL and other
MicroPower devices rank among the industrys lowest-power
devices. An increasing share of our MicroPower business comes
from pseudo-SRAM (PSRAM)
4
products with a one-transistor (1T) architecture.
These products offer higher density than standard six-transistor
cells at a lower cost. The demand for 1T products is being
driven by next-generation wireless devices with more robust
features. Since acquiring Cascade Semiconductor Corporation
(Cascade) during fiscal 2004, we have enhanced our
1T product portfolio to include devices ranging from 2 to 16
Mbits.
No Bus
Latencytm
(NoBLtm)
and Synchronous Burst SRAMs. NoBL synchronous SRAMs are
optimized for high-speed applications that require maximum bus
bandwidth, including those in the networking, instrumentation,
video and simulation businesses. Synchronous Burst SRAMs are
ideally suited for processor cache applications. Both types of
devices come in a variety of densities and I/ O configurations.
Our 72-Mbit NoBL SRAM, the industrys largest, manufactured
on our proprietary 90-nanometer technology.
Quad Data
Ratetm
(QDRtm)
SRAMs. QDR products are targeted toward next-generation
networking applications, particularly switches and routers that
operate at data rates beyond 300 MHz.
Image Sensors. We acquired FillFactory NV
(FillFactory) during fiscal 2004, gaining an entry
into the image sensor business. Complimentary Metal Oxide
Semiconductor (CMOS) image sensors will become the
primary imaging technology for high megapixel digital cameras by
2006. FillFactory image sensors provide a high fill
factor, enabling images with greater resolution and field
depth. In addition to digital still cameras, the technology is
also being used in machine vision, metrology, surveillance and
satellite systems.
Our Non-Memory business targets the networking, wireless
infrastructure and handsets, computation, consumer, automotive,
industrial and other markets. The category includes products
from our Timing Technology Division, Personal Communications
Division, Data Communications Division, along with products from
our subsidiaries (excluding SunPower). Our Non-Memory products
portfolio primarily includes the following:
Dual-Port Memories. Dual-ports, which can be accessed by
two different processors or buses simultaneously, target
shared-memory and switching applications, including networking
switches and routers, cellular base stations, mass storage
devices and telecommunications equipment. Our family of
synchronous and asynchronous Dual-Port RAMs range in density
from 8 Kbits to 18 Mbits in x8, x9, x16, x18 and x36
configurations.
First-In, First-Out (FIFO) Memories. FIFOs
are used as a buffer between systems operating at different
frequencies. We offer FIFO memories in a variety of
high-bandwidth synchronous and asynchronous architectures with
industry-standard pinouts.
Framers. Our high-performance Synchronous Optical
Network/ Synchronous Digital Hierarchy (SONET/ SDH)
framers transport SONET or SDH frames at the data rates of 2.488
Gbps and 9.952 Gbps. This family includes our
POSIC2GVCtm
framer, one of the industrys first devices to offer both
generic framing procedures and virtual concatenation. These
innovations enable the efficient transport of multiple data
protocols over existing SONET/ SDH networks.
POSICtm
framers are compatible with protocols including Ethernet, Fibre
Channel, Enterprise System Connection, Digital Video Broadcast
and a commercial video standard for the Society for Motion
Pictures and Television Engineers. We are developing the next
generation of framers to include enhanced features such as Link
Capacity Adjustment Scheme and Low-Order Virtual Concatenation,
which will enable dynamic bandwidth changes and the ability to
provide scalable data services from 1.5 Mbps to 1 Gbps.
Grating Light
Valvetm
(GLVtm).
The GLV was designed by Silicon Light Machines. GLV technology
switches, modulates and attenuates light in a variety of
applications. The GLV is used for applications in the
communications, digital imaging, simulation, display and
direct-to-print markets.
High-Speed Optical Transceiver Link
(HOTLink®) Physical Layer Devices
(PHYs). Our HOTLink and
HOTLink IItm
family of PHYs are physical-layer products for moving serial
data at rates from 50 Mbps to 1.5 Gbps. These products
support a variety of applications and industrial protocols
including
5
Gigabit Ethernet, 10-Gbps Ethernet, Fibre Channel, Enterprise
System Connection, Asynchronous Transfer Mode, Digital Video
Broadcast, Advanced Micro Devices Inc.s
TAXItm
protocol, and generic backplane and point-to-point applications.
The newest HOTLink PHYs, including the HOTLink II PHY, move
up to four channels of serial data at up to 1.5 Gbps. The newest
addition to this family is a single-chip solution for
professional-quality video.
Network Search Engines (NSEs). We offer
a variety of ternary content addressable memory
(TCAM) solutions for packet processing in network
applications. The
Ayamatm
family of NSEs is compatible with the Network Processing
Forum-approved LA-1 specification supporting commercial network
processors, and can be combined with our
Sahasratm
NSE to create TCAM and algorithmic solutions for large-scale
IPV6 applications. We also offer a line of NSEs optimized
for ASIC applications.
Physical Layer Devices. Our family of high-performance
SONET/ SDH and Serializer/ Deserializer (SERDES)
devices move SONET or SDH frames between equipment at SONET/ SDH
data rates of 51.85 Mbps (OC-1),
155.52 Mbps (OC-3/ STM-1) and 2.488 Gbps
(OC-48/ STM-16). Our OC-48 products meet the
requirements of wide area network switches and routers with
stringent, Bellcore-compliant jitter specifications.
QuadPort® Datapath Switching Elements
(DSEs). QuadPort DSEs are non-blocking switch
devices that allow four independent buses, processors or
backplanes to access the DSE simultaneously in separate time
domains. Applications for these devices include 4 x 4 switching,
packet-header manipulation, and datapath transport that can
reduce the need for large field-programmable gate array devices.
QuadPort DSEs are used in redundant arrays of independent disks
and storage switches, metropolitan area network/ wide area
network switches and routers, and wireless base station
applications.
Programmable Clocks. Programmable timing solutions
combine the flexibility and fast time to market of
field-programmable devices with high performance at a cost that
is competitive against custom clocks at equivalent volumes.
Working with our easy-to-use
CyClockstm
and
CyberClockstm
software, designers can select custom frequencies for a variety
of applications. We are the only supplier offering true
field-programmable clocks. All our clocks have the desired
characteristics of high drive, low jitter, low electromagnetic
interference (EMI) and low skew. During fiscal 2004,
we began sampling the industrys first programmable
spread-spectrum clock generator with an onboard crystal
oscillator. The device enables designers to accelerate
time-to-market while reducing cost, board space and EMI.
Programmable Logic Devices (PLDs). System
logic performs non-memory functions such as floating-point
mathematics or the organization and routing of signals
throughout a computer system. We manufacture several types of
PLDs, which facilitate the replacement of multiple standard
logic devices with a single programmable device, increasing
flexibility and reducing time to market. Our flagship product is
the
Delta39Ktm
Complex Programmable Logic Device, which operates at high speed
(233 MHz) and has more than 3,000 macrocells. All our
products are supported by the Warp® software
toolset, which enables designers to work in either very
high-speed integrated circuit hardware description language, an
industry standard developed by us, or in Verilog, another
industry standard.
Programmable
System-on-Chiptm
(PsoCtm).
Reconfigurable Mixed-Signal Arrays. PSoC products are
reconfigurable mixed-signal arrays with an on-board controller,
providing a low-cost, single-chip solution for a variety of
consumer, industrial and control applications, and taking the
place of multiple custom controllers. The PSoC family integrates
programmable blocks of analog and digital logic, a fast 8-bit
processor, 8 to 16 Kbytes of flash memory and 256 bytes of SRAM.
PSoC provides designers with a flexible architecture that can be
configured for a broad range of embedded applications and
dynamically reconfigured to extend the capabilities and value of
designers product.
Registered Buffers. As processor and signal speeds in
systems increase, buffers are required to move data to and from
memory more quickly. To meet the demands of high-capacity memory
modules in servers and workstations, our registered buffers
operate at clock frequencies up to 280 MHz, exceeding the
standards for chip-to-chip communication established by the
Joint Electronic Device Engineering Council organization.
6
RoboClock® Clock Buffers. Our RoboClock
family of high-performance programmable-skew clock buffers, the
flagship product of our Timing Technology Division, offers
features including zero propagation delay, 50/50 duty cycle,
multiply/divide functions and programmable skew. These features
allow customers to compensate for timing differences caused by
different circuit board trace lengths and device set-up and hold
times. The
RoboClock IItm
programmable clock skew buffer family operates at speeds up to
200 MHz, supports 18 outputs, and adds more multiply,
divide and programmable-skew options.
USB Controllers. USB is a four-wire connection between a
PC and peripherals, including keyboards, mice, printers,
joysticks, scanners and modems and among various non-PC systems.
The USB standard facilitates a plug-and-play
architecture that enables instant recognition and
interoperability when a USB-compatible peripheral is hooked into
a system. Cypress offers a full range of USB solutions,
including low-speed (1.5 Mbps), full-speed (12 Mbps)
and high-speed (480 Mbps) USB products. We also offer a
variety of USB hubs, transceivers, serial interface engines and
embedded-host products for a broad range of applications.
WirelessUSBtm
(WUSB). WirelessUSB is a wireless,
radio-system-on-a-chip solution developed by us and
second-sourced by Atmel, that enables designers of PC mice,
keyboards, video games and other systems to go cordless while
minimizing development time, cost, and power requirements, and
without sacrificing performance. Operating at 2.4 GHz,
WirelessUSB can connect multiple devices to a single receiver at
ranges of up to 50 meters apart or more with superior resistance
to interference. The technology is also an appealing solution
for designers of building automation and sensor network
applications.
Our SunPower subsidiary designs and manufactures
high-performance silicon solar cells based on an inter-digitated
backside contact design, leaving the entire front surface
uniformly dark and free of grid lines that normally block light
entry.
Solar Cells. SunPower recently began shipping the A-300
cell, an efficient, commercial low-cost silicon solar cell which
is based on a rear-contact design that maximizes the working
cell area, hides unsightly wires and makes automated production
easier.
Cypress, the Cypress logo, MoBL, QuadPort, HOTLink, Warp and
RoboClock are registered trademarks of Cypress Semiconductor
Corporation. HOTLink II, MicroPower, More Battery Life,
NoBL, No Bus Latency, MetroLink, POSIC, POSIC2GVC,
RoboClock II, WirelessUSB, CyClocks, CyberClocks and
Delta39K are trademarks of Cypress Semiconductor Corporation.
Programmable System-on-Chip and PSoC are trademarks of
Cypress MicroSystems, a subsidiary of Cypress.
Silicon Light Machines, Grating Light Valve and GLV are
trademarks of Silicon Light Machines, a subsidiary of
Cypress.
Quad Data
Ratetm
SRAM and
QDRtm
SRAM comprise a family of products developed by Cypress, IDT,
Micron Technology, NEC and Samsung Electronics.
Neuron and LONWORKS are registered trademarks of Echelon
Corporation in the US and other countries.
CellularRAM is a trademark of Micron Technology Inc. in the
United States and is a trademark of Infineon Technology outside
the United States.
TAXI is a trademark of Advanced Micro Devices Inc.
All other trademarks or registered trademarks are the
property of their respective owners.
7
Acquisitions
The markets in which we compete require a wide variety of
technologies, products and capabilities. We are committed to the
ongoing evaluation of strategic opportunities and, where
appropriate, to the acquisition of additional products,
technologies or businesses that are complementary to, or broaden
the markets for our products. During fiscal 2004, we completed
the following three acquisitions:
Prior to November 2004, SunPower was a majority-owned subsidiary
of Cypress. In November 2004, we acquired all of the minority
interests held in SunPower. SunPower designs and manufactures
silicon solar cells based on an inter-digitated all-back-contact
design. The acquisition of SunPower will enable us to expand and
diversify our product offerings and continue to build SunPower
into a provider of high-performance, cost-efficient solar cells
for a broad range of applications in the solar electric power
field.
We acquired 100% of the outstanding capital stock of FillFactory
in August 2004. FillFactory is a Belgium-based company
specializing in active pixel CMOS image sensor technology.
FillFactory offers a variety of high-performance custom and
standard products for some of the industrys most advanced
digital photography, high-speed imaging, machine vision and
automotive applications. Through this acquisition, our goals are
to increase sales into the mobile phone markets and to augment
our penetration of additional market segments, including digital
still cameras and automotive sensors.
We acquired 100% of the outstanding capital stock of Cascade in
January 2004. Cascade specializes in one-transistor
pseudo-static random access memory (1T PSRAM)
products for wireless applications. 1T PSRAM devices offer
higher density than conventional SRAMs at a lower cost, enabling
new features in next-generation wireless applications. Through
this acquisition, our goals are to enhance our product
development capabilities for the mobile phone markets and help
broaden our memory portfolio.
For a detailed discussion of these acquisitions, please refer to
Note 3 of Notes to Consolidated Financial Statements under
Item 8 of this Annual Report on Form 10-K.
|
|
|
SMaL Camera Technologies, Inc. (SCT) |
During the first quarter of fiscal 2005, we acquired 100% of the
outstanding capital stock of SCT. SCT specializes in digital
imaging solutions for a variety of business and consumer
applications, such as digital still cameras, automotive vision
systems, and mobile phone cameras. Through this acquisition, our
goals are to accelerate our entry into the high-volume CMOS
image sensor business and SCTs product line will
complement new mobile phone products introduced by FillFactory.
The result could position us with the broadest line of image
sensors currently available for the mobile phone markets.
Research and Development
Research and development expenses are primarily focused on the
development of new manufacturing process technologies and the
design of new products. We spent $261.6 million,
$251.4 million and $287.9 million on research and
development expenses in fiscal 2004, 2003 and 2002, respectively.
Our process technology research focuses primarily on the
continuous migration to smaller geometries. Our 90-nanometer
technology is now in production at our Minnesota facility. We
are currently developing our 65-nanometer technology in our
eight-inch research and development facility in San Jose,
California. In addition, we are developing derivatives of our
..13 micron and 90-nanometer technologies for use in new products
including image sensors.
8
We continued magnetic random access memories (MRAM)
process development for memory products and embedded
non-volatile applications in our San Jose, California
facility during fiscal 2004. MRAM technology offers customers an
improvement in read-write times, endurance and data retention
over currently available non-volatile memory products. In
January 2005, we announced our plan to sell our MRAM technology
and products.
We have both central and division-specific design groups that
focus on new product creation and improvement of design
methodologies. This group conducts ongoing efforts to reduce
design cycle time and increase first pass yield through
structured re-use of intellectual property (IP)
blocks from a controlled IP library, development of
computer-aided design tools and improved design business
processes. We currently have 39 design teams in place working on
new product designs. Design and related software development
work primarily occurs at design centers located in the United
States, Europe, India and Turkey.
During fiscal 2004, SunPower continued its research and
development efforts on the A-300 solar cell, transferred the
development to its Philippines manufacturing plant and brought
it to commercial production. SunPowers high efficiency
silicon solar cell technology is based on an inter-digitated
backside contact design that leaves the entire front surface
uniformly dark and free of grid lines that normally block light
entry. The A-300 is well-suited for applications where high
performance is desired, or where aesthetic value is important.
Manufacturing
During fiscal 2004, we manufactured approximately 71% of our
products at our two sub-micron wafer fabrication facilities in
Round Rock, Texas and Bloomington, Minnesota. These fabrication
facilities utilize our proprietary 90-nanometer and 0.13 through
0.8-micron CMOS, 0.25 and 0.8-micron BiCMOS, and 0.35-micron
Silicon Nitride Oxide Silicon (SONOS) processes.
Wafer foundries manufactured the balance of our products.
During fiscal 2004, we continued our transition to more advanced
process technologies in our facility in Bloomington, Minnesota
including our 90-nanometer and 0.13-micron CMOS process
technologies. This transition to processes with smaller line
widths results in more die per wafer thereby reducing die costs.
We conduct assembly and test operations, excluding SunPower
products, at our highly automated assembly and test facility in
the Philippines. This facility accounted for approximately 55%
of our total assembly output and approximately 83% of our total
test output in fiscal 2004. Various offshore subcontractors
performed the balance of the assembly and test operations.
Our Philippines facility manufactures primarily volume products
and packages where our ability to leverage manufacturing costs
is high. This facility has four fully integrated, automated
manufacturing lines enabling complete assembly and test
operations with minimal human intervention. These autolines have
shorter manufacturing cycle times than conventional
assembly/test operations, which enable us to respond more
rapidly to changes in demand.
Our SunPower subsidiary manufactures its solar cell products in
a separate facility in the Philippines. In fiscal 2004, SunPower
opened this manufacturing plant and shipped its first commercial
solar cells. SunPower currently has a single 25 MW
manufacturing line capable of producing eight million solar
cells a year. The overall building footprint is designed to
allow future capacity expansion to more than 100 MW.
Environmental Regulations
Federal, state and local regulations, in addition to those of
other countries in which we operate, impose various
environmental controls on the use and discharge of certain
hazardous substances used in semiconductor and solar cell
processing. Our facilities have been designed to comply with
these regulations through the implementation of environmental
management systems. We believe that our activities conform to
current environmental regulations. While to date we have not
experienced any material adverse impact on our business from
environmental regulations, we cannot provide assurance that
environmental laws will not be
9
amended so as to impose expensive obligations on us in the
future. In addition, violations of environmental laws by us or
impermissible discharges of hazardous substances could result in
the following actions:
|
|
|
|
|
additional capital improvements to comply with such regulations
or to restrict discharges; |
|
|
|
liabilities to our employees and/or third parties; and |
|
|
|
business interruptions as a consequence of permit suspensions or
revocations or as a consequence of the granting of injunctions
requested by governmental agencies or private parties. |
Marketing and Sales
We sell our Memory and Non-Memory products through several
channels: sales to direct original equipment manufacturers by
our sales force; sales by manufacturing representative firms;
sales through global domestically-based distributors; and sales
through international distributors and trading companies and
representative firms. SunPower products are sold to direct
original equipment manufacturers by our sales force. Our
marketing and sales efforts are organized around four regions:
North America, Europe, Japan and Asia/ Pacific. We also have a
global accounts group and a contract-manufacturing group which
are responsible for specific customers with worldwide
operations. We augment our sales effort with field application
engineers, specialists in our products, technologies and
services who work with customers to design our products into
their systems. Field application engineers also help us to
identify emerging markets and new products.
Sales to U.S. and non-U.S. based distributors accounted for 50%
of our total revenues in fiscal 2004, compared with 48% in
fiscal 2003 and 46% in fiscal 2002.
International revenues accounted for 66% of our total revenues
in fiscal 2004, compared with 63% in fiscal 2003 and 57% in
fiscal 2002.
Sales to Arrow Electronics, a distributor, accounted for 14.6%
of total revenues in fiscal 2004. No individual customer
accounted for greater than 10% of total revenues in fiscal 2003.
Sales to Motorola accounted for 10.2% of total revenues in
fiscal 2002. We typically warrant our products against defects
in materials and workmanship for a period of one year and that
product warranty is generally limited to a refund of the
original purchase price of the product or a replacement part.
For SunPower products, we provide warranties of 12 to
25 years for performance and 10 years for workmanship.
Backlog
Our sales typically rely upon standard purchase orders for
delivery of catalog products. Customer relationships are
generally not subject to long-term contracts. However, Cypress
has entered into long-term supply agreements with certain
customers. These long-term supply agreements generally do not
contain minimum purchase commitments. Products to be delivered
and the related delivery schedules are frequently revised to
reflect changes in customer needs. For these reasons, our
backlog at any particular date is not representative of actual
sales for any succeeding period and we believe that our backlog
is not a meaningful indicator of future revenues.
Competition
We face competition from domestic and foreign high-performance
integrated circuit manufacturers, many of which have advanced
technological capabilities and have increased their
participation in the markets in which we operate. We compete
with a large number of companies primarily in the
telecommunications, data communications, computation and
consumer markets. Competitors, including Altera, Applied Micro
Circuits, Atmel, Integrated Device Technology, Integrated
Circuit Systems, Microchip, Motorola, NEC, Opti, PMC-Sierra,
Samsung Electronics, STMicroelectronics, Standard Microsystems,
Texas Instruments, Vitesse Semiconductor and Xilinx, target
certain markets and compete directly with some of our products.
Competition is based on factors that can vary among products and
markets, including product design and quality, product
performance, price and service. In addition, our SunPower
subsidiary faces competition from
10
large solar power product manufacturers, including Sharp Solar,
Kyocera, Mitsubishi, BP Solar, Q-Cells, Shell Solar, RWE Schott,
and Sanyo.
The semiconductor and the solar cell industries are intensely
competitive. This intense competition results in a challenging
operating environment for most companies in the industries,
including Cypress. This environment is characterized by
potential erosion of product sale prices over the life of each
product, rapid technological change, limited product life cycles
and strong domestic and foreign competition in many markets. Our
ability to compete successfully in a rapidly evolving high
performance end of the technology spectrum depends on many
factors, including:
|
|
|
|
|
Our success in developing new products and manufacturing
technologies; |
|
|
|
The delivery, performance, quality and price of our products; |
|
|
|
The diversity of our product line; |
|
|
|
The cost effectiveness of our design, development, manufacturing
and marketing efforts; |
|
|
|
The pace at which customers incorporate our products into their
systems; and |
|
|
|
The number and nature of our competitors and general economic
conditions. |
We believe that we currently compete effectively in the above
areas to the extent they are within our control; however, given
the pace at which events change in the industry, our current
abilities are not a guarantee of future success. If we are not
able to compete successfully in this environment, our business,
operating results and financial condition will be harmed.
Patents, Licenses and Trademarks
We rely on a combination of patents, copyrights, trade secrets,
trademarks and proprietary information to maintain and enhance
our competitive position. We currently have over 1,200 patents
and approximately 700 additional patent applications on
file with the United States Patent and Trademark Office. We are
preparing to file more than 150 new patent applications in
fiscal 2005. In addition to factors such as innovation,
technological expertise and experienced personnel, we believe
that patents are increasingly important to remain competitive in
our industry. We have an active program to obtain patent and
other intellectual property protection.
We have entered into, and in the future may continue to enter
into, technology license agreements with third parties that give
those parties the right to use patents and other technology
developed by us. Some of these agreements also give us the right
to use patents and other technologies developed by such other
parties, some of which involve payment of royalties.
Historically, these arrangements have not been a material source
of revenues to us.
In addition, we vigorously defend our product and service marks.
For a list of our trademarks and registered trademarks, please
visit the Terms and Conditions section of our
website at www.cypress.com.
Employees
As of January 2, 2005, we had approximately 4,500
employees. None of our employees is represented by a collective
bargaining agreement, nor have we ever experienced organized
work stoppages.
Available Information
We make available our Annual Reports on Form 10-K,
Quarterly Reports on Form 10-Q, Current Reports on
Form 8-K, and amendments to those reports filed or
furnished pursuant to Section 13(a) or Section 15(d)
of the Securities Exchange Act of 1934 free of charge on our
website at www.cypress.com, as soon as reasonably practicable
after they are electronically filed or furnished to the
Securities and Exchange Commission. The contents of our website
are not incorporated into, or otherwise to be regarded as a part
of, this Annual Report on Form 10-K.
11
Risk Factors
|
|
|
We face periods of industry-wide semiconductor over-supply
that harm our results. |
The semiconductor industry has historically been characterized
by wide fluctuations in the demand for, and supply of,
semiconductors. These fluctuations have helped produce many
occasions when supply and demand for semiconductors have not
been in balance. During the second half of fiscal 2004, we
experienced a rapid softening of demand for our products that
may represent the beginning of such a period of over-supply. In
the past, these industry-wide fluctuations in demand, which have
resulted in under-utilization of our manufacturing capacity,
have seriously harmed our operating results. In some cases,
industry downturns with these characteristics have lasted more
than a year. Prior experience has shown that restructuring of
our operations, resulting in significant restructuring charges,
may become necessary if an industry downturn persists. In
response to the downturn that began in early 2001, we
restructured our manufacturing operations and administrative
areas in third quarter of fiscal 2001 and fourth quarter of
fiscal 2002 to increase cost efficiency with the goal of
maintaining an infrastructure that will enable us to grow when
sustainable economic recovery begins. In addition, in response
to the softening in market condition, management announced a
plan to restructure our organization in the first quarter of
fiscal 2005. When these cycles occur, they will likely seriously
harm our business, financial condition and results of operations
and we may need to take further action to respond to them.
|
|
|
Our financial results could be seriously harmed if the
markets in which we sell our products do not grow. |
Our continued success depends in large part on the continued
growth of various electronics industries that use our
semiconductors, including the following industries:
|
|
|
|
|
networking equipment; |
|
|
|
wireless telecommunications equipment; |
|
|
|
computers and computer-related peripherals; and |
|
|
|
consumer electronics, automotive electronics and industrial
controls. |
Many of our products are incorporated into data communications
and telecommunications products. Any reduction in the growth of,
or decline in the demand for, networking applications, mass
storage, telecommunications, cellular base stations, cellular
handsets and other personal communication devices that
incorporate our products could seriously harm our business,
financial condition and results of operations. In addition,
certain of our products, including USB microcontrollers and
high-frequency clocks, are incorporated into computer and
computer-related products, which have historically experienced,
and may in the future experience, significant fluctuations in
demand. We may also be seriously harmed by slower growth in the
other markets in which we sell our products.
|
|
|
Our business, financial condition and results of
operations will be seriously harmed if we fail to compete
successfully in our highly competitive industry and
markets. |
The semiconductor industry is intensely competitive. This
intense competition results in a difficult operating environment
that is marked by erosion of average selling prices over the
lives of each product, rapid technological change resulting in
limited product life cycles. In order to offset selling price
decreases, we attempt to decrease the manufacturing costs of our
products and to introduce new, higher priced products that
incorporate advanced features. If these efforts are not
successful or do not occur in a timely manner, or if our newly
introduced products do not gain market acceptance, our business,
financial condition and results of operations could be seriously
harmed. Furthermore, we expect our competitors to invest in new
manufacturing capacity and achieve significant manufacturing
yield improvements in the future. These developments could
dramatically increase the worldwide supply of competitive
products and result in further downward pressure on prices.
A primary cause of this highly competitive environment is the
strength of our competitors. The industry consists of major
domestic and international semiconductor companies, many of
which have substantially
12
greater financial, technical, marketing, distribution and other
resources than we do. We face competition from other domestic
and foreign high-performance integrated circuit manufacturers,
many of which have advanced technological capabilities and have
increased their participation in markets that are important to
us.
Our ability to compete successfully in the rapidly evolving high
performance portion of the semiconductor technology industry
depends on many factors, including:
|
|
|
|
|
our success in developing new products and manufacturing
technologies; |
|
|
|
the quality and price of our products; |
|
|
|
the diversity of our product line; |
|
|
|
the cost effectiveness of our design, development, manufacturing
and marketing efforts; |
|
|
|
our customer service; |
|
|
|
our customer satisfaction; |
|
|
|
the pace at which customers incorporate our products into their
systems; |
|
|
|
the number and nature of our competitors and general economic
conditions; and |
|
|
|
our access to and the availability of capital. |
Although we believe we currently compete effectively in the
above areas to the extent they are within our control, given the
pace of change in the industry, our current abilities are not a
guarantee of future success. If we are unable to compete
successfully in this environment, our business, financial
condition and results of operations will be seriously harmed.
In addition, our failure to further refine our technology and
develop and introduce new products could cause our products to
become obsolete, which could reduce our market share and cause
our sales to decline. The industry is rapidly evolving and
competitive. We will need to invest significant financial
resources in research and development to keep pace with
technological advances in the industry and to effectively
compete in the future. We believe that there is a variety of
competing technologies under development by other companies that
could result in lower manufacturing costs than those expected
for our products. Our development efforts may be rendered
obsolete by the technological advances of others, and other
technologies may prove more advantageous for the
commercialization of solar power products.
|
|
|
Our financial results could be adversely impacted if we
fail to develop, introduce and sell new products or fail to
develop and implement new technologies. |
Like many semiconductor companies, which frequently operate in a
highly competitive, quickly changing environment marked by rapid
obsolescence of existing products, our future success depends on
our ability to develop and introduce new products that customers
choose to buy. We introduce significant numbers of products each
year, which are important sources of revenue for us. If we fail
to introduce new product designs in a timely manner or are
unable to manufacture products according to the requirements of
these designs, or if our customers do not successfully introduce
new systems or products incorporating our products, or market
demand for our new products does not exist as anticipated, our
business, financial condition and results of operations could be
seriously harmed.
For us and many other semiconductor companies, introduction of
new products is a major manufacturing challenge. The new
products the market requires tend to be increasingly complex,
incorporating more functions and operating at faster speeds than
prior products. Increasing complexity generally requires smaller
features on a chip. This makes manufacturing new generations of
products substantially more difficult than prior generations.
Ultimately, whether we can successfully introduce these and
other new products depends on our ability to develop and
implement new ways of manufacturing semiconductors. If we are
unable to design, develop, manufacture, market and sell new
products successfully, our business, financial condition and
results of operations would be seriously harmed.
13
|
|
|
We must spend heavily on equipment to stay competitive and
will be adversely impacted if we are unable to secure financing
for such investments. |
In order to remain competitive, semiconductor manufacturers
generally make significant investments in capital equipment to
maintain or increase technology and design development and
manufacturing capacity and capability. This is particularly true
as companies develop technologies that would allow for
fabrication of products using smaller geometries in order to
increase performance of those products and also to reduce cost.
In addition, certain technology breakthroughs may only be
supported by 300mm equipment. This technology change would most
likely necessitate migrating our production into 300mm wafers
versus our existing 200mm capability, which could be
prohibitively expensive for us and could cause us to change our
business model. We anticipate significant continuing capital
expenditures in subsequent years. In the past, we have
reinvested a substantial portion of our cash flows from
operations in technology, design development and capacity
expansion and improvement programs.
If we are unable to decrease costs for our products at a rate at
least as fast as the rate of the decline in selling prices for
such products, we may not be able to generate enough cash flows
from operations to maintain or increase manufacturing capability
and capacity as necessary. In such a situation, we would need to
seek financing from external sources to satisfy our needs for
manufacturing equipment and, if cash flows from operations
declines too much, for operational cash needs as well. Such
financing, however, may not be available on terms that are
satisfactory to us or at all, in which case our business,
financial condition and results of operations would be seriously
harmed.
|
|
|
We must build semiconductors based on our forecasts of
demand, and if our forecasts are inaccurate, we may have large
amounts of unsold products or we may not be able to fill all
orders. |
We order materials and build semiconductors based primarily on
our internal forecasts and secondarily on existing orders, which
may be cancelled under many circumstances. Consequently, we
depend on our forecasts as a principal means to determine
inventory levels for our products and the amount of
manufacturing capacity that we need. Because our markets are
volatile and subject to rapid technological and price changes,
our forecasts may be wrong and we may make too many or too few
of certain products or have too much or too little manufacturing
capacity. Also, our customers frequently place orders requesting
product delivery almost immediately after the order is made,
which makes forecasting customer demand even more difficult,
particularly when supply is abundant. These factors also make it
difficult to forecast quarterly operating results. If we are
unable to predict accurately the appropriate amount of product
required to meet customer demand, our business, financial
condition and results of operations could be seriously harmed,
either through missed revenue opportunities because inventory
for sale was insufficient or through excessive inventory that
would require write-downs.
|
|
|
Our ability to meet our cash requirements depends on a
number of factors, many of which are beyond our control. |
Our ability to meet our cash requirements (including our debt
service obligations) is dependent upon our future performance,
which will be subject to financial, business and other factors
affecting our operations, many of which are beyond our control.
We cannot guarantee that our business will generate sufficient
cash flows from operations to fund our cash requirements. If we
were unable to meet our cash requirements from operations, we
would be required to fund these cash requirements by alternative
financing. The degree to which we may be leveraged could
materially and adversely affect our ability to obtain financing
for working capital, acquisitions or other purposes, could make
us more vulnerable to industry downturns and competitive
pressures or could limit our flexibility in planning for, or
reacting to, changes and opportunities in our industry, which
may place us at a competitive disadvantage. There can be no
assurance that we would be able to obtain alternative financing,
that any such financing would be on acceptable terms or that we
will be permitted to do so under the terms of our existing
financing arrangements. In the absence of such financing, our
ability to respond to changing business and economic conditions,
make future acquisitions, react to adverse operating results,
meet our debt service obligations, or fund required capital
expenditures may be adversely affected.
14
|
|
|
The complex nature of our manufacturing activities makes
us highly susceptible to manufacturing problems and these
problems can have a substantial negative impact on us when they
occur. |
Making semiconductors is a highly complex and precise process,
requiring production in a tightly controlled, clean environment.
Even very small impurities in our manufacturing materials,
difficulties in the wafer fabrication process, defects in the
masks used to print circuits on a wafer or other factors can
cause a substantial percentage of wafers to be rejected or
numerous chips on each wafer to be non-functional. We may
experience problems in achieving an acceptable success rate in
the manufacture of wafers and the likelihood of facing such
difficulties is higher in connection with the transition to new
manufacturing methods. The interruption of wafer fabrication or
the failure to achieve acceptable manufacturing yields at any of
our facilities would seriously harm our business, financial
condition and results of operations. We may also experience
manufacturing problems in our assembly and test operations and
in the introduction of new packaging materials.
|
|
|
Problems in the performance or availability of other
companies we hire to perform certain manufacturing tasks can
seriously harm our financial performance. |
A high percentage of our products are fabricated in our
manufacturing facilities located in Texas, Minnesota and the
Philippines. However, we also rely on independent contractors to
manufacture some of our products. If market demand for our
products exceeds our internal manufacturing capacity, we may
seek additional foundry manufacturing arrangements. A shortage
in foundry manufacturing capacity, which is more likely to occur
at times of increasing demand, could hinder our ability to meet
demand for our products and therefore adversely affect our
operating results.
A high percentage of our products are assembled, packaged and
tested at our manufacturing facility located in the Philippines.
We rely on independent subcontractors to assemble, package and
test the balance of our products. This reliance involves certain
risks, because we have less control over manufacturing quality
and delivery schedules, whether these companies have adequate
capacity to meet our needs and whether they discontinue or phase
out assembly processes we require. We cannot be certain that
these subcontractors will continue to assemble, package and test
products for us on acceptable economic and quality terms or at
all and it might be difficult for us to find alternatives if
they do not do so.
|
|
|
We may not be able to use all of our existing or future
manufacturing capacity, which can negatively impact our
business. |
We have in the past spent, and will continue to spend,
significant amounts of money to upgrade and increase our wafer
fabrication, assembly and test manufacturing capability and
capacity. If we do not need some of this capacity and capability
for a variety of reasons, such as inadequate demand or a
significant shift in the mix of product orders that makes our
existing capacity and capability inadequate or in excess of our
actual needs, our fixed costs per semiconductor produced will
increase, which will harm our business, financial condition and
results of operations. In addition, if the need for more
advanced products requires accelerated conversion to
technologies capable of manufacturing semiconductors having
smaller features or requires the use of larger wafers, we are
likely to face higher operating expenses and may need to
write-off capital equipment made obsolete by the technology
conversion, either of which could seriously harm our business,
financial condition and results of operations. For example, in
response to various downturns and changes in our business, we
have not been able to use all of our existing equipment and we
have restructured our operations. These restructurings have
resulted in material charges, which have negatively affected our
business.
|
|
|
Interruptions in the availability of raw materials can
seriously harm our financial performance. |
Our semiconductor manufacturing and solar cell operations
require raw materials that must meet exacting standards. We
generally have more than one source available for these
materials, but for certain of our products there are only a
limited number of suppliers capable of delivering the raw
materials that meet our standards. If we need to use other
companies as suppliers, they must go through a qualification
process, which can be difficult and lengthy. In addition, the
raw materials we need for certain of our products could become
15
scarcer as worldwide demand for semiconductors and solar cells
increases. Interruption of our sources of raw materials could
seriously harm our business, financial condition and results of
operations.
|
|
|
We depend on third parties to transport our
products. |
We rely on independent carriers and freight haulers to move our
products between manufacturing plants and our customers. Any
transport or delivery problems because of their errors or
because of unforeseen interruptions in their activities due to
factors such as strikes, political instability, terrorism,
natural disasters and accidents could seriously harm our
business, financial condition and results of operations and
ultimately impact our relationship with our customers.
|
|
|
If solar power technology is not suitable for widespread
adoption or sufficient demand for solar power products does not
develop or takes longer to develop than we anticipate, our sales
could be adversely affected. |
The market for solar power products manufactured by SunPower is
emerging and rapidly evolving. If solar power technology proves
unsuitable for widespread commercial deployment or if demand for
solar power products fails to develop sufficiently, our revenues
and profitability could be affected adversely. In addition,
demand for solar power products in the markets and geographic
regions we target may not develop or may develop more slowly
than we anticipate. Many factors will influence the adoption of
solar power technology and demand for solar power products,
including:
|
|
|
|
|
cost effectiveness of solar power technologies as compared with
conventional and non-solar alternative energy technologies; |
|
|
|
performance and reliability of solar power products as compared
with conventional and non-solar alternative energy products; |
|
|
|
success of alternative distributed generation technologies; |
|
|
|
fluctuations in economic and market conditions which impact the
viability of conventional and non-solar alternative energy
sources, such as increases or decreases in the prices of oil and
other fossil fuels; |
|
|
|
continued deregulation of the electric power industry and
broader energy industry; and |
|
|
|
availability of, and dependence on, subsidies and other
incentives provided by various governmental agencies. |
|
|
|
Any guidance that we may provide about our business or
expected future results may prove to differ from actual
results. |
From time to time we have shared our views in press releases or
SEC filings, on public conference calls and in other contexts
about current business conditions and our expectations as to
potential future results. Identifying correctly the key factors
affecting business conditions and predicting future events is
inherently an uncertain process. Our analyses and forecasts have
in the past and, given the complexity and volatility of our
business, will likely in the future, prove to be incorrect. We
offer no assurance that such predictions or analysis will
ultimately be accurate, and investors should treat any such
predictions or analyses with appropriate caution.
In addition, because we recognize revenues from sales to certain
distributors only when these distributors make a sale to
customers, we are highly dependent on the accuracy of their
resale estimates. The occurrence of inaccurate estimates also
contributes to the difficulty in predicting our quarterly
revenue and results of operations and we can fail to meet
expectations if we are not accurate in our estimates.
Any analysis or forecast that we make which ultimately proves to
be inaccurate may adversely affect our stock price.
16
|
|
|
We may be unable to protect our intellectual property
rights adequately and may face significant expenses as a result
of ongoing or future litigation. |
Protection of our intellectual property rights is essential to
keeping others from copying the innovations that are central to
our existing and future products. Consequently, we may become
involved in litigation to enforce our patents or other
intellectual property rights, to protect our trade secrets and
know-how, to determine the validity or scope of the proprietary
rights of others or to defend against claims of invalidity. We
are also from time to time involved in litigation relating to
alleged infringement by us of others patents or other
intellectual property rights.
Intellectual property litigation is frequently expensive to both
the winning party and the losing party and could take up
significant amounts of managements time and attention. In
addition, if we lose such a lawsuit, a court could find that our
intellectual property rights are invalid, enabling our
competitors to use our technology, or require us to pay
substantial damages and/or royalties or prohibit us from using
essential technologies. For these and other reasons, this type
of litigation could seriously harm our business, financial
condition and results of operations. Also, although in certain
instances we may seek to obtain a license under a third
partys intellectual property rights in order to bring an
end to certain claims or actions asserted against us, we may not
be able to obtain such a license on reasonable terms or at all.
For a variety of reasons, we have entered into technology
license agreements with third parties that give those parties
the right to use patents and other technology developed by us
and/or give us the right to use patents and other technology
developed by them. Historically, these arrangements have not
been a material source of revenue to the Company. We anticipate
that we will continue to enter into these kinds of licensing
arrangements in the future. It is possible, however, that
licenses we want will not be available to us on commercially
reasonable terms or at all. If we lose existing licenses to key
technology, or are unable to enter into new licenses that we
deem important, our business, financial condition and results of
operations could be seriously harmed.
It is critical to our success that we are able to prevent
competitors from copying our innovations. Therefore, we intend
to continue to seek intellectual property protection for our
technologies. The process of seeking patent protection can be
long and expensive and we cannot be certain that any currently
pending or future applications will actually result in issued
patents, or that, even if patents are issued, they will be of
sufficient scope or strength to provide meaningful protection or
any commercial advantage to us. Furthermore, others may develop
technologies that are similar or superior to our technology or
design around the patents we own.
We also rely on trade secret protection for our technology, in
part through confidentiality agreements with our employees,
consultants and third parties. However, these parties may breach
these agreements and we may not have adequate remedies for any
breach. Also, others may come to know about or determine our
trade secrets through a variety of methods. In addition, the
laws of certain countries in which we develop, manufacture or
sell our products may not protect our intellectual property
rights to the same extent as the laws of the United States.
|
|
|
We are subject to many different environmental regulations
and compliance with them may be costly. |
We are subject to many different governmental regulations
related to the storage, use, discharge and disposal of toxic,
volatile or otherwise hazardous chemicals used in our
manufacturing process. Compliance with these regulations can be
costly. In addition, over the last several years, the public has
paid a great deal of attention to the potentially negative
environmental impact of semiconductor manufacturing operations.
This attention and other factors may lead to changes in
environmental regulations that could force us to purchase
additional equipment or comply with other potentially costly
requirements. If we fail to control the use of, or to adequately
restrict the discharge of, hazardous substances under present or
future regulations, we could face substantial liability or
suspension of our manufacturing operations, which could
seriously harm our business, financial condition and results of
operations.
17
|
|
|
We face additional problems and uncertainties associated
with international operations that could seriously harm
us. |
International revenues accounted for 66%, 63% and 57% of our
total revenues in fiscal 2004, 2003 and 2002, respectively. At
the end of fiscal 2004, our long-lived assets were held
primarily in the United States with approximately 9% held in the
Philippines and 1% in other foreign countries. Our Philippine
fabrication, assembly and test operations, as well as our
international sales offices, face risks frequently associated
with foreign operations including:
|
|
|
|
|
currency exchange fluctuations; |
|
|
|
the devaluation of local currencies; |
|
|
|
political instability; |
|
|
|
changes in local economic conditions; |
|
|
|
import and export controls; and |
|
|
|
changes in tax laws, tariffs and freight rates. |
To the extent any such risks materialize, our business,
financial condition and results of operations could be seriously
harmed.
|
|
|
We may face automotive product liability claims that are
disproportionately higher than the value of the products
involved. |
Although all of our products sold in the automotive market are
covered by our standard warranty, we could incur costs not
covered by our warranties including, but not limited to, labor
and other costs of replacing defective parts, lost profits and
other damages. These costs could be disproportionately higher
than the revenue and profits we receive from the products
involved. If we are required to pay for damages resulting from
quality or performance issues of our automotive products, our
business, financial condition and results of operations could be
adversely affected.
|
|
|
We compete with others to attract and retain key
personnel, and any loss of, or inability to attract, such
personnel would harm us. |
To a greater degree than most non-technology companies, we
depend on the efforts and abilities of certain key members of
management and other technical personnel. Our future success
depends, in part, upon our ability to retain such personnel and
to attract and retain other highly qualified personnel,
particularly product and process engineers. We compete for these
individuals with other companies, academic institutions,
government entities and other organizations. Competition for
such personnel is intense and we may not be successful in hiring
or retaining new or existing qualified personnel.
If we lose existing qualified personnel or are unable to hire
new qualified personnel, as needed, our business, financial
condition and results of operations could be seriously harmed.
|
|
|
Our operations and financial results could be severely
harmed by certain natural disasters. |
Our headquarters, some manufacturing facilities and some of our
major vendors facilities are located near major earthquake
faults. We have not been able to maintain earthquake insurance
coverage at reasonable costs. Instead, we rely on self-insurance
and preventative/safety measures. If a major earthquake or other
natural disaster occurs, we may need to spend significant
amounts to repair or replace our facilities and equipment and we
could suffer damages that could seriously harm our business,
financial condition and results of operations.
18
|
|
|
Changes in stock option accounting rules may adversely
impact our reported operating results prepared in accordance
with generally accepted accounting principles, our stock price
and our competitiveness in the employee marketplace. |
Technology companies like ours have a history of using
broad-based employee stock option programs to hire, incentivize
and retain our workforce in a competitive marketplace.
Currently, Statement of Financial Accounting Standards
(SFAS) No. 123, Accounting for
Stock-Based Compensation, allows companies the choice of
either using a fair value method of accounting for options,
which would result in expense recognition for all options
granted, or using an intrinsic value method, as prescribed by
Accounting Principles Board Opinion (APB)
No. 25, Accounting for Stock Issued to
Employees, with a pro forma disclosure of the impact on
net income of using the fair value recognition method. We have
elected to apply APB 25 and accordingly, we generally do
not recognize any expense with respect to employee stock options
as long as such options are granted at exercise prices equal to
the fair value of our common stock on the date of grant.
In December 2004, the Financial Accounting Standards Board
issued SFAS No. 123(R), Share-Based
Payment, which replaces SFAS No. 123 and
supersedes APB Opinion No. 25. Under
SFAS No. 123(R), companies are required to measure the
compensation costs of share-based compensation arrangements
based on the grant-date fair value and recognize the costs in
the financial statements over the period during which employees
are required to provide services. Public companies will be
required to apply SFAS No. 123(R) as of the first
interim or annual reporting period beginning after June 15,
2005.
The implementation of SFAS No. 123(R) beginning in the
third quarter of fiscal 2005 will have a significant adverse
impact on our Consolidated Statement of Operations as we will be
required to expense the fair value of our stock options rather
than disclosing the impact on results of operations within our
footnotes in accordance with the disclosure provisions of
SFAS No. 123. This will result in lower reported
earnings per share, which could negatively impact our future
stock price. In addition, this could impact our ability to
utilize broad-based employee stock plans to reward employees and
could result in a competitive disadvantage to us in the employee
marketplace.
|
|
|
We may fail to integrate our business and technologies
with those of companies that we have recently acquired and that
we may acquire in the future. |
We completed three acquisitions during fiscal 2004, none in
fiscal 2003 and one in fiscal 2002. In addition, we have
completed one acquisition in February 2005, and we may pursue
additional acquisitions in the future. If we fail to integrate
these businesses successfully or properly, our quarterly and
annual results may be seriously harmed. Integrating these
businesses, people, products and services with our existing
business could be expensive, time-consuming and a strain on our
resources. Specific issues that we face with regard to prior and
future acquisitions include:
|
|
|
|
|
integrating acquired technology or products; |
|
|
|
integrating acquired products into our manufacturing facilities; |
|
|
|
assimilating and retaining the personnel of the acquired
companies; |
|
|
|
coordinating and integrating geographically dispersed operations; |
|
|
|
our ability to retain customers of the acquired company; |
|
|
|
the potential disruption of our ongoing business and distraction
of management; |
|
|
|
the maintenance of brand recognition of acquired businesses; |
|
|
|
the failure to successfully develop acquired in-process
technology, resulting in the impairment of amounts currently
capitalized as intangible assets; |
|
|
|
unanticipated expenses related to technology integration; |
|
|
|
the development and maintenance of uniform standards, corporate
cultures, controls, procedures and policies; |
19
|
|
|
|
|
the impairment of relationships with employees and customers as
a result of any integration of new management personnel; and |
|
|
|
the potential unknown liabilities associated with acquired
businesses. |
|
|
|
We may incur losses in connection with loans made under
our stock purchase assistance plan. |
We have outstanding loans, consisting of principal and
cumulative accrued interest, of $54.1 million as of
January 2, 2005, to employees and former employees under
the shareholder-approved 2001 Employee Stock Purchase Assistance
Plan. We made the loans to employees for the purpose of
purchasing our common stock. Each loan is evidenced by a full
recourse promissory note executed by the employee in favor of
Cypress and is secured by a pledge of the shares of our common
stock purchased with the proceeds of the loan. The primary
benefit to us from this program is increased employee retention.
In accordance with the plan, the Chief Executive Officer and the
Board of Directors do not participate in this program. To date,
there have been immaterial bad debt write-offs. As of
January 2, 2005, we had an allowance for uncollectible
accounts against these loans of $8.5 million. In
determining the allowance for uncollectible accounts, management
considered various factors, including a review of borrower
demographics (including geographic location and job grade), loan
quality and an independent fair value analysis of the loans and
the underlying collateral. While the loans are secured by the
shares of our stock purchased with the loan proceeds, the value
of this collateral would be adversely affected if our stock
price declined significantly.
Our results of operations may be adversely affected if a
significant amount of these loans were not repaid. Similarly, if
our stock price were to decrease, our employees bear greater
repayment risk and we would have increased risk to our results
of operations. However, we are willing to pursue every available
avenue, including those covered under the Uniform Commercial
Code, to recover these loans by pursuing employees
personal assets should the employees not repay these loans.
|
|
|
We maintain self-insurance for certain indemnities we have
made to our officers and directors. |
Our certificate of incorporation, by-laws and indemnification
agreements require us to indemnify our officers and directors
for certain liabilities that may arise in the course of their
service to us. We self-insure with respect to potential
indemnifiable claims. If we were required to pay a significant
amount on account of these liabilities for which we self-insure,
our business, financial condition and results of operations
could be seriously harmed.
Executive Officers of the Registrant
Certain information as of January 2, 2005 regarding each of
our executive officers is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive | |
|
|
|
|
|
|
Officer | |
Name |
|
Age | |
|
Position |
|
Since | |
|
|
| |
|
|
|
| |
T. J. Rodgers
|
|
|
57 |
|
|
President, Chief Executive Officer and Director |
|
|
1982 |
|
Antonio R. Alvarez
|
|
|
48 |
|
|
Executive Vice President, Memory Products Division |
|
|
1993 |
|
Emmanuel T. Hernandez
|
|
|
49 |
|
|
Executive Vice President, Finance and Administration and Chief
Financial Officer |
|
|
1993 |
|
Ralph H. Schmitt
|
|
|
44 |
|
|
Executive Vice President, Sales and Marketing |
|
|
2000 |
|
Christopher Seams
|
|
|
42 |
|
|
Executive Vice President, Worldwide Manufacturing &
Research and Development |
|
|
2002 |
|
Christopher Norris
|
|
|
42 |
|
|
Vice President, Data Communications Division |
|
|
2003 |
|
Cathal Phelan
|
|
|
41 |
|
|
Vice President, Personal Communications Division |
|
|
2003 |
|
Ilhan Refioglu
|
|
|
56 |
|
|
Vice President, Time Technology Division |
|
|
2003 |
|
20
T.J. Rodgers is a co-founder of Cypress and has been a
Director and its President and Chief Executive Officer since
1982. Mr. Rodgers serves as a director of SolarFlare
Communications Inc., Infinera, and ION America.
Antonio R. Alvarez joined Cypress in May 1987 as a senior
technical engineer. Mr. Alvarez was transferred to our
former subsidiary, Aspen Semiconductor Corporation, in April
1988 as the manager of BiCMOS technology. In October 1989,
Mr. Alvarez returned to the corporate office as Vice
President, Research and Development. In 1998, Mr. Alvarez
became responsible for the Memory Products Division.
Mr. Alvarez was named Executive Vice President in April
1997. Mr. Alvarez has been an executive officer since 1993.
Emmanuel T. Hernandez joined Cypress in June 1993 as
Corporate Controller. In January 1994, Mr. Hernandez was
promoted to Senior Vice President, Finance and Administration
and Chief Financial Officer. Prior to joining Cypress,
Mr. Hernandez held various financial positions with
National Semiconductor Corporation from 1976 through 1993.
Mr. Hernandez was named Executive Vice President in May
1997. Mr. Hernandez has been an executive officer since
1993. Mr. Hernandez serves as a board member of ON
Semiconductor and Integration Associates.
Ralph H. Schmitt joined Cypress in 1987 as our first
account manager. In 1991, Mr. Schmitt became responsible
for the Mid-Atlantic sales region. In 1993, Mr. Schmitt was
named Director of Worldwide Strategic Accounts. In 1995,
Mr. Schmitt left Cypress to found GroupTec LLC and was a
Partner and President of this firm. Mr. Schmitt rejoined
Cypress in January 1998 as sales director with responsibility
for transitioning the sales and marketing organization to align
with Cypresss shift to a market-based strategy. He was
appointed Vice President, Segment Sales and Marketing in
September 1999 and named Vice President, Sales and Marketing in
June 2000. Mr. Schmitt was named an Executive Vice
President in July 2000 and has served as an executive officer
since that time. He serves as a board member of Azanda Network
Devices and StarGen, Inc.
Christopher Seams joined Cypress in 1990 and held a
variety of positions in process and assembly technology research
and development and manufacturing operations. In 2001,
Mr. Seams became responsible for Research and Development.
Mr. Seams was appointed Executive Vice President, Worldwide
Manufacturing and Research and Development in November 2001 and
has served as an executive officer since 2002. Mr. Seams
serves as a board member of
1st
Silicon and Ronal Systems Corporation.
Christopher Norris joined Cypress in 1988 as a senior
design engineer. Mr. Norris has held a number of positions
within Cypress including design manager, director of new product
development, and general manager of the programmable logic
division. In 1996, Mr. Norris was promoted to Vice
President, Programmable Logic Division and in 2000 became
responsible for the Data Communications Division where he is
responsible for developing Cypresss products for the wide
area networking, storage networking, and wireless infrastructure
markets. Mr. Norris became an executive officer in 2003.
Cathal Phelan joined Cypress in 1991 as a senior design
engineer. Mr. Phelan has held a number of positions within
Cypress including design director, new products director, and
business unit manager. In 1999, Mr. Phelan was promoted to
Vice President, Personal Communications Division where he is
responsible for developing products for the USB, WirelessUSB and
High Speed Serial Interconnect markets. Mr. Phelan became
an executive officer in 2003.
Ilhan Refioglu joined Cypress in February 2001 as Vice
President of the Timing Technology Division. Prior to joining
Cypress, Mr. Refioglu was President and Chief Executive
Officer of International Microcircuits, Inc., which Cypress
acquired in 2001, for five years. Mr. Refioglu served as
Vice President at Exar Corp from 1984 to 1995, where he was
responsible for all business divisions of the company.
Mr. Refioglu became an executive officer in 2003.
Mr. Refioglu left Cypress in January 2005.
There are no family relationships between any of our directors
or executive officers.
21
Our executive offices are located in an owned building in
San Jose, California. The table below sets out our major
owned and leased properties as of January 2, 2005:
|
|
|
|
|
|
|
|
|
|
|
Location |
|
Square Footage | |
|
Primary Use |
|
|
|
|
| |
|
|
Owned:
|
|
|
|
|
|
|
|
|
|
|
San Jose, California |
|
|
111,000 |
|
|
Administrative offices |
|
|
Bloomington, Minnesota |
|
|
170,000 |
|
|
Manufacturing |
|
|
Round Rock, Texas |
|
|
100,000 |
|
|
Manufacturing |
|
|
Lynnwood, Washington |
|
|
69,000 |
|
|
Administrative offices, manufacturing |
|
|
Cavite, The Philippines |
|
|
182,000 |
|
|
Manufacturing |
|
|
Laguna, The Philippines |
|
|
221,000 |
|
|
Administrative offices, research and development, manufacturing |
Leased
|
|
: |
|
|
|
|
|
|
|
|
San Jose, California(1) |
|
|
256,000 |
|
|
Administrative offices, research and development, manufacturing |
|
|
Sunnyvale, California |
|
|
40,000 |
|
|
Administrative offices, research and development |
|
|
Bloomington, Minnesota(1) |
|
|
100,000 |
|
|
Manufacturing |
|
|
Mechelen, Belgium |
|
|
16,000 |
|
|
Administrative offices, research and development |
|
|
Manila, The Philippines |
|
|
12,000 |
|
|
Administrative offices |
|
|
(1) |
Synthetic leases (see Note 21 of Notes to Consolidated
Financial Statements under Item 8 of this Annual Report on
Form 10-K for a detailed discussion of the synthetic lease
transactions). |
We lease additional space for sales and design centers in the
United States, Belgium, Canada, China, Finland, France, Germany,
India, Ireland, Italy, Japan, Korea, Singapore, Sweden, Taiwan,
Turkey and the United Kingdom.
As of the end of fiscal 2004, we believe that our current
properties are suitable for our foreseeable needs.
|
|
ITEM 3. |
LEGAL PROCEEDINGS |
In January 1998, an attorney representing the estate of
Mr. Jerome Lemelson contacted us and charged that we
infringed certain patents owned by Mr. Lemelson and/or a
partnership controlled by Mr. Lemelsons estate. On
February 26, 1999, the Lemelson Partnership sued us and 87
other companies in the United States District Court for the
District of Arizona for infringement of 16 patents. In May 2000,
the Court stayed litigation on 14 of the 16 patents in view of
concurrent litigation in the United States District Court,
District of Nevada, on the same 14 patents. On January 23,
2004, the Nevada Court held in favor of plaintiffs that all
asserted claims of the 14 patents are unenforceable, invalid,
and not infringed. The Nevada ruling is now being appealed, and
the 14 patents remain stayed as to Cypress during the appeal. In
October 2001, the Lemelson Partnership amended its Arizona
complaint to add allegations that two more patents were
infringed. Therefore, there are currently four patents that are
not stayed in this litigation. The case is in the claim
construction (i.e., patent claim interpretation) phase on
the four non-stayed patents. The claim construction hearing
concluded on December 10, 2004, and we are awaiting the
Judges order. We have reviewed and investigated the
allegations in both Lemelsons original and amended
complaints. We believe that we have meritorious defenses to
these allegations and will vigorously defend ourselves in this
matter. However, because of the nature and inherent
uncertainties of litigation, should the outcome of this action
be unfavorable, our business, financial condition, results of
operations or cash flows could be materially and adversely
affected.
22
We are currently a party to various other legal proceedings,
claims, disputes and litigation arising in the ordinary course
of business, including those noted above. We currently believe
that the ultimate outcome of these proceedings, individually and
in the aggregate, will not have a material adverse effect on our
financial position, results of operation or cash flows. However,
because of the nature and inherent uncertainties of litigation,
should the outcome of these actions be unfavorable, our
business, financial condition, results of operations or cash
flows could be materially and adversely affected.
|
|
ITEM 4. |
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS |
No matters were submitted to a vote of the security holders
during the fiscal quarter ended January 2, 2005.
PART II
|
|
ITEM 5. |
MARKET FOR REGISTRANTS COMMON EQUITY, RELATED
STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY
SECURITIES. |
Our common stock is listed on the New York Stock Exchange under
the trading symbol CY. The following table sets
forth, for the periods indicated, the low and high sales prices
per share for the common stock.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Low | |
|
High | |
|
Close | |
|
|
| |
|
| |
|
| |
Fiscal year ended January 2, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First quarter
|
|
$ |
19.25 |
|
|
$ |
24.08 |
|
|
$ |
20.41 |
|
|
Second quarter
|
|
|
13.17 |
|
|
|
21.56 |
|
|
|
14.00 |
|
|
Third quarter
|
|
|
8.58 |
|
|
|
14.24 |
|
|
|
9.12 |
|
|
Fourth quarter
|
|
|
8.45 |
|
|
|
11.83 |
|
|
|
11.73 |
|
Fiscal year ended December 28, 2003:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First quarter
|
|
$ |
4.91 |
|
|
$ |
7.75 |
|
|
$ |
7.34 |
|
|
Second quarter
|
|
|
6.80 |
|
|
|
13.79 |
|
|
|
12.00 |
|
|
Third quarter
|
|
|
11.49 |
|
|
|
19.68 |
|
|
|
17.89 |
|
|
Fourth quarter
|
|
|
17.36 |
|
|
|
23.70 |
|
|
|
20.95 |
|
As of March 1, 2005, there were 69,991 holders of record of
our common stock. We have not paid cash dividends and have no
present plans to do so.
The following table provides information with respect to our
repurchases of the common stock during the fourth quarter of
fiscal 2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Number of | |
|
Total Dollar | |
|
|
|
|
|
|
Shares Purchased | |
|
Value of Shares | |
|
|
Total Number | |
|
|
|
as Part of Publicly | |
|
that May Yet Be | |
|
|
of Shares | |
|
Average Price |
|
Announced | |
|
Purchased under | |
Period |
|
Purchased | |
|
Paid per Share |
|
Programs | |
|
the Programs(1) | |
|
|
| |
|
|
|
| |
|
| |
September 27, 2004 - October 24, 2004
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
15,000,000 |
|
October 25, 2004 - November 21, 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000,000 |
|
November 22, 2004 - January 2, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000,000 |
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000,000 |
|
|
|
(1) |
On October 14, 2002, our board of directors authorized a
discretionary repurchase program to acquire shares of our common
stock in the open market at any time. The total amount that can
be repurchased |
23
|
|
|
under this program is limited to $15.0 million. This
program does not have an expiration date. This was the only
active stock repurchase program during the fourth quarter of
fiscal 2004. |
During the fourth quarter of fiscal 2004, we issued
approximately 319,000 unregistered shares of our common stock in
connection with the acquisition of Cascade Semiconductor
Corporation. The issuances were exempt from registration under
the Securities Act of 1933, as amended, by virtue of
Section 3(a)(10) thereof. No underwriters were used in
connection with the transaction.
|
|
ITEM 6. |
SELECTED CONSOLIDATED FINANCIAL DATA |
The following selected consolidated financial data is not
necessarily indicative of results of future operations, and
should be read in conjunction with Managements Discussion
and Analysis of Financial Condition and Results of Operations
under Item 7, and the Consolidated Financial Statements and
Notes to the Consolidated Financial Statements under Item 8
of this Annual Report on Form 10-K:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended(1)(2) | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
December 30, | |
|
December 31, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands, except-per share amounts) | |
Statement of operations data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$ |
948,438 |
|
|
$ |
836,756 |
|
|
$ |
774,746 |
|
|
$ |
819,192 |
|
|
$ |
1,287,787 |
|
Restructuring, acquisition and other costs
|
|
$ |
54,334 |
|
|
$ |
27,530 |
|
|
$ |
123,127 |
|
|
$ |
293,366 |
|
|
$ |
55,729 |
|
Operating income (loss)
|
|
$ |
(1,382 |
) |
|
$ |
(8,304 |
) |
|
$ |
(231,344 |
) |
|
$ |
(459,618 |
) |
|
$ |
328,839 |
|
Income (loss) before income taxes
|
|
$ |
(1,877 |
) |
|
$ |
(2,509 |
) |
|
$ |
(246,260 |
) |
|
$ |
(437,196 |
) |
|
$ |
370,170 |
|
Net income (loss)
|
|
$ |
24,698 |
|
|
$ |
(5,331 |
) |
|
$ |
(249,098 |
) |
|
$ |
(407,412 |
) |
|
$ |
277,308 |
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
0.20 |
|
|
$ |
(0.04 |
) |
|
$ |
(2.02 |
) |
|
$ |
(3.28 |
) |
|
$ |
2.29 |
|
|
Diluted
|
|
$ |
0.17 |
|
|
$ |
(0.04 |
) |
|
$ |
(2.02 |
) |
|
$ |
(3.28 |
) |
|
$ |
2.03 |
|
Weighted-average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
124,580 |
|
|
|
121,509 |
|
|
|
123,112 |
|
|
|
124,135 |
|
|
|
121,126 |
|
|
Diluted
|
|
|
134,592 |
|
|
|
121,509 |
|
|
|
123,112 |
|
|
|
124,135 |
|
|
|
144,228 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of(1)(2) | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
December 30, | |
|
December 31, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Balance sheet data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and short-term Investments(3)
|
|
$ |
244,897 |
|
|
$ |
198,617 |
|
|
$ |
127,937 |
|
|
$ |
205,422 |
|
|
$ |
884,601 |
|
Working capital
|
|
$ |
330,270 |
|
|
$ |
307,716 |
|
|
$ |
314,187 |
|
|
$ |
372,333 |
|
|
$ |
983,359 |
|
Total assets
|
|
$ |
1,572,994 |
|
|
$ |
1,575,685 |
|
|
$ |
1,552,912 |
|
|
$ |
1,886,436 |
|
|
$ |
2,361,754 |
|
Long-term debt (excluding current portion)
|
|
$ |
606,724 |
|
|
$ |
615,724 |
|
|
$ |
468,900 |
|
|
$ |
524,058 |
|
|
$ |
631,055 |
|
Stockholders equity
|
|
$ |
660,358 |
|
|
$ |
569,188 |
|
|
$ |
673,623 |
|
|
$ |
868,428 |
|
|
$ |
1,327,668 |
|
|
|
(1) |
We operate on a 52- or 53-week fiscal year ending on the Sunday
closest to December 31. Fiscal 2003, 2002, 2001 and 2000
were 52-week fiscal years. Fiscal 2004 was a 53-week fiscal year. |
|
(2) |
The tables present financial information including three
acquisitions completed in fiscal 2004 and one in fiscal 2002.
See Note 3 of Notes to Consolidated Financial Statements
under Item 8 of this Annual Report on Form 10-K for
the discussions of the acquisitions, which may affect the
comparability of the data. |
24
|
|
(3) |
We had available-for-sale investments classified as long-term
investments in fiscal 2003 and prior years. As of the end of
fiscal 2004, we classified all available-for-sale investments as
cash equivalents or short-term investments as they are now
intended to be used in current operations. |
|
|
ITEM 7. |
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS |
The discussion in this Annual Report on Form 10-K contains
forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 that
involve risks and uncertainties, including, but not limited to,
statements as to our future financial results, operating
performance and business plans, our prospects and the prospects
of our subsidiaries and the semiconductor industry generally,
and statements as to the utilization of our Philippines factory,
pressure on and trends for average selling prices, entering into
licensing arrangements with third parties, capital expenditures,
future acquisitions, the impact of SunPower Corporation
(SunPower) and our other subsidiaries on the
Companys future financial results, the general economy and
its impact to the market segments we serve, the cycles of the
semiconductor industry, expected inventory corrections and
levels of demand in 2005, the rate at which new products are
introduced, our outlook for fiscal 2005, our expected revenue
for fiscal 2005, our expected improvements in gross margin in
fiscal 2005, our expectations to generate positive cash flow
from operations in fiscal 2005, successful integration and
achieving the objectives of the acquired businesses, adequacy of
cash and working capital, our research and development
investments and project timelines, and other liquidity risks. We
use words such as anticipates, believes,
expects, future, intends and
similar expressions to identify forward-looking statements. Our
actual results could differ materially from those projected in
the forward-looking statements for any reason, including the
factors set forth in the Risk Factors and elsewhere
in this Annual Report on Form 10-K. All forward-looking
statements included in this Annual Report on Form 10-K are
based upon information available to Cypress as of the date of
this Annual Report, which may change. In addition, past
financial and/or operating performance is not necessarily a
reliable indicator of future performance and you should not use
our historical performance to anticipate results or trends for
future period. In evaluating these forward-looking statements,
you should specifically consider the risks described below under
Risk Factors which follows our discussion on
critical accounting policies and in other parts of this Annual
Report on Form 10-K. Except as required by law, we assume
no obligation to update any such forward-looking statements to
reflect events or circumstances that arise after the date of
this Annual Report on Form 10-K.
Executive Summary
We design, develop, manufacture and market a broad line of
high-performance digital and mixed-signal integrated circuits
for a broad range of markets including networking, wireless
infrastructure and handsets, computation, consumer, automotive,
and industrial. In addition, we design and manufacture
high-performance silicon solar cells. We have four product
divisions and four subsidiaries, organized into three reportable
business segments: Memory, Non-Memory and SunPower. In addition,
in order to enhance our focus on the communications market and
our end customers, we report information by the following market
segments: Wide Area Networks and Storage Area Networks
(WAN/ SAN); Wireless Infrastructure and Wireless
Terminal (WIN/ WIT); Computation and Consumer; and
our Cypress Subsidiaries. (See Note 22 of Notes to
Consolidated Financial Statements for further information).
Our revenues for fiscal 2004 were $948.4 million, an
increase of $111.7 million or 13.3% compared to revenues
for fiscal 2003, and an increase of $173.7 million or 22.4%
compared to revenues for fiscal 2002. The revenue increase in
fiscal 2004 was attributable primarily to an increase in unit
shipments. Average Selling Prices (ASPs) remained
stable in the first half of fiscal 2004, increased 10.3% in the
third quarter of fiscal 2004 before decreasing 20.5% in the
fourth quarter of fiscal 2004. In addition, our revenues
improved across all of our market segments except for
Computation and Consumer, which remained flat to the prior year.
In general, as we look ahead to fiscal 2005, we believe that
inventory corrections and soft demand in certain segments will
continue in the first quarter of the year, resulting in revenues
that are similar to the fourth quarter of fiscal 2004. We
believe revenues will show sequential improvement during fiscal
2005, with
25
significant contributions from SunPower and acquisitions we made
in fiscal 2004, resulting in a slight increase in fiscal 2005
compared to fiscal 2004. During fiscal 2004, we completed the
acquisitions of FillFactory NV (FillFactory) and
Cascade Semiconductor Corporation (Cascade), which
contributed $59.6 million to our total revenues. SunPower
contributed $10.7 million to our total revenues in fiscal
2004. Our gross margins improved to 48.1% in fiscal 2004
compared to 47.9% in fiscal 2003 as changes in product mix and
increased manufacturing efficiencies more than offset the small
overall ASP decline. However, we experienced a drop in gross
margin in the fourth quarter of fiscal 2004 to 37.6% due to
under-utilization of our manufacturing facilities and decreasing
ASPs. We expect gross margin in the first quarter of fiscal 2005
to remain relatively flat to the fourth quarter of fiscal 2004
and then increase sequentially during the remainder of fiscal
2005 such that the overall fiscal 2005 gross margin percentage
will be between 38% to 42%.
One of the growth drivers we expect in fiscal 2005 is our entry
into the solar cell market through SunPower. SunPowers
business model is different from the other businesses, such that
we expect the gross margins on these products to be lower than
our historical average gross margin, thus effectively diluting
our aggregate gross margin percentage. However, the SunPower
business model targets lower operating expenses, such that their
operating margin contribution should be in line with the rest of
our businesses and not detrimental to our overall financial
performance.
Research and development and selling, general and administrative
expenses for fiscal 2004 were $403.4 million, which were
$21.6 million or 5.4% higher than fiscal 2003 primarily as
a result of higher sales commissions driven by higher sales, a
modest company-wide salary increase in April 2004, increase in
professional fees and an increase in research and development
supply and facilities costs driven by the ramp up of our
SunPower manufacturing facility.
From a liquidity and capital resources standpoint, management
has emphasized generating a positive cash flow from operations.
Our long-term strategy is to maintain a minimum amount of cash
and cash equivalents for operational purposes and to invest the
remaining amount of our cash in interest bearing and highly
liquid cash equivalents and marketable debt securities. As of
the end of fiscal 2004, total cash, cash equivalents, short-term
investments and restricted cash were $307.6 million, a
$72.2 million reduction from the end of fiscal 2003. This
decrease was primarily due to cash used for acquisitions,
capital investment and retirement of debt, partially offset by a
positive cash flow from operations.
Results of Operations
Business Segment Net Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Memory
|
|
$ |
400,818 |
|
|
$ |
334,779 |
|
|
$ |
303,388 |
|
Non-Memory
|
|
|
536,915 |
|
|
|
497,305 |
|
|
|
471,358 |
|
SunPower
|
|
|
10,705 |
|
|
|
4,672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net revenues
|
|
$ |
948,438 |
|
|
$ |
836,756 |
|
|
$ |
774,746 |
|
|
|
|
|
|
|
|
|
|
|
Memory:
The semiconductor industry utilizes several types of metrics to
analyze price performance and industry trends. We use two
measurements of pricing for memory products: ASP per unit and
ASP per megabit (Mbit).
These metrics indicate the price and technology trends that
impact memory revenues. As the memory capacity (Mbit density) of
units sold increases, the ASP of each unit tends to increase
(i.e., a 16 Mbit part will sell at a higher price than an 8 Mbit
part). However, unit pricing does not scale linearly by Mbit,
which usually means increasing the unit sales of higher priced,
higher density units typically yields a lower ASP per
26
Mbit. Therefore, if we sell an increasing number of higher
priced, higher density units, ASP per unit will most likely
increase while the ASP per Mbit will most likely decrease.
We use the metrics ASP per unit and ASP per Mbit in conjunction
with one another as indicators of market trends and our
operational performance.
The metric ASP per unit utilizes total product revenues and
total units sold as the basis for the calculation. An increasing
ASP per unit metric here indicates that we are selling units at
a higher average price, which usually indicates that either more
units are being sold at higher densities or that average prices
are going up, both positive trends for us.
The metric ASP per Mbit utilizes product revenues and the
aggregate volume of megabits sold. ASP per Mbit shows the
average selling price for 1 million bits (1 Mbit) of memory
capacity. ASP per Mbit is calculated by dividing the ASP per
unit by the average size of the memory products sold. Since unit
pricing does not scale linearly by Mbit, increasing the unit
sales of higher priced, higher density units typically yields a
lower ASP per Mbit, but is a positive indicator of our
performance as it implies sales of higher density units which
typically indicates sales into newer and higher value-added
technology applications, both positive trends for us.
In reviewing these two metrics (ASP and ASP per Mbit) in
combination with one another, we would expect the two metrics to
move in opposition to one another. Increasing ASP per unit and
decreasing ASP per Mbit at the same relative rate should be
construed as a favorable situation. Conversely, decreasing ASP
per unit and increasing ASP per Mbit could indicate an
unfavorable market trend for us. We routinely receive questions
regarding these metrics from industry analysts familiar with the
dynamics of these metrics in public forums.
Revenues for the sales of Memory products for fiscal 2004
increased $66.0 million or 19.7% compared with revenues for
fiscal 2003. The increase was primarily due to a 71.5% increase
in Mbits sold, offset partially by a 30.0% decrease in ASP per
Mbit. This was indicative of selling more units at higher
density, given that price per Mbit does not scale linearly as
density increases. This revenue increase was also indicative of
Mbits per unit sales increasing faster than the decrease in ASP
per Mbit.
Revenues for the sales of Memory products for fiscal 2003
increased $31.4 million or 10.3% compared with revenues for
fiscal 2002. A 45.8% increase in Mbits sold was partially offset
by a 33.3% decrease in ASP per Mbit. This revenue increase was
also indicative of Mbits per unit sales increasing faster than
the decrease in ASP per Mbit.
Non-Memory:
Revenues in fiscal 2004 from the sales of Non-Memory products
increased $39.6 million or 8.0% compared with revenues for
fiscal 2003. The increase in Non-Memory product revenues was
primarily driven by $26.1 million revenue growth from our
network search engine products and $24.1 million revenue
growth from our universal serial bus family of products. A
$12.9 million decrease in our timing product revenues in
fiscal 2004 partially offset the revenue increases. In fiscal
2004, overall ASPs remained flat compared to fiscal 2003 for
Non-Memory products.
Revenues in fiscal 2003 from the sales of Non-Memory products
increased $25.9 million or 5.5% compared with revenues for
fiscal 2002. The increase in Non-Memory product revenues, as
compared to fiscal 2002, was driven by revenue growth from our
network search engines, programmable logic devices, physical
layer devices, multi-ports devices and universal serial bus
family of products. Our subsidiaries Silicon Light Machine
(SLM) and Cypress MicroSystems (CMS)
also contributed to the revenue growth. In fiscal 2003, ASPs
decreased 6.0% as compared to fiscal 2002 for Non-Memory
products.
27
SunPower:
Revenues in fiscal 2004 from the sales of SunPower products
increased $6.0 million or 129.1% compared with revenues for
fiscal 2003. The increase was primarily due to the initial sales
of solar cell A-300 products in the second half of fiscal 2004.
Market Segment Net Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
WAN/ SAN
|
|
$ |
304,412 |
|
|
$ |
268,978 |
|
|
$ |
253,205 |
|
WIN/ WIT
|
|
|
313,209 |
|
|
|
249,150 |
|
|
|
246,800 |
|
Computation and Consumer
|
|
|
283,124 |
|
|
|
284,572 |
|
|
|
254,615 |
|
Cypress Subsidiaries
|
|
|
47,693 |
|
|
|
34,056 |
|
|
|
20,126 |
|
|
|
|
|
|
|
|
|
|
|
|
Total net revenues
|
|
$ |
948,438 |
|
|
$ |
836,756 |
|
|
$ |
774,746 |
|
|
|
|
|
|
|
|
|
|
|
WAN/SAN:
Revenues from the sale of WAN/ SAN products for fiscal 2004
increased $35.4 million or 13.2% compared to fiscal 2003.
Our growing network search engine business contributed
approximately $26.1 million of this increase. Other
products contributing to the segment growth included our
Micropower synchronous static random access memory
(SRAM) and high-speed synchronous SRAM products.
Revenues from the sale of WAN/ SAN products for fiscal 2003
increased $15.8 million or 6.2% compared to fiscal 2002.
Improvement in the overall enterprise networking market has been
followed by increases in broader-based networking sales. WAN/
SAN product revenues increased as compared to fiscal 2002 due to
increased demand for our network search engines. This segment
also experienced growth due to our acquisition of Micron
Technologys high-performance communications orientated
SRAM product portfolio inventory in the second quarter of fiscal
2003.
WIN/WIT:
Revenues from the sale of WIN/ WIT products for fiscal 2004
increased $64.1 million or 25.7% compared to fiscal 2003.
Approximately $28.2 million of this growth was contributed
by our Micropower SRAMs, which was driven by the adoption of our
one-transistor pseudo SRAM products. This segment has also
benefited from a slight increase in our timing products.
Revenues from the sale of WIN/ WIT products for fiscal 2003
increased $2.4 million or 1.0% compared to fiscal 2002. The
revenue increase was attributable in part to strength in the
handset business and a continued shift to a higher-density SRAM
product mix. Revenue in this segment is dominated by our MoBL
and Micropower SRAMs product families.
Computation and Consumer:
Revenues from the sale of Computation and Consumer products for
fiscal 2004 decreased $1.4 million or 0.5% compared to
fiscal 2003. The decrease in revenue was primarily due to a
reduction in sales of our frequency timing products compared to
2003. The fiscal 2004 revenue decrease was partially offset by
the inclusion of image sensor revenue from our acquisition of
FillFactory in the third quarter of fiscal 2004.
Revenues from the sale of Computation and Consumer products for
fiscal 2003 increased $30.0 million or 11.8% compared to
fiscal 2002. In the computation sector, PC-related demand grew
due to the increase in the adoption rate of USB 2.0 technology,
a serial plug-and-play connection standard for PCs and
peripherals. Growth in the consumer sector was driven by sales
of our programmable clocks.
28
Cypress Subsidiaries:
Revenues from the Cypress Subsidiaries for fiscal 2004 increased
$13.6 million or 40.0% compared to fiscal 2003. This
increase was driven primarily by the continued production ramp
of PSoC products from CMS, and the late 2004 market introduction
of SunPower solar cells.
Revenues from the Cypress Subsidiaries for fiscal 2003 increased
$13.9 million or 69.2% compared to fiscal 2002. The growth
was driven by increased PSoC product revenue from CMS, and
increased non-recurring engineering revenue, product revenue,
and license revenue from SLM. In addition, revenue increased as
a result of the consolidation of SunPower, effective at the
beginning of fiscal 2003.
Cost of Revenues/ Gross Margin
Cost of revenues was $492.1 million, $435.7 million
and $443.4 million in fiscal 2004, fiscal 2003 and fiscal
2002, respectively.
Although our overall ASPs declined 1.3% during fiscal 2004, we
were generally able to offset this effect and increase our gross
margin percentage by 0.2% as compared with fiscal 2003. This
increase in gross margin was attributable to the continued
reduction of manufacturing cycle times, reduced die size,
improved labor productivity, more efficient use of capital
resources, improved defect densities, improved yields and
ultimately lower manufacturing cost, partially offset by the
decline in the favorable impact of inventory adjustments, as
discussed below.
Although our overall ASPs declined 2.8% during fiscal 2003, we
were generally able to offset this effect and increase our gross
margin percentage by 5.1% as compared with fiscal 2002. This
increase in gross margin is attributable to the continued
reduction of manufacturing cycle times, reduced die size,
improved labor productivity, more efficient use of capital
resources, improved defect densities, improved yields and
ultimately lower manufacturing costs.
Inventory Reserves:
Our gross margin has been impacted by the timing of inventory
adjustments related to inventory write-downs and the subsequent
sale of these written-down products caused by the general state
of our business including our inventory profile. The table below
sets forth the gross margin and the impact of inventory
adjustments on gross margin.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Gross margin
|
|
$ |
456.4 |
|
|
$ |
401.0 |
|
|
$ |
331.4 |
|
Impact of inventory adjustments: benefit
|
|
$ |
7.0 |
|
|
$ |
17.7 |
|
|
$ |
20.1 |
|
The amount of reserved inventory on hand was $29.4 million,
$64.1 million and $100.3 million at the end of fiscal
2004, 2003 and 2002, respectively.
We record inventory write-downs as a result of our normal
analysis of demand forecasts and the aging profile of the
inventory. We record charges to cost of goods sold in accordance
with generally accepted accounting principles to write down the
carrying values of our inventories when their estimated market
values are less than their carrying values. The inventory
write-downs reflect estimates of future market pricing relative
to the costs of production and inventory carrying values and
projected timing of product sales. The semiconductor industry
has historically been highly cyclical and volatile. In recent
years, a combination of global economic conditions and a slowing
growth rate in the demand for semiconductors, coupled with
worldwide increases in semiconductor production capacity, caused
significant declines in demand and average selling prices for
semiconductor components. These trends could continue in the
future and could cause us to re-evaluate our inventory costs,
which could result in additional inventory reserves.
In reviewing our inventory reserves, we follow methodologies
that are consistent with those used by other companies within
the semiconductor industry. At the time of an inventory
write-down, we make a determination, based on demand forecasts
and the aging profile of the inventory, that there is a very high
29
probability that the inventory that was reserved would not be
sold. Once the inventory is written down, a new cost basis is
effectively established through the use of a contra asset
account (i.e. a reserve). In accordance with Staff Accounting
Bulletin No. 100, the contra asset account is relieved
at the time the inventory is either sold or scrapped. We have
formal programs to periodically scrap reserved inventory. At
January 2, 2005, the remaining reserve represented excess
and obsolete inventories that have not been scrapped or sold.
Segment Cost of Revenues/ Gross Margin
Our gross margin improved 0.2% to 48.1% in fiscal 2004 compared
to 47.9% in fiscal 2003. Our gross margin improved 5.1% to 47.9%
in fiscal 2003 compared to 42.8% in fiscal 2002. Following is
gross margin discussion by our segments:
Business segments Small increases in our
fiscal 2004 Memory segment gross margin percentage were offset
by small decreases in our fiscal 2004 Non-Memory segment gross
margin percentage. As SunPower began shipments of solar cells in
the fourth quarter of fiscal 2004, the impact of its margin to
the business segments in fiscal 2004 compared to fiscal 2003 was
not significant. Our gross margin improvement in fiscal 2003
compared to fiscal 2002 was primarily attributable to the
improvement in the Non-Memory segment. In fiscal 2002, SunPower
had no gross margin impact on business segment margins as we had
not begun consolidating its results.
Market segments Small increases in gross
margin percentage of our WIN/ WIT and Computation and Consumer
segments were offset by small decreases in gross margin
percentage of our WAN/ SAN market segment. Our gross margin
improvement in fiscal 2003 compared to fiscal 2002 was primarily
attributable to improvements in the Computation and Consumer
segment.
Research and Development
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Revenues
|
|
$ |
948,438 |
|
|
$ |
836,756 |
|
|
$ |
774,746 |
|
Research and development
|
|
$ |
261,629 |
|
|
$ |
251,432 |
|
|
$ |
287,909 |
|
Research and development as a percentage of revenues
|
|
|
27.6 |
% |
|
|
30.0 |
% |
|
|
37.2 |
% |
Research and development (R&D) expenditures in
fiscal 2004 increased from fiscal 2003 primarily due to a
$3.9 million increase in salaries and other compensation
due to a moderate pay increase, and a $6.8 million increase
in expenses related to SunPower consisting primarily of costs of
test operations and facility expenses in the Philippines
manufacturing site. SunPower began shipments of solar cell
products in the fourth quarter of fiscal 2004, and prior to this
period, expenses were primarily R&D and selling, general and
administrative. The increase in R&D expenses was partially
offset by $3.0 million in depreciation. R&D expenses in
fiscal 2003 decreased from fiscal 2002 due to closing down of
design centers, headcount reductions in existing locations and a
reduction in non-cash deferred stock compensation. To keep pace
with changing business conditions and with our customers
needs, we have scaled back on some of our process and design
engineering projects and refocused our attention on fewer
projects that are critical to our success.
Selling, General and Administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Revenues
|
|
$ |
948,438 |
|
|
$ |
836,756 |
|
|
$ |
774,746 |
|
Selling, general and administrative
|
|
$ |
141,799 |
|
|
$ |
130,349 |
|
|
$ |
151,689 |
|
Selling, general and administrative as a percentage of revenues
|
|
|
15.0 |
% |
|
|
15.6 |
% |
|
|
19.6 |
% |
30
Selling, general and administrative (SG&A)
expenses in fiscal 2004 increased from fiscal 2003 primarily due
to an approximately $6.2 million increase in salaries and
other compensation due to a moderate pay increase, a
$2.9 million increase in professional fees primarily
associated with new requirements under the Sarbanes-Oxley Act, a
$2.1 million increase in sales commissions driven by
increased revenues, a $2.0 million increase in travel
expenses and a $2.0 million charge for a damage claim
settlement. The increase in SG&A expenses was partially
offset by a $7.8 million credit primarily associated with
the release of the allowance for uncollectible accounts relating
to outstanding loans to employees under the employee stock
purchase assistance plan.
SG&A expenses in fiscal 2003 decreased from fiscal 2002
primarily due to continuing cost cutting measures including our
efforts to utilize tight control on outside services and
discretionary spending, and a decrease in non-cash deferred
compensation and contingent compensation charges related to our
acquisitions of $3.4 million. SG&A also benefited in
fiscal 2003 compared with fiscal 2002 due to an increase in our
allowance for uncollectible accounts of $14.8 million in
fiscal 2002 for loans outstanding to employees under our
employee stock purchase assistance plan.
Amortization and Impairment of Intangible Assets
The following table summarizes the components:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Amortization of intangible assets
|
|
$ |
38,898 |
|
|
$ |
37,716 |
|
|
$ |
41,945 |
|
Impairment of intangible assets
|
|
|
|
|
|
|
|
|
|
|
20,303 |
|
|
|
|
|
|
|
|
|
|
|
Total amortization and impairment of intangible assets
|
|
$ |
38,898 |
|
|
$ |
37,716 |
|
|
$ |
62,248 |
|
|
|
|
|
|
|
|
|
|
|
Amortization of Intangible Assets:
Intangible assets with finite useful lives are amortized using
the straight-line method over their useful lives ranging from 2
to 6 years.
Impairment of Intangible Assets:
During the third quarter of fiscal 2002, SLM, a subsidiary of
Cypress, continued to experience a severe economic downturn in
the optical market in which SLM participates. In accordance with
Statement of Financial Accounting Standards (SFAS)
No. 144, Accounting for the Impairment or Disposal of
Long-Lived Assets, we performed an impairment review on
all of SLMs intangible assets and recorded an impairment
charge of $20.3 million related to purchased technology. No
impairment existed in other intangible assets. The fair value of
purchased technology was determined using the income approach
method, which was based on a discounted forecast of the
estimated net future cash flows to be generated from the
intangible assets using a discount rate of 25%. The carrying
amount of purchased technology was $25.5 million and the
fair value was determined to be $5.2 million, resulting in
an impairment loss of $20.3 million. We noted no impairment
indicators related to our intangible assets in fiscal 2004 and
2003.
Impairment of Goodwill
During the fourth quarter of fiscal 2002, as part of our annual
impairment review of the carrying value of our goodwill under
SFAS No. 142, Goodwill and Other Intangible
Assets, we recorded a goodwill impairment charge of
$14.4 million related to SLM. No impairment existed in
goodwill associated with other reporting units. The fair value
of goodwill associated with SLM was determined based on the
income approach method, which estimated the fair value based on
the future discounted cash flows using a discount rate of 20%.
The carrying amount of goodwill was $14.4 million and the
fair value was deemed to be zero, resulting in an impairment
charge of $14.4 million.
31
We performed our annual goodwill impairment assessment in the
fourth quarters of fiscal 2004 and 2003 and determined that
there was no impairment related to our goodwill.
In-Process Research and Development Charges
In connection with our acquisitions, we identified in-process
research and development projects in areas for which
technological feasibility have not been established and no
alternative future use existed. The in-process research and
development charge of $15.6 million in fiscal 2004 was
related to the acquisition of FillFactory and the
$2.2 million charge in fiscal 2002 was related to our
equity-method investment in SunPower.
For the acquisition of FillFactory, in-process research and
development projects include the development of new image
sensors in FillFactorys custom and standard product
applications. Specifically, the custom products include
industrial, automotive, medical and high-end photography, and
the standard products include high-end photography, digital
still cameras and wireless terminal cameras. In assessing the
projects, we considered key characteristics of the technology as
well as its future prospects, the rate of technology changes in
the industry, product life cycles, and various projects
stage of development. We allocated $15.6 million of the
purchase price to the in-process research and development
projects and wrote off the amount in the third quarter of fiscal
2004 as technology feasibility has not been established and no
alternative future uses existed.
The value of in-process research and development was determined
using the income approach method, which calculated the sum of
the discounted future cash flows attributable to the projects
once commercially viable using discount rates ranging from 28%
to 50%, which was derived from a weighted-average cost of
capital analysis and adjusted to reflect the stage of completion
of the projects and the level of risks associated with the
projects. The percentage of completion for each project was
determined by identifying the research and development expenses
invested in the project as a ratio of the total estimated
development costs required to bring the project to technical and
commercial feasibility. The following table summarizes certain
information of each significant project as of the acquisition
date:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Stage |
|
Total Estimated |
|
Estimated |
Projects |
|
of Completion |
|
Costs to Complete |
|
Completion Dates |
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
|
Industrial
|
|
|
54 |
% |
|
$ |
6,495 |
|
|
|
05/02/2005 |
|
Digital still and wireless terminal cameras
|
|
|
11 |
% |
|
|
3,609 |
|
|
|
06/01/2005 |
|
Medical
|
|
|
46 |
% |
|
|
2,395 |
|
|
|
06/01/2005 |
|
Automotive
|
|
|
50 |
% |
|
|
971 |
|
|
|
01/01/2006 |
|
High-end photography
|
|
|
31 |
% |
|
|
659 |
|
|
|
04/28/2005 |
|
To date, there have been no significant differences between the
actual and estimated results of the in-process research and
development projects. As of January 2, 2005, we have
incurred total costs of approximately $10.7 million to date
related to the in-process research and development projects and
estimate that an additional investment of approximately
$4.0 million will be required to complete the projects. We
expect to complete the remaining projects within the timeframe
as originally estimated.
The development of these technologies remains a significant risk
due to factors including the remaining efforts to achieve
technical viability, rapidly changing customer markets,
uncertain standards for new products, and competitive threats.
The nature of the efforts to develop these technologies into
commercially viable products consists primarily of planning,
designing, experimenting, and testing activities necessary to
determine that the technologies can meet market expectations,
including functionality and technical requirements. Failure to
bring these products to market in a timely manner could result
in a loss of market share or a lost opportunity to capitalize on
emerging markets and could have a material adverse impact on our
business and operating results.
32
Other Charges (Credits)
2003:
During fiscal 1995, in connection with the construction of a
facility, we entered into a tax abatement agreement with a
development agency, which called for job creation and capital
investment by us in return for a reduction in certain local
taxes payable. We were not able to fulfill certain terms of the
agreement. Accordingly, at the time it became probable that
certain terms of the agreement would not be met, we recorded an
accrual of $1.5 million, representing amounts payable under
the agreement. We never received any claim for repayment from
the development agency. At the end of fiscal 2003, we determined
that given the passage of time, there was a remote likelihood
that the development agency would seek reimbursement of the
amounts payable. As a result, we reversed the accrual of
$1.5 million and recorded the amount as a credit in the
Consolidated Statement of Operations.
During fiscal 1999, we decided to halt the construction of our
facility and recorded an accrual of $2.0 million,
representing primarily the cancellation penalties payable to
suppliers. Subsequently, no claims were made against us by the
suppliers. During fiscal 2003, we determined that the passage of
time had made the likelihood of us being obligated to make these
payments remote. As a result, we reversed the accrual of
$2.0 million and recorded the amount as a credit in the
Consolidated Statement of Operations.
2002:
Other charges of $6.1 million were related to certain
abandoned fixed assets.
Restructuring
The semiconductor industry has historically been characterized
by wide fluctuations in demand for, and supply of,
semiconductors. In some cases, industry downturns have lasted
more than a year. Prior experience has shown that restructuring
of operations, resulting in significant restructuring charges,
may become necessary if an industry downturn persists. As of
January 2, 2005, we had two active restructuring
plans one initiated in the fourth quarter of fiscal
2002 (Fiscal 2002 Restructuring Plan) and one
initiated in the third quarter of fiscal 2001 (Fiscal 2001
Restructuring Plan).
We recorded initial restructuring charges under the Fiscal 2002
Restructuring Plan and the Fiscal 2001 Restructuring Plan based
on assumptions that we deemed appropriate for the economic
environment that existed at the time these estimates were made.
As the semiconductor industry we operate in is subject to rapid
change, cyclical patterns and high volatility, we have taken
additional actions and made appropriate adjustments for property
and equipment, leased facilities and personnel costs under both
the Fiscal 2002 Restructuring Plan and the Fiscal 2001
Restructuring Plan. The restructuring actions were aimed to
reduce our future operating expenses and improve our cash flows
primarily as a result of reduced employee expenses and reduced
depreciation due to the removal of equipment.
As of December 28, 2003, both restructuring events have
been substantially completed with reserves remaining only for
restructured leased facilities and employee benefits. As of
January 2, 2005, reserves remained for restructured leased
facilities, which will decrease over time as we continue to make
lease payments.
See Note 11 of Notes to Consolidated Financial Statements
under Item 8 of this Annual Report on Form 10-K for a
detailed discussion of the two restructuring events.
33
Other Income and Expense
The following table summarizes the components of other income
and expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Interest income
|
|
$ |
11,115 |
|
|
$ |
13,024 |
|
|
$ |
23,117 |
|
Interest expense
|
|
|
(11,354 |
) |
|
|
(15,613 |
) |
|
|
(19,197 |
) |
Other income and (expense), net
|
|
|
(256 |
) |
|
|
8,384 |
|
|
|
(18,836 |
) |
|
|
|
|
|
|
|
|
|
|
Total interest income and expense and other
|
|
$ |
(495 |
) |
|
$ |
5,795 |
|
|
$ |
(14,916 |
) |
|
|
|
|
|
|
|
|
|
|
Interest Income:
Interest income consisted primarily of interest earned on cash
equivalents, short-term investments and restricted investments.
In addition, interest income included interest income related to
our loans to employees under the employee stock purchase
assistance plan. The decrease in interest income in fiscal 2004
compared with fiscal 2003 was primarily attributable to a
decrease of $3.7 million in interest income related to our
employee stock purchase assistance plan due to lower loan
balances, partially offset by an $1.8 million increase in
interest income due to an increase in average cash and
investment balances. The decrease in interest income in fiscal
2003 compared with fiscal 2002 was primarily due to lower loan
balances related to our employee stock purchase assistance plan,
coupled with lower average cash and investment balances and
lower interest rates.
Interest Expense:
Interest expense was primarily associated with our convertible
subordinated notes. The decrease in interest expense in fiscal
2004 compared with fiscal 2003 was primarily attributable to a
decrease of approximately $8.2 million in interest expense
associated with our 3.75% convertible subordinated notes
(3.75% Notes) and 4.0% convertible
subordinated notes (4.0% Notes). We redeemed a
portion of our 3.75% Notes and all of our 4.0% Notes
in June and July 2003, resulting in a decrease in interest
expense in fiscal 2004 compared with fiscal 2003. The decrease
in interest expense associated with our 3.75% Notes and
4.0% Notes in fiscal 2004 was partially offset by an
increase of approximately $3.8 million in interest expense
associated with our 1.25% convertible subordinated notes
(1.25% Notes). We issued our 1.25% Notes
in June 2003.
During the fourth quarter of fiscal 2004, we redeemed all of the
outstanding 3.75% Notes. There was no gain or loss upon
redemption.
Interest expense decreased in fiscal 2003 compared with fiscal
2002 primarily due to the redemption of our 3.75% Notes and
4.0% Notes in June and July 2003, partially offset by
additional interest expense associated with our 1.25% Notes
issued in June 2003.
34
Other Income and (Expense), Net:
The following table summarizes the components of other income
and (expenses), net:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Amortization of bond issuance costs
|
|
$ |
(4,071 |
) |
|
$ |
(3,686 |
) |
|
$ |
(2,834 |
) |
Equity in net income (loss) of partnership investment
|
|
|
1,424 |
|
|
|
1,540 |
|
|
|
(844 |
) |
Gain (loss) on repurchase of convertible subordinated notes
|
|
|
|
|
|
|
(7,524 |
) |
|
|
5,946 |
|
Gain on sale of investment in NVE Corporation
|
|
|
|
|
|
|
17,126 |
|
|
|
|
|
Investment impairment and other charges
|
|
|
(1,123 |
) |
|
|
(1,792 |
) |
|
|
(18,992 |
) |
Foreign exchange gains, net
|
|
|
1,122 |
|
|
|
473 |
|
|
|
915 |
|
Gain (loss) on investments held in trust for employee elected
deferred compensation
|
|
|
1,218 |
|
|
|
1,912 |
|
|
|
(1,905 |
) |
Minority interest
|
|
|
144 |
|
|
|
1,045 |
|
|
|
|
|
Other
|
|
|
1,030 |
|
|
|
(710 |
) |
|
|
(1,122 |
) |
|
|
|
|
|
|
|
|
|
|
Total other income and (expense), net
|
|
$ |
(256 |
) |
|
$ |
8,384 |
|
|
$ |
(18,836 |
) |
|
|
|
|
|
|
|
|
|
|
Other expense, net for fiscal 2004 consisted primarily of
amortization of deferred financing costs and impairment charges
related to certain development stage companies, offset by our
equity earnings in a partnership investment and foreign exchange
gains. Other income, net for fiscal 2003 consisted primarily of
our gain on the sale of an investment in NVE Corporation, offset
by our loss on the repurchase of our 4.0% Notes and
3.75% Notes and amortization of deferred financing costs.
Other expense, net for fiscal 2002 consisted primarily of
write-downs of investments in certain development stage
companies and the amortization of deferred financing costs.
These expenses were partially offset by gains recognized on the
repurchase of our 3.75% Notes.
During fiscal 2003, we sold our investment in NVE Corporation, a
publicly-traded company, and recognized total gains of
$17.1 million from the transactions. The sales consisted of
0.7 million shares of NVE Corporations common stock
in the open market. The fair market value of the investment was
based on the market prices of NVE Corporations common
stock on the dates of sales, ranging from $31.5 to
$34.7 per share. Gains on the sales were determined as the
difference between the total proceeds of $23.3 million less
the carrying value of our investment of $6.2 million.
As of January 2, 2005, we held warrants to
purchase 400,000 shares of NVE Corporations
common stock at $15.00 per share, which do not allow for
net exercise. If we exercise the warrants, we will not be
allowed to sell the underlying shares in a public market
transaction for 12 months. The warrants will expire in
April 2005 if not exercised.
Investment impairment and other charges for fiscal 2002 were
primarily attributable to the $18.1 million write-downs of
our investments in privately-held development stage companies.
Our ability to recover our investments is primarily dependent on
how successfully these companies are able to execute to their
business plans and how well their products are ultimately
accepted, as well as their ability to obtain venture capital
funding to continue operations. We periodically review our
investments for impairment and in the event the carrying value
of an investment exceeds its fair value and the decline is
determined to be other-than-temporary, an impairment charge is
recorded and a new cost basis for the investment is established.
This impairment analysis includes assessment of each
investees financial condition, the business prospects for
its products and technology, its projected results and cash
flows, the likelihood of obtaining subsequent rounds of
financing, and the impact of any relevant contractual equity
preferences held by us or other investors.
During the periods from fiscal 1999 to 2001, we made investments
in several privately-held development stage companies whose
valuations subsequently proved to be high. As the equity markets
continued to decline
35
significantly, these development stage companies were either
unable to raise additional funding and therefore forced to cease
operations, or were able to obtain additional funding but at a
valuation lower than the carrying amount of our investments. As
the carrying amount of these investments exceeded their fair
value and we determined that the decline in values was
other-than-temporary, we recorded impairment charges of
$18.1 million, which represented the total amount of the
write-downs to the fair value of our remaining investment in
each respective investee. For those investees who ceased
operations, the fair value of our investment was zero, and for
those investees who have obtained additional funding at a lower
valuation than the carrying amount of our investments, the fair
value was based on the new share price of the additional funding.
Benefit from (Provision for) Income Taxes
A tax benefit of $26.6 million was recognized in fiscal
2004, compared to tax expense of $2.8 million in fiscal
2003 and tax expense of $2.8 million in fiscal 2002. The
tax benefit in fiscal 2004 was primarily attributable to a
release of $29.9 million of previously accrued taxes as
discussed below, offset by foreign income taxes in certain
jurisdictions. The expense in fiscal 2003 and 2002 was largely
attributable to foreign income taxes in certain jurisdictions.
No tax benefit was recognized in fiscal 2003 and 2002 for the
future tax benefit of operating losses, as management believed
it was more likely than not that the benefit would not be
realized. Our effective tax rate varies from the
U.S. statutory rate primarily due to our assessment of the
utilization of loss carryovers and earnings of foreign
subsidiaries taxed at different rates. The net deferred tax
assets of $194.7 million at January 2, 2005 were fully
reserved due to uncertainty of realization in accordance with
SFAS No. 109, Accounting for Income Taxes.
The calculation of tax liabilities involves dealing with
uncertainties in the application of complex global tax
regulations. We regularly assess our tax positions in light of
legislative, bilateral tax treaty, regulatory and judicial
developments in the many countries in which we and our
affiliates do business.
We and our affiliates file tax returns in each jurisdiction in
which we are registered to do business. In the U.S. and many of
the state jurisdictions, and in many foreign countries in which
we file tax returns, a statute of limitations period exists.
After a statute of limitations period expires, the respective
tax authorities may no longer assess additional income tax for
the expired period. Similarly, we are no longer eligible to file
claims for refund for any tax that we may have overpaid.
During the third quarter of fiscal 2004, the statute of
limitations expired for several tax jurisdictions. The
expiration of the statute of limitations led to
managements assessment that the previously accrued income
taxes were no longer necessary. Accordingly, during the third
quarter of fiscal 2004, we recorded a benefit of
$29.9 million for the reversal of previously accrued income
taxes.
Liquidity and Capital Resources
The following table summarizes our cash and investments, working
capital and long-term debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Cash, cash equivalents and short-term investments
|
|
$ |
244,897 |
|
|
$ |
198,617 |
|
|
$ |
127,937 |
|
Restricted cash
|
|
|
62,743 |
|
|
|
62,814 |
|
|
|
62,380 |
|
Long-term investments(1)
|
|
|
|
|
|
|
118,437 |
|
|
|
16,574 |
|
Working capital
|
|
|
330,270 |
|
|
|
307,716 |
|
|
|
314,187 |
|
Long-term debt (excluding current portion)
|
|
|
606,724 |
|
|
|
615,724 |
|
|
|
468,900 |
|
|
|
(1) |
We had available-for-sale investments classified as long-term
investments in fiscal 2003 and prior years. As of the end of
fiscal 2004, we classified all available-for-sale investments as
cash equivalents or short-term investments as they are intended
for use in current operations. |
36
Key Components of Cash Flow:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Net cash flow generated from operating activities
|
|
$ |
155,793 |
|
|
$ |
99,152 |
|
|
$ |
23,474 |
|
Net cash flow used for investing activities
|
|
|
(207,826 |
) |
|
|
(119,948 |
) |
|
|
(19,949 |
) |
Net cash flow generated from (used for) financing activities
|
|
|
(33,372 |
) |
|
|
91,923 |
|
|
|
(32,627 |
) |
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
$ |
(85,405 |
) |
|
$ |
71,127 |
|
|
$ |
(29,102 |
) |
|
|
|
|
|
|
|
|
|
|
During fiscal 2004, cash generated from operations was
$155.8 million, compared with $99.2 million in fiscal
2003. This $56.6 million increase was primarily due to net
income generated in fiscal 2004 compared with a net loss in
fiscal 2003, adjusted for certain non-cash items and changes in
operating assets and liabilities.
In fiscal 2004, purchases of investments, net of sales and
maturities, used cash of $13.2 million, acquisition of
property, plant, and equipment used an additional
$132.3 million in cash, and we spent a total of
$89.9 million in our acquisitions, net of cash received, of
both Cascade and FillFactory. These uses of cash were partially
offset by the collection of loans from employees under the stock
purchase assistance plan of $28.4 million.
During fiscal 2004, we used $68.7 million to redeem the
remaining 3.75% Notes. This was partially offset by
$36.4 million from the issuance of shares upon exercise of
stock options by employees.
During fiscal 2003, cash generated from operations was
$99.2 million, compared with $23.5 million in fiscal
2002. This $75.7 million increase was primarily due to a
smaller net loss in fiscal 2003, adjusted for certain non-cash
items and changes in operating assets and liabilities. Cash
generated from operations included an increase in working
capital of $51.0 million. Inventory reductions due to
increased sales were more than offset by a significant increase
in accounts receivable and a significant decrease in accounts
payable.
Purchases of investments, net of sales and maturities, used cash
of $101.1 million in fiscal 2003, as we made additional
investments due to our improved cash position. Acquisition of
property, plant, and equipment used an additional
$78.5 million in cash. These reductions in cash were
partially offset by an increase from sale of our investment in
NVE Corporation of $23.4 million and the collection of
loans from employees under the stock purchase assistance plan of
$29.9 million.
During fiscal 2003, we issued $600.0 million in aggregate
principal amount of our 1.25% Notes. Of the proceeds
received, we used $400.2 million to retire all of our
4.0% Notes and a portion of our 3.75% Notes,
$98.5 million to repurchase 9.3 million shares of
our common stock, $18.5 million for debt issuance costs and
$49.3 million to purchase a call spread option on our
common stock to mitigate the potential dilution of the
1.25% Notes.
During fiscal 2002, cash generated from operations was
$23.5 million, which resulted from our net loss adjusted
for certain non-cash items and changes in operating assets and
liabilities. Cash generated from operations included an increase
in working capital of $33.3 million. With continued weak
sales, manufacturing capacity was reduced to avoid additional
inventory builds. Accounts payable declined as we significantly
slowed purchases of capital equipment in the latter part of
fiscal 2002. These changes were partially offset by a decline in
net accounts receivable commensurate with the change in revenues.
Net of purchases, sales and maturities of investments generated
$143.5 million in cash in fiscal 2002, as we liquidated
investments to fund capital expenditures and business
acquisitions. This was offset by the acquisition of
$158.5 million in property, plant and equipment and
$24.8 million in investments in other companies.
37
In fiscal 2002, the issuance of common shares upon exercise of
stock options by employees, net of repurchases, generated
$20.0 million while the purchase of our 3.75% Notes
consumed $48.8 million.
Liquidity:
Based on our current plan, we expect to generate positive cash
flow from operations in the fiscal year ending January 1,
2006. Our expected significant investment and financing cash
outlays for fiscal 2005 includes capital expenditures of
approximately $145 million for investment in our product
development and technology initiatives. The Board of Directors
has approved programs authorizing the repurchase of our common
stock or convertible subordinated notes in the open market or in
privately negotiated transactions at anytime. The actual total
amount of common shares that can be repurchased is limited to
$15.0 million and is subject to cash flow restrictions.
We have $600.0 million of aggregate principal amount in the
1.25% Notes that are due in June 2008. The 1.25% Notes
are subject to compliance with certain covenants that do not
contain financial ratios. As of January 2, 2005, we were in
compliance with these covenants. If we failed to be in
compliance with these covenants beyond any applicable grace
period, the trustee of the 1.25% Notes, or the holders of a
specific percentage thereof, would have the ability to demand
immediate payment of all amounts outstanding.
During the fourth quarter of fiscal 2004, we called for
redemption all of our outstanding 3.75% Notes at total
costs of $69.8 million, which included outstanding
principal of $68.7 million and accrued interest of
$1.1 million.
In conjunction with our 1.25% Notes offering, we purchased
a call spread option on 32.0 million of our common shares
expiring in July 2004 for $49.3 million in cash. The call
spread option was designed to mitigate stock dilution from
conversion of the 1.25% Notes. The call spread option was
restructured in May 2004 into a single contract of two equal
parts maturing on August 16 and September 30, 2004. As of
each of the maturity dates, the call spread option was out of
the money and expired. The expiration of the call spread option
had no impact on our cash balances or statement of operations in
fiscal 2004.
On June 27, 2003, we entered into a synthetic operating
lease agreement for U.S. manufacturing and office
facilities. The lease agreement requires us to purchase the
properties or to arrange for the properties to be acquired by a
third party at lease expiration. If we had exercised our right
to purchase all the properties subject to these leases at
January 2, 2005, we would have been required to make a
payment and record assets totaling $62.7 million. We are
required to maintain restricted cash or investments to serve as
collateral for these leases. As of January 2, 2005, the
amount of restricted cash was $62.7 million, which was
classified as a non-current asset in the Consolidated Balance
Sheets.
In September 2003, we entered into a $50.0 million,
24-month revolving line of credit with a major financial
institution. In December 2004, this line of credit was extended
to December 2006 and the total amount was increased to
$70.0 million. As of January 2, 2005,
$4.0 million was outstanding. Loans made under the line of
credit bear interest based upon the Wall Street Journal Prime
Rate or LIBOR plus a spread at our election. The line of credit
agreement includes a variety of covenants including restrictions
on the incurrence of indebtedness, incurrence of loans, the
payment of dividends or distribution on our capital stock, and
transfers of assets and financial covenants with respects to
tangible net worth and a quick ratio. As of January 2,
2005, we were in compliance with all of the covenants. Our
obligations under the line of credit are guaranteed and secured
by the common stock of certain of our subsidiaries. We intend to
use the line of credit on an as-needed basis to fund working
capital and capital expenditures.
At January 2005, we had long-term loan agreements primarily with
two lenders with an aggregate principal amount equal to
$24.7 million. These agreements are collateralized by
specific equipment located at our U.S. manufacturing
facilities. Principal amounts are to be repaid in monthly
installments inclusive of accrued interest, over a three- to
four-year period. The applicable interest rates are variable
based on changes to LIBOR rates. Both loans are subject to
financial and non-financial covenants. As of January 2,
2005, the aggregate principal outstanding was $13.9 million
and we were in compliance with the covenants.
38
On August 4, 2004, we completed the acquisition of 100% of
the outstanding capital stock of FillFactory. We acquired
FillFactory for a total cash consideration of
$91.7 million, net of cash received.
Several of our acquisitions obligate us to pay certain
contingent cash compensation based on continued employment and
meeting certain revenue project milestones. As of
January 2, 2005, total contingent compensation that could
be paid in cash under our acquisition agreements assuming all
contingencies are met was $8.6 million.
Capital Resources and Financial Condition:
Our long-term strategy is to maintain a minimum amount of cash
and cash equivalents for operational purposes and to invest the
remaining amount of our cash in interest-bearing and highly
liquid cash equivalents and marketable debt securities.
Accordingly, at the end of fiscal 2004, in addition to the
$66.6 million in cash and cash equivalents, we had
$178.3 million invested in short-term investments that are
available for current operating, financing and investing
activities, for a total liquid cash and investment position of
$244.9 million. We had an additional $62.7 million of
restricted cash related to our synthetic lease for a total cash,
investment and restricted cash position of $307.6 million.
As of January 2, 2005, we had outstanding $600 million
in principal amount of our 1.25% Notes. We also maintain
the ability to issue an aggregate of approximately
$112.5 million in debt, equity and other securities under a
shelf registration statement we filed with the Securities and
Exchange Commission in fiscal 2000.
We believe that liquidity provided by existing cash, cash
equivalents, investments, and our borrowing arrangements
described above and cash generated from operations, will provide
sufficient capital to meet our requirements for at least the
next twelve months. However, should prevailing economic
conditions and/or financial, business and other factors beyond
our control adversely affect our estimates of our future cash
requirements (including our debt obligations), we would be
required to fund our cash requirements by alternative financing.
There can be no assurance that additional financing, if needed,
would be available on terms acceptable to us or at all.
We may choose at any time to raise additional capital to
strengthen our financial position, facilitate growth, and
provide us with additional flexibility to take advantage of
business opportunities that arise.
Contractual Obligations:
The following table summarizes the fixed payments related to
certain contractual obligations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Periods | |
|
|
| |
|
|
|
|
Less Than | |
|
|
|
More than | |
|
|
Total | |
|
1 Year | |
|
2-3 Years | |
|
4-5 Years | |
|
5 Years | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible subordinated notes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.25% Notes principal
|
|
$ |
599,998 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
599,998 |
|
|
$ |
|
|
|
|
1.25% Notes interest
|
|
|
26,250 |
|
|
|
7,500 |
|
|
|
15,000 |
|
|
|
3,750 |
|
|
|
|
|
|
Other principal
|
|
|
17,924 |
|
|
|
11,234 |
|
|
|
6,690 |
|
|
|
|
|
|
|
|
|
|
Other interest
|
|
|
1,030 |
|
|
|
672 |
|
|
|
358 |
|
|
|
|
|
|
|
|
|
Operating leases:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Synthetic lease
|
|
|
8,292 |
|
|
|
1,968 |
|
|
|
4,884 |
|
|
|
1,440 |
|
|
|
|
|
|
Other
|
|
|
30,056 |
|
|
|
11,038 |
|
|
|
10,749 |
|
|
|
5,832 |
|
|
|
2,437 |
|
Purchase obligations(1)
|
|
|
48,603 |
|
|
|
44,174 |
|
|
|
4,429 |
|
|
|
|
|
|
|
|
|
Customer advances(2)
|
|
|
6,151 |
|
|
|
6,151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total contractual obligations
|
|
$ |
738,304 |
|
|
$ |
82,737 |
|
|
$ |
42,110 |
|
|
$ |
611,020 |
|
|
$ |
2,437 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39
|
|
(1) |
Purchase obligations represent principally our open purchase
orders for services, software, manufacturing equipment and
facilities. Purchase orders for raw materials and other similar
goods and services are not included. For purposes of this table,
purchase obligations are defined as enforceable agreements that
are legally binding on us and that specify all significant
terms, including quantity, price and timing. Our purchase orders
for raw materials and other similar goods and services are based
on our current manufacturing needs and are fulfilled by our
vendors within short time horizons. We do not have significant
agreements for the purchase of raw materials or other similar
goods and services specifying minimum quantities or set prices
that exceed our expected requirements for three months. Blanket
purchase orders are also excluded because they generally
represent authorizations to purchase rather than binding
agreements. We also enter into contracts for outsourced
services; however, the obligations under these contracts are not
significant and the contracts generally contain clauses allowing
for cancellation without significant penalty. |
|
(2) |
Customer advances were related to a financing and supply
agreement and certain custom design contracts. |
Off-Balance Sheet Arrangements:
On June 27, 2003, we entered into a synthetic operating
lease agreement for manufacturing and office facilities located
in Minnesota and California. The synthetic lease enables us to
lease rather than acquire the facilities. This results in
improved cash flow through lower lease payments compared to
expending much more cash in a direct acquisition of the
properties. The synthetic lease requires us to purchase the
properties or to arrange for the properties to be acquired by a
third party at lease expiration, which is in June 2008. If we
had exercised our right to purchase all the properties subject
to the synthetic lease at January 2, 2005, we would have
been required to make a payment and record assets totaling
$62.7 million (the Termination Value). If we
had exercised our option to sell the properties to a third
party, the proceeds from such a sale could be less than the
properties Termination Value, and we would be required to
pay the difference up to the guaranteed residual value of
$54.5 million (the Guaranteed Residual Value).
We are required to evaluate periodically the expected fair value
of the properties at the end of the lease term. In the event we
determine that it is estimable and probable that the expected
fair value of the properties at the end of the lease term will
be less than the Termination Value, we will ratably accrue the
loss over the remaining lease term. During fiscal 2004, we
performed the analysis and recorded a loss contingency of
approximately $1.8 million in other long-term liabilities
on the Consolidated Balance Sheet relating to the potential
decline in the fair value of the facilities in California. The
loss accrual was determined by management with the assistance of
a market analysis performed by an independent appraisal firm.
The synthetic lease agreements require periodic payments that
vary based on the LIBOR rate, plus a spread. The total amount of
such payments (which reflect payments under the existing
synthetic lease and prior synthetic leases which have been
terminated) were $1.3 million, $1.7 million and
$2.2 million in fiscal 2004, 2003 and 2002, respectively.
We are required to maintain restricted cash or investments to
serve as collateral for this lease. As of January 2, 2005,
the amount of restricted cash recorded was $62.7 million
and was classified in other assets on the Consolidated Balance
Sheet. As of January 2, 2005, we were in compliance with
the financial covenants.
As of January 2, 2005, we had outstanding a series of
equity options on our common stock with an initial cost of
$26.0 million that were originally entered into in fiscal
2001. These options were included in stockholders equity
in the Consolidated Balance Sheets (see Note 18 of Notes to
Consolidated Financial Statements under Item 8 of this
Annual Report on Form 10-K). We entered into the
equity options as part of our 2001 stock repurchase program.
Depending upon our common stock price at the maturity date of the
40
equity options, we either take delivery of our common stock
resulting in a reduction to our outstanding common stock or
receive cash resulting in a return on the cash expended.
In conjunction with the issuance of the 1.25% Notes, we
purchased a call spread option on our common stock (the
Call Spread Option) maturing on July 15, 2004
for $49.3 million in cash. The Call Spread Option has been
accounted for as an equity transaction in accordance with
Emerging Issues Task Force (EITF) No. 00-19,
Accounting for Derivative Financial Instruments Indexed
to, and Potentially Settled in, a Companys Own
Stock. The Call Spread Option covered 32.0 million
shares of our common stock. The Call Spread Option was designed
to mitigate dilution from conversion of the 1.25% Notes.
The Call Spread Option was restructured in May 2004 into a
single contract of two equal parts maturing on August 16,
2004 and September 30, 2004, respectively. As of each of
the maturity dates, the Call Spread Option was out of the money
and expired. The expiration of the Call Spread Option had no
impact on our cash balances or operating results.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and the
results of our operations are based upon our Consolidated
Financial Statements included in this Annual Report on
Form 10-K and the data used to prepare them. Our
Consolidated Financial Statements have been prepared in
accordance with accounting principles generally accepted in the
United States and we are required to make estimates, judgments
and assumptions in the course of such preparation. Note 1
of Notes to Consolidated Financial Statements under Item 8
of this Annual Report on Form 10-K describes the
significant accounting policies and methods used in the
preparation of the Consolidated Financial Statements. On an
ongoing basis, we re-evaluate our judgments and estimates
including those related to revenue recognition, product returns,
allowances for doubtful accounts receivable and employee loans,
inventories, valuation of long-lived assets including
intangibles, goodwill impairments, investment impairments,
restructuring charges, litigation and settlement costs, and
income taxes. We base our estimates and judgments on our
historical experience, knowledge of current conditions and our
beliefs of what could occur in the future considering available
information. Actual results may differ from these estimates
under different assumptions or conditions. We believe the
following are our critical accounting policies that are affected
by significant estimates, assumptions and judgments used in the
preparation of our Consolidated Financial Statements.
Revenue Recognition:
We generate revenue by selling products to original equipment
manufacturers and distributors. Our policy is to recognize
revenue from sales to customers when titles and the rights and
risks of ownership have passed to the customer, persuasive
evidence of an arrangement exists, the product has been
delivered, the price is fixed and determinable, and customer
acceptance and collection of the resulting receivable is
reasonably assured.
We offer price protection and similar rights to certain
U.S.-based distributors. In addition, we provide limited stock
rotation rights to these distributors. Given the uncertainties
associated with the levels of returns and other price protection
credits to these distributors, revenues and costs relating to
the distributor sales are deferred, on a gross basis, until such
rights lapse, which is generally upon receiving notifications
from the distributors that they have resold the products. Our
method of deferral is based on certain assumptions. Reserves are
provided for estimated returns relating to rights of return and
other credits for price protection. If actual results differ
from our estimates, operating results could be adversely
affected.
Sales to certain other primarily non-U.S. based
distributors carry no price adjustments or rights of return. We
have historically recognized revenue from sales to these
distributors on shipment, with a related allowance for potential
returns established at the time of sale. We must make estimates
of potential future product returns and revenue adjustments
related to current period product revenue. In that regard,
management analyzes historical returns, current economic trends
in the semiconductor industry, changes in customer demand and
acceptance of our products when evaluating the adequacy of
allowance for sales returns. If management made different
judgments or utilized different estimates, material differences
in the amount of
41
our reported revenue may result. We provide for these situations
based on our experience with specific customers and our
expectations for revenue adjustments based on economic
conditions within the semiconductor industry. At January 2,
2005 and December 28, 2003, our reserves for sales returns
were $2.7 million and $2.4 million, respectively.
Our principal post-shipment obligations to our customers are:
(1) rights to limited stock rotation to our U.S.-based
distributors as discussed above, and (2) quality-related
issues for which a warranty reserve is provided by us. In
addition, we provide a volume-pricing discount to certain
contract manufacturers, which is recorded as a reduction in
revenue. Such volume discounts have not been significant
historically.
Allowance for Doubtful Accounts and Employee Loans:
We maintain an allowance for doubtful accounts for losses that
we estimate will arise from our customers inability to
make required payments. We make our estimates of the
collectibility of our accounts receivable by analyzing
historical bad debts, specific customer creditworthiness and
current economic trends. The allowance for doubtful accounts was
$0.9 million as of both January 2, 2005 and
December 28, 2003.
As of January 2, 2005 and December 28, 2003, we had
outstanding loans, consisting of principal and cumulative
accrued interest, of $54.1 million and $80.5 million,
respectively, to employees and former employees under the
shareholder-approved 2001 employee stock purchase assistance
plan. Each loan is evidenced by a full recourse promissory note
executed by the employee in favor of Cypress and is secured by a
pledge of the shares of our common stock purchased with the
proceeds of the loan. As of January 2, 2005 and
December 28, 2003, we had an allowance for uncollectible
accounts against these accounts of $8.5 million and
$16.2 million, respectively. In determining the allowance
for uncollectible accounts, management considered various
factors, including a review of borrower demographics (including
geographic location and job grade), loan quality and an
independent fair value analysis of the loans and the underlying
collateral. As of January 2, 2005 and December 28,
2003, the carrying value of the loans exceeded the underlying
common stock collateral by $28.2 million and
$6.4 million, respectively. If the underlying assumptions
supporting our reserve requirements, including the value of our
stock price, change, future operating results could be adversely
affected.
Valuation of Inventory:
We write down our inventory for lower of cost or
market reserves, aged inventory reserves and obsolescence
reserves. Inventory reserves are generally recorded when the
inventory for a device exceeds nine months of demand for that
device and/or when individual parts have been in inventory for
greater than six months. Inventory reserves are not relieved
until the related inventory has been sold or scrapped. Our
inventories represent high-technology parts that may be subject
to rapid technological obsolescence and which are sold in a
highly competitive industry. If actual product demand or selling
prices are less favorable than we estimate, we may be required
to take additional inventory write-downs. Conversely, if demand
grows for items that have been fully reserved, our future
margins may be higher.
Valuation of Long-Lived Assets:
Our business requires heavy investment in manufacturing
facilities that are technologically advanced but can quickly
become significantly under-utilized or rendered obsolete by
rapid changes in demand for semiconductors produced in those
facilities. In addition, we have recorded intangible assets with
finite lives related to our acquisitions.
We evaluate our long-lived assets, including property and
equipment and purchased intangible assets with finite lives, for
impairment whenever events or changes in circumstances indicate
that the carrying value of such assets may not be recoverable.
Factors considered important that could result in an impairment
review include significant underperformance relative to expected
historical or projected future operating results, significant
changes in the manner of use of acquired assets or the strategy
for our business, significant negative industry or economic
trends, and a significant decline in our stock price for a
sustained period of time. Impairments are recognized based on
the difference between the fair value of the asset and its
carrying value,
42
and fair value is generally measured based on discounted cash
flow analyses. We recorded $20.3 million of impairment
charges related to certain intangible assets in fiscal 2002 and
no impairment charges in fiscal 2004 and 2003. If there is a
significant decrease in our business in the future, we may be
required to record impairment charges in the future.
Goodwill Impairment:
We perform goodwill impairment tests on an annual basis and
between annual tests in certain circumstances for each reporting
unit. The process of evaluating the potential impairment of
goodwill is highly subjective and requires significant judgment
at many points during the analysis. In estimating the fair value
of the businesses with recognized goodwill, we made estimates
and judgments about the future cash flows of these businesses.
Our cash flow forecasts were based on assumptions that are
consistent with the plans and estimates we are using to manage
the underlying businesses. In addition, we made certain
judgments about allocating shared assets such as accounts
receivable and inventory to the estimated balance sheet for
those businesses. We also considered our market capitalization
on the dates of our impairment tests in determining the fair
value of the respective businesses.
In connection with the adoption of Statement of Financial
Accounting Standards (SFAS) No. 142,
Goodwill and Other Intangible Assets, effective in
the beginning of fiscal 2002, we completed the required
transitional analysis in the first quarter of fiscal 2002 with
no impairment charge required. In addition, as required by
SFAS No. 142, we performed our annual goodwill
impairment test and determined that no goodwill impairment
existed for fiscal 2004 and 2003, and recorded goodwill
impairment charges of $14.4 million for fiscal 2002.
However, changes in these estimates, including projected cash
flows of our market capitalization, could cause one or more of
the businesses to be valued differently, which could result in a
future impairment of our remaining goodwill.
Investments in Privately-Held Companies:
As of January 2, 2005, the carrying value of our portfolio
of strategic investments in non-marketable equity securities
(privately-held companies) totaled $8.8 million. Our
ability to recover our investments in private, non-marketable
equity securities and to earn a return on these investments is
primarily dependent on how successfully these companies are able
to execute to their business plans and how well their products
are ultimately accepted, as well as their ability to obtain
venture capital funding to continue operations and to grow. In
the current equity market environment, their ability to obtain
additional funding as well as to take advantage of liquidity
events, such as initial public offerings, mergers and private
sales, is significantly constrained.
Under our accounting policy, the carrying value of a
non-marketable investment is the amount paid for the investment
unless it has been determined to be other than temporarily
impaired, in which case we write the investment down to its
impaired value. We review all of our investments periodically
for impairment; however, for non-marketable equity securities,
the impairment analysis requires significant judgment. This
analysis includes assessment of each investees financial
condition, the business outlook for its products and technology,
its projected results and cash flows, the likelihood of
obtaining subsequent rounds of financing and the impact of any
relevant contractual equity preferences held by us or others. If
an investee obtains additional funding at a valuation lower than
our carrying amount, we presume that the investment is other
than temporarily impaired, unless specific facts and
circumstances indicate otherwise, for example, when we hold
contractual rights that give us a preference over the rights of
other investors. As the equity markets have declined
significantly over the past few years, we have experienced
substantial impairments in our portfolio of non-marketable
equity securities. If equity market conditions do not improve,
as companies within our portfolio attempt to raise additional
funds, the funds may not be available to them, or they may
receive lower valuations, with more onerous investment terms
than in previous financings, and the investments will likely
become impaired. However, we are not able to determine at the
present time which specific investments are likely to be
impaired in the future, or the extent or timing of individual
impairments. We recorded impairments of non-marketable equity
investments of $1.1 million in fiscal 2004,
$1.8 million in fiscal 2003 and $18.1 million in
fiscal 2002.
43
Restructuring Expenses:
We currently have two active restructuring plans one
initiated in the third quarter of fiscal 2001 and the other
initiated in the fourth quarter of fiscal 2002. In addition, we
have announced a restructuring plan in the first quarter of
fiscal 2005. These plans were designed to reduce costs and
expenses in order to return the company to profitability. In
connection with these plans, we have recorded, and will record,
estimated expenses for severance and outplacement costs, lease
cancellations, asset write-offs and other restructuring costs.
Given the significance of, and the timing of the execution of
such activities, this process is complex and involves periodic
reassessments of estimates made at the time the original
decisions were made. We continually evaluate the adequacy of the
remaining liabilities under our restructuring initiatives.
Although we believe that these estimates accurately reflect the
costs of our restructuring plans, actual results may differ,
thereby requiring us to record additional provisions or reverse
a portion of such provisions.
Litigation and Settlement Costs:
From time to time, we are involved in legal actions arising in
the ordinary course of business. We are aggressively defending
our current litigation matters. However, there are many
uncertainties associated with any litigation, and we cannot be
certain that these actions or other third-party claims against
us will be resolved without costly litigation and/or substantial
settlement payments. If that occurs, our business, financial
condition and results of operations could be materially and
adversely affected. If information becomes available that causes
us to determine that a loss in any of our pending litigation is
probable, and we can reasonably estimate the loss associated
with such litigation, we will record the loss in accordance with
accounting principles generally accepted in the United States.
However, the actual liability in any such litigation may be
materially different from our estimates, which could result in
the need to record additional costs.
Accounting for Income Taxes:
Our global operations involve manufacturing, research and
development and selling activities. Profit from non-U.S.
activities are subject to local country taxes but are not
subject to U.S. tax until repatriated to the U.S. It
is our intention to permanently reinvest these earnings outside
the U.S. We record a valuation allowance to reduce our
deferred tax assets to the amount that is more likely than not
to be realized. We consider historical levels of income,
expectations and risks associated with estimates of future
taxable income and ongoing prudent and feasible tax planning
strategies in assessing the need for the valuation allowance.
Should we determine that we would be able to realize deferred
tax assets in the future in excess of the net recorded amount,
we would record an adjustment to the deferred tax asset
valuation allowance. This adjustment would increase income in
the period such determination is made.
The calculation of tax liabilities involves dealing with
uncertainties in the application of complex global tax
regulations. We recognize potential liabilities for anticipated
tax audit issues in the U.S. and other tax jurisdictions based
on our estimate of whether, and the extent to which, additional
taxes will be due. If payment of these amounts ultimately proves
to be unnecessary, the reversal of the liabilities would result
in tax benefits being recognized in the period when we determine
the liabilities are no longer necessary. If the estimate of tax
liabilities proves to be less than the ultimate tax assessment,
a further charge to expense would result.
Recent Accounting Pronouncements
In December 2004, the Financial Accounting Standards Board
(FASB) issued FASB Staff Position (FSP)
No. 109-2, Accounting and Disclosure Guidance for the
Foreign Earnings Repatriation Provision within the American Jobs
Creation Act of 2004. The American Jobs Creation Act
introduces a special one-time dividends received deduction on
the repatriation of certain foreign earnings to
U.S. companies, provided certain criteria are met. FSP
No. 109-2 provides accounting and disclosure guidance on
the impact of the repatriation provision on a companys
income tax expense and deferred tax liability. We are currently
studying the impact of the one-time favorable foreign dividend
provision and intend to complete the analysis by the end
44
of fiscal 2005. Accordingly, we have not adjusted our income tax
expense or deferred tax liability to reflect the tax impact of
any repatriation of non-U.S. earnings we may make.
In December 2004, the FASB issued SFAS No. 123(R),
Share-Based Payment, which replaces
SFAS No. 123 and supersedes APB Opinion No. 25.
Under SFAS No. 123(R), companies are required to
measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize
the costs in the financial statements over the period during
which employees are required to provide services. Share-based
compensation arrangements include stock options, restricted
share plans, performance-based awards, share appreciation rights
and employee share purchase plans. Public companies will be
required to apply SFAS No. 123(R) as of the first
interim or annual reporting period beginning after June 15,
2005. The Company expects to adopt SFAS No. 123(R)
beginning the third quarter of fiscal 2005.
SFAS No. 123(R) permits public companies to adopt its
requirements using one of two methods. We are currently
evaluating which method to adopt. The adoption of
SFAS No. 123(R)s fair value method will have a
significant adverse impact on our results of operations,
although it will have no impact on our overall financial
position. The impact of adoption of SFAS No. 123(R)
cannot be predicted at this time because it will depend on
levels of share-based payments granted in the future. However,
had we adopted SFAS No. 123(R) in prior periods, the
impact of that standard would have approximated the impact of
SFAS No. 123 as described in the disclosure of pro
forma net income and earnings per share in Note 1 of Notes
to Consolidated Financial Statements under Item 8 of this
Annual Report on Form 10-K. SFAS No. 123(R) also
requires the benefits of tax deductions in excess of recognized
compensation cost to be reported as a financing cash flow,
rather than as an operating cash flow as required under current
literature. This requirement will reduce net operating cash
flows and increase net financing cash flows in periods after
adoption. While we cannot estimate what those amounts will be in
the future (because they depend on, among other things, when
employees exercise stock options), the amount of operating cash
flows recognized in prior periods for such excess tax deductions
were zero in fiscal 2004, 2003 and 2002, respectively.
In December 2004, the FASB issued SFAS No. 153,
Exchanges of Nonmonetary Assets an Amendment
of APB Opinion No. 29, which eliminates the exception
for nonmonetary exchanges of similar productive assets and
replaces it with a general exception for exchanges of
nonmonetary assets that do not have commercial substance. A
nonmonetary exchange has commercial substance if the future cash
flows of the entity are expected to change significantly as a
result of the exchange. SFAS No. 153 will be effective
for nonmonetary asset exchanges occurring in fiscal periods
beginning after June 15, 2005. We are currently evaluating
SFAS No. 153 and do not expect the adoption will have
a material impact on our consolidated statements of operations
or financial condition.
In November 2004, the FASB issued SFAS No. 151,
Inventory Costs an Amendment of ARB
No. 43, Chapter 4, which clarifies the
accounting for abnormal amounts of idle facility expense,
freight, handling costs and wasted material (spoilage). This
Statement requires that those items be recognized as
current-period charges regardless of whether they meet the
criterion of so abnormal. In addition, this
Statement requires that allocation of fixed production overheads
to the costs of conversion be based on the normal capacity of
the production facilities. SFAS No. 151 will be
effective for inventory costs incurred in fiscal periods
beginning after June 15, 2005. We are currently evaluating
SFAS No. 151 and do not expect the adoption will have
a material impact on our results of operations or financial
condition.
In March 2004, the Emerging Issues Task Force (EITF)
reached a consensus on Issue No. 03-01, The Meaning
of Other-Than-Temporary Impairment and Its Application to
Certain Investments. EITF Issue No. 03-01 provides
guidance on recording other-than-temporary impairments of cost
method investments and requires additional disclosures for those
investments. In September 2004, the FASB delayed the accounting
provisions of EITF Issue No. 03-01; however, the disclosure
requirements remain effective for annual periods ended after
June 15, 2005. We will evaluate the impact of EITF Issue
No. 03-01 once final guidance is issued.
45
ITEM 7A. QUANTITATIVE AND
QUALITATIVE DISCLOSURE ABOUT MARKET RISK
Interest and Foreign Currency Exchange Rates
We are exposed to financial market risks, including changes in
interest rates and foreign currency exchange rates. To mitigate
these risks, we utilize derivative financial instruments. We do
not use derivative financial instruments for speculative or
trading purposes.
The fair value of our investment portfolio would not be
significantly impacted by either a 100 basis point increase
or decrease in interest rates due mainly to the short-term
nature of the major portion of our investment portfolio. An
increase in interest rates would not significantly increase
interest expense due to the fixed nature of our debt obligations.
The majority of our revenues, expenses and capital spending is
transacted in U.S. dollars. However, we do enter into
transactions in other currencies, primarily Euro and Japanese
Yen. To protect against reductions in value and the volatility
of future cash flows caused by changes in foreign exchange
rates, we have established cash flow and balance sheet hedging
programs. Our hedging programs reduce, but do not always
eliminate, the impact of foreign currency exchange rate
movements. During fiscal 2004, we entered into a series of Euro
forward contracts to hedge expected cash flow from one of our
subsidiaries. The total notional amount of the contracts was
$34.0 million. If the forecasted cash flow fails to
materialize, we will have to close out the contracts at the then
prevailing market rates, resulting in gains or losses. A 10%
unfavorable currency movement would result in approximately a
$3.4 million loss on these contracts.
All of the potential changes noted above were based on
sensitivity analyses performed on our balances as of
January 2, 2005.
Equity Options
At January 2, 2005, we had outstanding a series of equity
options on our common stock with an initial cost of
$26.0 million which was classified in stockholders
equity in the Consolidated Balance Sheets. The contracts require
physical settlement and the expiration date will be April 2005.
Upon expiration of the options, if our stock price is above the
threshold price of $21.0 per share, we will receive a
settlement value totaling $30.3 million. If our stock price
is below the threshold price of $21.0 per share, we will
receive 1.4 million shares of our common stock.
Alternatively, the contracts may be renewed and extended. During
fiscal 2004 and 2003, we received total premiums of
$1.8 million and $0.7 million, respectively, upon
extensions of the contracts. The amounts were recorded as a
credit to additional paid-in capital in the Consolidated Balance
Sheets.
In conjunction with the issuance of our 1.25% convertible
subordinated notes (1.25% Notes) in June 2003,
we purchased a call spread option (the Call Spread
Option) on 32.0 million of our common shares
expiring in July 2004 for $49.3 million. The Call Spread
Option was designed to mitigate stock dilution from conversion
of the 1.25% Notes. The Call Spread Option was restructured
in May 2004 into a single contract of two equal parts maturing
on August 16 and September 30, 2004. As of each of the
maturity dates, the Call Spread Option was out of the money and
expired. The expiration of the Call Spread Option had no impact
on our cash balances or operating results in fiscal 2004.
Investments in Privately-Held Companies
We have invested in several privately-held companies, all of
which can be considered in the startup or development stages.
These investments are inherently risky as the market for the
technologies or products they have under development are
typically in the early stages and may never materialize. As of
January 2, 2005, the carrying value of our investments in
development stage companies was $8.8 million.
As our equity investments generally do not permit us to exert
significant influence or control over the entity in which we are
investing, these amounts generally represent our cost of the
investment, less any adjustments we make when we determine that
an investments net realizable value is less than its
carrying cost.
46
The process of assessing whether a particular equity
investments net realizable value is less than its carrying
cost requires a significant amount of judgment. In making this
judgment, we carefully consider the investees cash
position, projected cash flows (both short- and long-term),
financing needs, most recent valuation data, the current
investing environment, management/ownership changes, and
competition. This evaluation process is based on information
that we request from these privately-held companies. This
information is not subject to the same disclosure and audit
requirements as the reports required of U.S. public
companies, and as such, the reliability and accuracy of the data
may vary. Based on our evaluation, we recorded impairment
charges of $1.1 million in fiscal 2004, $1.8 million
in fiscal 2003 and $18.1 million in fiscal 2002, as we
deemed the decline in values was other-than-temporary.
Estimating the net realizable value of investments in
privately-held early-stage technology companies is inherently
subjective and may contribute to volatility in our reported
results of operations and we may in the future incur additional
impairments to our equity investments in privately-held
companies.
Stock Purchase Assistance Plan
At the end of fiscal 2004, other current assets included
$54.1 million of principal and cumulative accrued interest
relating to employees and former employees under the
shareholder-approved 2001 employee stock purchase assistance
plan. We made the loans to employees for the purpose of
purchasing our common stock. Each loan is evidenced by a full
recourse promissory note executed by the employee in favor of
Cypress and is secured by a pledge of the shares of our common
stock purchased with the proceeds of the loan. The primary
benefit to us from this program is increased employee retention.
In accordance with the plan, the chief executive officer and the
Board of Directors do not participate in this program. To date,
there have been immaterial write-offs. As of January 2,
2005, we had an allowance for uncollectible accounts against
these loans of $8.5 million. In determining the allowance
for uncollectible accounts, management considered various
factors, including a review of borrower demographics (including
geographic location and job grade), loan quality and an
independent fair value analysis of the loans and the underlying
collateral. As of January 2, 2005, the carrying value of
the loans exceeded the underlying common stock collateral by
$28.2 million.
In the first quarter of fiscal 2004, we instituted a program
directed at minimizing losses as a result of our common stock
price fluctuations. Under this program, either a limit sale
order or a stop loss order is placed on the common stock
purchased by each employee with the loan proceeds once the
common stock price exceeds that employees break-even
point. If the common stock price reaches the sale limit order or
declines to the stop loss price, the common stock purchased by
the employee under the plan will be automatically sold and the
proceeds utilized to repay the employees outstanding loan
to us.
47
ITEM 8. FINANCIAL STATEMENTS
AND SUPPLEMENTARY DATA
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
Page | |
|
|
| |
|
|
|
49 |
|
|
|
|
50 |
|
|
|
|
51 |
|
|
|
|
52 |
|
|
|
|
53 |
|
|
|
|
103 |
|
|
|
|
105 |
|
48
CYPRESS SEMICONDUCTOR CORPORATION
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands, except per- | |
|
|
share amounts) | |
ASSETS |
Current assets:
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
66,619 |
|
|
$ |
152,024 |
|
|
Short-term investments
|
|
|
178,278 |
|
|
|
46,593 |
|
|
|
|
|
|
|
|
|
|
Total cash, cash equivalents and short-term investments
|
|
|
244,897 |
|
|
|
198,617 |
|
|
Accounts receivable, net
|
|
|
107,288 |
|
|
|
121,756 |
|
|
Inventories
|
|
|
99,709 |
|
|
|
72,085 |
|
|
Other current assets
|
|
|
111,986 |
|
|
|
134,125 |
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
563,880 |
|
|
|
526,583 |
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
444,651 |
|
|
|
442,887 |
|
Goodwill
|
|
|
382,284 |
|
|
|
322,208 |
|
Intangible assets
|
|
|
64,719 |
|
|
|
53,275 |
|
Long-term investments
|
|
|
|
|
|
|
118,437 |
|
Other assets
|
|
|
117,460 |
|
|
|
112,295 |
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
1,572,994 |
|
|
$ |
1,575,685 |
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
Current liabilities:
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
78,624 |
|
|
$ |
60,601 |
|
|
Accrued compensation and employee benefits
|
|
|
42,750 |
|
|
|
39,704 |
|
|
Other current liabilities
|
|
|
75,295 |
|
|
|
87,594 |
|
|
Deferred income on sales to distributors
|
|
|
33,426 |
|
|
|
28,292 |
|
|
Income taxes payable
|
|
|
3,515 |
|
|
|
2,676 |
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
233,610 |
|
|
|
218,867 |
|
|
|
|
|
|
|
|
Convertible subordinated notes
|
|
|
599,998 |
|
|
|
668,652 |
|
Deferred income taxes and other tax liabilities
|
|
|
68,477 |
|
|
|
101,254 |
|
Other long-term liabilities
|
|
|
10,551 |
|
|
|
17,724 |
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
912,636 |
|
|
|
1,006,497 |
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 21)
|
|
|
|
|
|
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
|
Preferred stock, $.01 par value, 5,000 shares
authorized; none issued and outstanding
|
|
|
|
|
|
|
|
|
|
Common stock, $.01 par value, 650,000 and
650,000 shares authorized; 142,157 and 139,164 shares
issued; 128,493 and 120,483 shares outstanding at
January 2, 2005 and December 28, 2003, respectively
|
|
|
1,421 |
|
|
|
1,391 |
|
Additional paid-in-capital
|
|
|
1,149,267 |
|
|
|
1,115,684 |
|
Deferred stock compensation
|
|
|
(1,989 |
) |
|
|
(5,950 |
) |
Accumulated other comprehensive income (loss)
|
|
|
(2,124 |
) |
|
|
1,393 |
|
Accumulated deficit
|
|
|
(306,312 |
) |
|
|
(260,723 |
) |
|
|
|
|
|
|
|
|
|
|
840,263 |
|
|
|
851,795 |
|
Less: shares of common stock held in treasury, at cost; 13,664
and 18,681 shares at January 2, 2005 and
December 28, 2003, respectively
|
|
|
(179,905 |
) |
|
|
(282,607 |
) |
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
660,358 |
|
|
|
569,188 |
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$ |
1,572,994 |
|
|
$ |
1,575,685 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
49
CYPRESS SEMICONDUCTOR CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands, except per-share amounts) | |
Revenues
|
|
$ |
948,438 |
|
|
$ |
836,756 |
|
|
$ |
774,746 |
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues
|
|
|
492,058 |
|
|
|
435,749 |
|
|
|
443,365 |
|
|
Research and development
|
|
|
261,629 |
|
|
|
251,432 |
|
|
|
287,909 |
|
|
Selling, general and administrative
|
|
|
141,799 |
|
|
|
130,349 |
|
|
|
151,689 |
|
|
Restructuring
|
|
|
(164 |
) |
|
|
(6,685 |
) |
|
|
38,251 |
|
|
Amortization and impairment of intangible assets
|
|
|
38,898 |
|
|
|
37,716 |
|
|
|
62,248 |
|
|
Impairment of goodwill
|
|
|
|
|
|
|
|
|
|
|
14,409 |
|
|
In-process research and development charges
|
|
|
15,600 |
|
|
|
|
|
|
|
2,166 |
|
|
Other charges (credits)
|
|
|
|
|
|
|
(3,501 |
) |
|
|
6,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses
|
|
|
949,820 |
|
|
|
845,060 |
|
|
|
1,006,090 |
|
|
|
|
|
|
|
|
|
|
|
Operating loss
|
|
|
(1,382 |
) |
|
|
(8,304 |
) |
|
|
(231,344 |
) |
Interest income
|
|
|
11,115 |
|
|
|
13,024 |
|
|
|
23,117 |
|
Interest expense
|
|
|
(11,354 |
) |
|
|
(15,613 |
) |
|
|
(19,197 |
) |
Other income and (expense), net
|
|
|
(256 |
) |
|
|
8,384 |
|
|
|
(18,836 |
) |
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
(1,877 |
) |
|
|
(2,509 |
) |
|
|
(246,260 |
) |
Benefit from (provision for) income taxes
|
|
|
26,575 |
|
|
|
(2,822 |
) |
|
|
(2,838 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
24,698 |
|
|
$ |
(5,331 |
) |
|
$ |
(249,098 |
) |
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
0.20 |
|
|
$ |
(0.04 |
) |
|
$ |
(2.02 |
) |
|
Diluted
|
|
$ |
0.17 |
|
|
$ |
(0.04 |
) |
|
$ |
(2.02 |
) |
Weighted-average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
124,580 |
|
|
|
121,509 |
|
|
|
123,112 |
|
|
Diluted
|
|
|
134,592 |
|
|
|
121,509 |
|
|
|
123,112 |
|
The accompanying notes are an integral part of these
consolidated financial statements.
50
CYPRESS SEMICONDUCTOR CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other | |
|
Retained | |
|
|
|
|
Common Stock | |
|
Additional | |
|
|
|
|
|
Comprehensive | |
|
Earnings/ | |
|
Total | |
|
|
| |
|
Paid-In | |
|
Deferred Stock | |
|
Treasury | |
|
Income | |
|
(Accumulated | |
|
Stockholders | |
|
|
Shares | |
|
Amount | |
|
Capital | |
|
Compensation | |
|
Stock | |
|
(Loss) | |
|
Deficit) | |
|
Equity | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Balances at December 30, 2001
|
|
|
121,495 |
|
|
$ |
1,391 |
|
|
$ |
1,162,642 |
|
|
$ |
(53,141 |
) |
|
$ |
(349,046 |
) |
|
$ |
2,722 |
|
|
$ |
103,860 |
|
|
$ |
868,428 |
|
Comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(249,098 |
) |
|
|
(249,098 |
) |
Net unrealized loss on available for sale investments, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,689 |
) |
|
|
|
|
|
|
(1,689 |
) |
Net unrealized gain on derivatives, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,343 |
|
|
|
|
|
|
|
1,343 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(249,444 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock and provision for deferred stock-based
compensation in relation to acquisition
|
|
|
112 |
|
|
|
|
|
|
|
6,271 |
|
|
|
(6,606 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(335 |
) |
Repurchase of common stock under stock put program
|
|
|
(250 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,925 |
) |
|
|
|
|
|
|
|
|
|
|
(4,925 |
) |
Re-issuance of treasury shares and issuance of common stock
under employee stock plans and other
|
|
|
2,386 |
|
|
|
|
|
|
|
3,537 |
|
|
|
|
|
|
|
32,372 |
|
|
|
|
|
|
|
(10,678 |
) |
|
|
25,231 |
|
Amortization of deferred stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
(2,007 |
) |
|
|
34,464 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,457 |
|
Repayment from stockholders for notes receivable
|
|
|
|
|
|
|
|
|
|
|
439 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
439 |
|
Premiums received from issuance of put options
|
|
|
|
|
|
|
|
|
|
|
198 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
198 |
|
Structured purchase of options, net
|
|
|
|
|
|
|
|
|
|
|
1,574 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,574 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 29, 2002
|
|
|
123,743 |
|
|
|
1,391 |
|
|
|
1,172,654 |
|
|
|
(25,283 |
) |
|
|
(321,599 |
) |
|
|
2,376 |
|
|
|
(155,916 |
) |
|
|
673,623 |
|
Comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,331 |
) |
|
|
(5,331 |
) |
Net unrealized loss on available for sale investments, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(698 |
) |
|
|
|
|
|
|
(698 |
) |
Net unrealized loss on derivatives, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(285 |
) |
|
|
|
|
|
|
(285 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,314 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repurchase of common stock
|
|
|
(9,300 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(98,903 |
) |
|
|
|
|
|
|
|
|
|
|
(98,903 |
) |
Cash paid for call-spread option
|
|
|
|
|
|
|
|
|
|
|
(49,300 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(49,300 |
) |
Re-issuance of treasury shares and issuance of common stock
under employee stock plans and other
|
|
|
6,040 |
|
|
|
|
|
|
|
1,283 |
|
|
|
|
|
|
|
137,895 |
|
|
|
|
|
|
|
(99,476 |
) |
|
|
39,702 |
|
Amortization of deferred stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
(9,159 |
) |
|
|
19,333 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,174 |
|
Issuance to stockholders for notes receivable
|
|
|
|
|
|
|
|
|
|
|
(445 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(445 |
) |
Structured purchase of options, net
|
|
|
|
|
|
|
|
|
|
|
651 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
651 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 28, 2003
|
|
|
120,483 |
|
|
|
1,391 |
|
|
|
1,115,684 |
|
|
|
(5,950 |
) |
|
|
(282,607 |
) |
|
|
1,393 |
|
|
|
(260,723 |
) |
|
|
569,188 |
|
Comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,698 |
|
|
|
24,698 |
|
Net unrealized loss on available for sale investments, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(828 |
) |
|
|
|
|
|
|
(828 |
) |
Net unrealized loss on derivatives, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,689 |
) |
|
|
|
|
|
|
(2,689 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,181 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock in relation to acquisitions
|
|
|
2,995 |
|
|
|
30 |
|
|
|
32,192 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,222 |
|
Re-issuance of treasury shares and issuance of common stock
under employee stock plans and other
|
|
|
5,155 |
|
|
|
1 |
|
|
|
4,009 |
|
|
|
|
|
|
|
102,702 |
|
|
|
|
|
|
|
(70,287 |
) |
|
|
36,425 |
|
Retirement of shares in relation to acquisition
|
|
|
(140 |
) |
|
|
(1 |
) |
|
|
(2,741 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,742 |
) |
Amortization of deferred stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
(1,667 |
) |
|
|
3,961 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,294 |
|
Structured purchase of options, net
|
|
|
|
|
|
|
|
|
|
|
1,790 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,790 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at January 2, 2005
|
|
|
128,493 |
|
|
$ |
1,421 |
|
|
$ |
1,149,267 |
|
|
$ |
(1,989 |
) |
|
$ |
(179,905 |
) |
|
$ |
(2,124 |
) |
|
$ |
(306,312 |
) |
|
$ |
660,358 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
51
CYPRESS SEMICONDUCTOR CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Cash flow from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
24,698 |
|
|
$ |
(5,331 |
) |
|
$ |
(249,098 |
) |
Adjustments to reconcile net income (loss) to net cash generated
from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
173,038 |
|
|
|
169,054 |
|
|
|
178,296 |
|
|
Amortization of deferred stock-based compensation
|
|
|
2,294 |
|
|
|
10,174 |
|
|
|
32,457 |
|
|
Impairment of goodwill and other intangible assets
|
|
|
|
|
|
|
|
|
|
|
34,712 |
|
|
Impairment of investments
|
|
|
1,123 |
|
|
|
1,792 |
|
|
|
18,100 |
|
|
Impairment related to synthetic lease guarantee
|
|
|
1,825 |
|
|
|
|
|
|
|
|
|
|
In-process research and development charges
|
|
|
15,600 |
|
|
|
|
|
|
|
2,666 |
|
|
Gain on sale of investment in NVE Corp.
|
|
|
|
|
|
|
(17,126 |
) |
|
|
|
|
|
Loss on sales/ write-offs of property, plant and equipment, net
|
|
|
1,259 |
|
|
|
492 |
|
|
|
495 |
|
|
Employee stock purchase assistance plan (SPAP)
interest
|
|
|
(2,013 |
) |
|
|
(3,874 |
) |
|
|
(5,231 |
) |
|
Increase (decrease) in SPAP allowance
|
|
|
(7,752 |
) |
|
|
257 |
|
|
|
14,798 |
|
|
Loss on early retirement of debt
|
|
|
|
|
|
|
3,864 |
|
|
|
754 |
|
|
Equity in losses of SunPower
|
|
|
|
|
|
|
|
|
|
|
1,159 |
|
|
Changes on foreign currency derivatives
|
|
|
(93 |
) |
|
|
954 |
|
|
|
(368 |
) |
|
Restructuring charges (credits)
|
|
|
(407 |
) |
|
|
(8,485 |
) |
|
|
20,335 |
|
|
Stock received for manufacturing services
|
|
|
(5,000 |
) |
|
|
|
|
|
|
|
|
|
Deferred income taxes and other tax liabilities
|
|
|
(32,128 |
) |
|
|
(296 |
) |
|
|
3,408 |
|
|
Other adjustments
|
|
|
(1,509 |
) |
|
|
(1,317 |
) |
|
|
4,281 |
|
Changes in assets and liabilities, net of affects of
acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, net
|
|
|
24,775 |
|
|
|
(30,526 |
) |
|
|
12,525 |
|
|
Inventories, net
|
|
|
(23,192 |
) |
|
|
20,636 |
|
|
|
(19,453 |
) |
|
Other assets
|
|
|
(4,306 |
) |
|
|
6,874 |
|
|
|
7,107 |
|
|
Accounts payable, accrued and other liabilities
|
|
|
(16,968 |
) |
|
|
(54,058 |
) |
|
|
(37,224 |
) |
|
Deferred income on sales to distributors
|
|
|
5,133 |
|
|
|
4,684 |
|
|
|
3,763 |
|
|
Income taxes payable
|
|
|
(584 |
) |
|
|
1,384 |
|
|
|
(8 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash flow generated from operating activities
|
|
|
155,793 |
|
|
|
99,152 |
|
|
|
23,474 |
|
|
|
|
|
|
|
|
|
|
|
Cash flow from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of investments
|
|
|
(117,668 |
) |
|
|
(173,199 |
) |
|
|
(54,317 |
) |
|
Sales or maturities of investments
|
|
|
104,465 |
|
|
|
72,113 |
|
|
|
197,777 |
|
|
Acquisition of property, plant and equipment
|
|
|
(132,280 |
) |
|
|
(78,450 |
) |
|
|
(158,532 |
) |
|
Cash (paid) refunded for acquisitions, net of cash acquired
|
|
|
(89,931 |
) |
|
|
1,247 |
|
|
|
(582 |
) |
|
Sale (purchase) of investment in NVE Corp.
|
|
|
|
|
|
|
23,354 |
|
|
|
(8,319 |
) |
|
Other investments
|
|
|
(884 |
) |
|
|
(1,537 |
) |
|
|
(16,513 |
) |
|
Collection of SPAP loans from employees
|
|
|
28,437 |
|
|
|
29,942 |
|
|
|
17,017 |
|
|
Proceeds from sale of equipment
|
|
|
35 |
|
|
|
6,582 |
|
|
|
3,520 |
|
|
|
|
|
|
|
|
|
|
|
Net cash flow used for investing activities
|
|
|
(207,826 |
) |
|
|
(119,948 |
) |
|
|
(19,949 |
) |
|
|
|
|
|
|
|
|
|
|
Cash flow from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from borrowings
|
|
|
4,000 |
|
|
|
24,678 |
|
|
|
|
|
|
Repayment of borrowings
|
|
|
(7,144 |
) |
|
|
(8,729 |
) |
|
|
|
|
|
Proceeds for issuance of convertible debt
|
|
|
|
|
|
|
600,000 |
|
|
|
|
|
|
Debt issuance costs
|
|
|
|
|
|
|
(18,450 |
) |
|
|
|
|
|
Retirement of convertible debt
|
|
|
(68,443 |
) |
|
|
(400,248 |
) |
|
|
(48,824 |
) |
|
Repurchase of common shares
|
|
|
|
|
|
|
(98,903 |
) |
|
|
(4,925 |
) |
|
Issuance of common shares
|
|
|
36,425 |
|
|
|
39,702 |
|
|
|
24,896 |
|
|
Purchase of call spread on common stock
|
|
|
|
|
|
|
(49,300 |
) |
|
|
|
|
|
(Issuance) repayment of notes to/from stockholders, net
|
|
|
|
|
|
|
(445 |
) |
|
|
439 |
|
|
Premiums received from put options
|
|
|
|
|
|
|
|
|
|
|
198 |
|
|
Structured purchase of options, net
|
|
|
1,790 |
|
|
|
651 |
|
|
|
1,574 |
|
|
Other liabilities, including minority interest
|
|
|
|
|
|
|
2,967 |
|
|
|
(5,985 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash flow generated from (used for) financing activities
|
|
|
(33,372 |
) |
|
|
91,923 |
|
|
|
(32,627 |
) |
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
(85,405 |
) |
|
|
71,127 |
|
|
|
(29,102 |
) |
Cash and cash equivalents, beginning of year
|
|
|
152,024 |
|
|
|
80,897 |
|
|
|
109,999 |
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of year
|
|
$ |
66,619 |
|
|
$ |
152,024 |
|
|
$ |
80,897 |
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid (received) during the year for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$ |
12,580 |
|
|
$ |
22,227 |
|
|
$ |
21,877 |
|
|
|
Income taxes
|
|
$ |
2,645 |
|
|
$ |
2,110 |
|
|
$ |
(7,993 |
) |
|
Non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for acquisitions
|
|
$ |
32,222 |
|
|
$ |
|
|
|
$ |
2,300 |
|
|
|
Retirement of shares for acquisition
|
|
$ |
2,742 |
|
|
$ |
|
|
|
$ |
|
|
|
|
Stock received for manufacturing services
|
|
$ |
5,000 |
|
|
$ |
|
|
|
$ |
|
|
The accompanying notes are an integral part of these
Consolidated Financial Statements.
52
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1 Description of Business and Summary
of Significant Accounting Policies
Description of Business
Cypress Semiconductor Corporation (Cypress or the
Company) designs, develops, manufactures and markets
a broad line of high-performance digital and mixed-signal
integrated circuits for a broad range of markets including
networking, wireless infrastructure and handsets, computation,
consumer, automotive, and industrial. In addition, the Company
designs and manufactures high-performance silicon solar cells.
The Company has four product divisions and four subsidiaries,
organized into three reportable business segments: Memory,
Non-Memory and SunPower. In addition, in order to enhance focus
on the communications market and our end customers, the Company
reports information by the following market segments: Wide Area
Networks and Storage Area Networks (WAN/ SAN),
Wireless Infrastructure and Wireless Terminal (WIN/
WIT), Computation and Consumer, and Cypress Subsidiaries.
See Note 22 for a detailed discussion on segment
information.
The Companys operations outside of the U.S. include
its manufacturing facility, assembly and test plant and regional
headquarters in the Philippines, and several sales offices and
design centers located in various parts of the world.
Financial Statement Preparation
The consolidated financial statements are prepared in accordance
with accounting principles generally accepted in the United
States and include the accounts of the Company and all of its
subsidiaries. Inter-company transactions and balances have been
eliminated in consolidation.
Fiscal Years
The Companys fiscal year ends on the Sunday closest to
December 31. Fiscal 2004 ended on January 2, 2005 and
included 53 weeks. Fiscal 2003 and 2002 ended on
December 28, 2003 and December 29, 2002, respectively,
and each included 52 weeks. The Companys fiscal
quarters end on the Sunday closest to the end of the applicable
calendar quarter, except in a 53-week fiscal year, in which case
the additional week falls into the fourth quarter of that fiscal
year.
Management Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States
requires management to make estimates and assumptions that
affect the amounts reported in the financial statements and
accompanying notes. Significant estimates in these financial
statements primarily include reserves for inventory, reserves
for deferred income, reserves for price adjustment on sales to
distributors, sales return reserves, restructuring charges,
allowances for doubtful accounts, asset impairments, reserves
for loans under the shareholder-approved 2001 employee stock
purchase assistance plan, certain accrued liabilities, income
taxes and tax valuation allowances. Actual results could differ
from those estimates.
Reclassifications
Certain prior-year amounts have been reclassified to conform to
current-year presentations.
Fair Value of Financial Instruments
For certain of the Companys financial instruments,
including cash and cash equivalents, accounts receivable,
accounts payable and other current liabilities, the carrying
amounts approximate their fair value due to the relatively short
maturity of these items. Investments in debt and equity
securities and foreign
53
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
currency derivative financial instruments are carried at fair
value based on quoted market prices or estimated based on quoted
market prices for financial instruments with similar
characteristics.
Cash and Cash Equivalents
Highly liquid investments with original or remaining maturities
of ninety days or less at the date of purchase are considered
cash equivalents.
Investments
All of the Companys investments in debt securities are
classified as available-for-sale. Available-for-sale securities
with maturities greater than twelve months are classified as
short term when they represent investments of cash that are
intended for use in current operations. Investments in
available-for-sale securities are reported at fair value with
unrealized gains and losses, net of related tax, as a component
of accumulated other comprehensive income (loss). The Company
also has other minority equity investments in privately-held
companies. These investments are included in other assets on the
Consolidated Balance Sheets and are generally carried at cost.
The Company monitors these investments for impairment
periodically and records appropriate reductions in carrying
values when declines are deemed to be other-than-temporary.
Inventories
Inventories are stated at the lower of standard cost (which
approximates actual cost on a first-in, first-out basis) or
market. Market is based on estimated net realizable value. The
Company establishes lower of cost or market reserves, aged
inventory reserves and obsolescence reserves. Inventory reserves
are generally recorded when the inventory for a device exceeds
nine months of demand for that device or when slow-moving parts
have not been sold for more than six months. Inventory reserves
are not relieved until the related inventory has been sold or
scrapped.
Goodwill and Purchased Intangibles
Effective fiscal 2002, the Company adopted Statement of
Financial Accounting Standards (SFAS) No. 142,
Goodwill and Other Intangible Assets. Goodwill and
purchased intangibles with indefinite lives are not amortized
but are tested for impairment on an annual basis or whenever
events or changes in circumstances indicate that the carrying
amount of these assets may not be recoverable. Purchased
intangible assets with finite useful lives are amortized using
the straight-line method over their useful lives ranging from 2
to 6 years and are reviewed for impairment in accordance
with SFAS No. 144, Accounting for the Impairment
or Disposal of Long-Lived Assets.
Property, Plant and Equipment
Property, plant and equipment are stated at cost, less
accumulated depreciation. Depreciation is computed for financial
reporting purposes using the straight-line method over the
estimated useful lives of the assets as presented below.
Leasehold improvements and leasehold interests are amortized
over the shorter of the estimated useful lives of the assets or
the remaining term of the lease.
|
|
|
|
|
|
|
Useful Lives | |
|
|
| |
|
|
(In years) | |
Equipment
|
|
|
3 to 7 |
|
Buildings and leasehold improvements
|
|
|
5 to 20 |
|
Furniture and fixtures
|
|
|
5 to 7 |
|
54
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Long-Lived Assets
The Company evaluates its long-lived assets, including property,
plant and equipment and purchased intangible assets with finite
lives, for impairment whenever events or changes in
circumstances indicate that the carrying value of such assets
may not be recoverable in accordance with
SFAS No. 144. Factors considered important that could
result in an impairment review include significant
underperformance relative to expected historical or projected
future operating results, significant changes in the manner of
use of acquired assets, significant negative industry or
economic trends, and a significant decline in the Companys
stock price for a sustained period of time. Impairments are
recognized based on the difference between the fair value of the
asset and its carrying value. Fair value is generally measured
based on either quoted market prices, if available, or
discounted cash flow analyses.
Revenue Recognition
The Company generates revenues by selling products to original
equipment manufacturers and distributors. The Companys
policy is to recognize revenues from sales to customers when
titles and the rights and risks of ownership have passed to the
customers, persuasive evidence of arrangements exist, products
have been delivered, prices are fixed and determinable, and
collection of the resulting receivables is reasonably assured.
Customers do not have post-delivery product acceptance rights.
The Companys policies related to post-shipment
obligations, rebates and other dealer/distributor incentives,
and price protection or similar rights are as follows:
|
|
|
|
|
Post-shipment obligations the Companys
principal obligations are: (i) rights to limited stock
rotation to U.S.-based distributors for which revenues and
related cost of sales are deferred as discussed below, and
(ii) quality-related issues for which a warranty reserve is
provided by the Company. |
|
|
|
Rebates and other dealer/distributor incentives the
Company provides a volume-pricing discount to certain contract
manufactures, which is recorded as a reduction in revenue. These
volume discounts have not historically been significant. |
|
|
|
Price protection or similar rights the Company
offers price protection and similar rights to certain U.S.-based
distributors. In addition, the Company provides limited stock
rotation rights to these distributors. Given the uncertainties
associated with the levels of returns and price adjustments and
similar credits granted to these distributors, revenues and
related costs of sales are deferred, on a gross basis, until
such rights lapse, which is generally upon receiving
notifications from the distributors that they have resold the
products. |
Shipping and Handling Costs
Cypress records costs related to shipping and handling in cost
of sales.
Advertising Costs
Advertising costs consist of development and placement costs of
our advertising campaigns and are charged to expense when
incurred. Advertising expense was approximately
$3.6 million, $3.7 million and $6.1 million for
fiscal 2004, 2003 and 2002, respectively.
Net Income (Loss) Per Share
Basic net income (loss) per share and diluted net loss per share
are computed using the weighted-average common shares
outstanding. Diluted net income per share is computed using the
weighted-average common
55
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
shares outstanding plus any potentially dilutive securities,
except when their effect is anti-dilutive. Dilutive securities
include stock options and convertible debt.
Translation of Foreign Currencies
The Company uses the U.S. dollar as its functional currency
for all foreign subsidiaries. Accordingly, assets and
liabilities of these subsidiaries are translated using exchange
rates in effect at the end of the period, except for
non-monetary assets, such as property, plant and equipment,
which are translated using historical exchange rates. Revenues
and costs are translated using average exchange rates for the
period, except for income items related to non-monetary assets
and liabilities, such as depreciation, that are translated using
historical exchange rates. The resulting translation gains and
losses are included in other income and (expense), net in the
Consolidated Statements of Operations.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to
concentrations of credit risk are primarily investments in debt
and equity securities and trade accounts receivable. The
Companys investment policy requires cash investments to be
placed with high-credit quality institutions and to limit the
amount of credit risk from any one issuer.
The Company sells its products to original equipment
manufacturers and distributors throughout the world. The Company
performs ongoing credit evaluations of its customers
financial condition whenever deemed necessary and generally does
not require collateral. The Company maintains an allowance for
doubtful accounts based upon the expected collectibility of all
accounts receivable. Arrow Electronics, a distributor, accounted
for approximately 13% and 14% of total accounts receivable at
January 2, 2005 and December 28, 2003, respectively.
No individual customer accounted for greater than 10% of total
accounts receivable at December 29, 2002.
Sales to distributors accounted for 50% of our total revenues in
fiscal 2004, compared with 48% in fiscal 2003 and 46% in fiscal
2002.
Sales to Arrow Electronics accounted for approximately 15% of
total revenues in fiscal 2004. No individual customer accounted
for greater than 10% of total revenues in fiscal 2003. Sales to
Motorola accounted for approximately 10% of total revenues in
fiscal 2002.
Accounting for Stock-Based Compensation
The Company has a number of stock-based employee compensation
plans and accounts for these plans under the recognition and
measurement principles of Accounting Principles Board
(APB) Opinion No. 25, Accounting for
Stock Issued to Employees, and the related interpretation.
In certain instances, the Company reflects stock-based employee
compensation cost in net income (loss). If there is any
compensation under APB No. 25, the expense is amortized
using an accelerated method prescribed under the rules of FASB
Interpretation No. 28, Accounting for Stock
Appreciation Rights and Other Variable Stock Option or Award
Plans. The following table illustrates the effect on net
income (loss) and related per-share amounts if the
56
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Company had applied the fair value recognition provisions of
SFAS No. 123, Accounting for Stock-Based
Compensation, to all stock-based employee awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands, except per-share amounts) | |
Net income (loss) as reported
|
|
$ |
24,698 |
|
|
$ |
(5,331 |
) |
|
$ |
(249,098 |
) |
Add: Total stock-based employee compensation expense
reported in net income (loss), net of related tax effects
|
|
|
2,294 |
|
|
|
10,174 |
|
|
|
32,457 |
|
Deduct: Total stock-based employee compensation expense
determined under fair value based method for all awards, net of
related tax effects
|
|
|
(87,572 |
) |
|
|
(62,590 |
) |
|
|
(130,953 |
) |
|
|
|
|
|
|
|
|
|
|
Net loss pro forma
|
|
$ |
(60,580 |
) |
|
$ |
(57,747 |
) |
|
$ |
(347,594 |
) |
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic as reported
|
|
$ |
0.20 |
|
|
$ |
(0.04 |
) |
|
$ |
(2.02 |
) |
|
Diluted as reported
|
|
$ |
0.17 |
|
|
$ |
(0.04 |
) |
|
$ |
(2.02 |
) |
|
Basic pro forma
|
|
$ |
(0.49 |
) |
|
$ |
(0.48 |
) |
|
$ |
(2.82 |
) |
|
Diluted pro forma
|
|
$ |
(0.50 |
) |
|
$ |
(0.48 |
) |
|
$ |
(2.82 |
) |
Shares used in per-share calculation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic as reported
|
|
|
124,580 |
|
|
|
121,509 |
|
|
|
123,112 |
|
|
Diluted as reported
|
|
|
134,592 |
|
|
|
121,509 |
|
|
|
123,112 |
|
|
Basic pro forma
|
|
|
124,580 |
|
|
|
121,509 |
|
|
|
123,112 |
|
|
Diluted pro forma
|
|
|
124,800 |
|
|
|
121,509 |
|
|
|
123,112 |
|
Income Taxes
The provision for income taxes is determined using the asset and
liability approach of accounting for income taxes. Under this
approach, deferred taxes represent the future tax consequences
expected to occur when the reported amounts of assets and
liabilities are recovered or paid. The provision for income
taxes represents income taxes paid or payable for the current
year plus the change in deferred taxes during the year. Deferred
taxes result from differences between the financial and tax
basis of the Companys assets and liabilities and are
adjusted for changes in tax rates and tax laws when changes are
enacted. Valuation allowances are recorded to reduce deferred
tax assets when it is more likely than not that a tax benefit
will not be realized.
The Company is currently studying the impact of the one-time
favorable foreign dividend provision recently enacted as part of
the American Jobs Creation Act of 2004, and intends to complete
the analysis by the end of fiscal 2005. As of January 2,
2005, and based on the tax laws in effect at that time, it was
the Companys intention to continue to indefinitely
reinvest its undistributed foreign earnings and accordingly, no
deferred tax liability has been recorded on these undistributed
foreign earnings.
The calculation of tax liabilities involves dealing with
uncertainties in the application of complex global tax
regulations. The Company recognizes potential liabilities for
anticipated tax audit issues in the U.S. and other tax
jurisdictions based on its estimate of whether, and the extent
to which, additional taxes will be due. If payment of these
amounts ultimately proves to be unnecessary, the reversal of the
liabilities would result in tax benefits being recognized in the
period when the Company determines the liabilities are no longer
necessary.
57
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
If the estimate of tax liabilities proves to be less than the
ultimate assessment, a further charge to expense would result.
Recent Accounting Pronouncements
In December 2004, the Financial Accounting Standards Board
(FASB) issued FASB Staff Position (FSP)
No. 109-2, Accounting and Disclosure Guidance for the
Foreign Earnings Repatriation Provision within the American Jobs
Creation Act of 2004. The American Jobs Creation Act
introduces a special one-time dividends received deduction on
the repatriation of certain foreign earnings to
U.S. companies, provided certain criteria are met. FSP
No. 109-2 provides accounting and disclosure guidance on
the impact of the repatriation provision on a companys
income tax expense and deferred tax liability. The Company is
currently studying the impact of the one-time favorable foreign
dividend provision and intends to complete the analysis by the
end of fiscal 2005. Accordingly, the Company has not adjusted
its income tax expense or deferred tax liability to reflect the
tax impact of any repatriation of non-U.S. earnings it may
make.
In December 2004, the FASB issued SFAS No. 123(R),
Share-Based Payment, which replaces
SFAS No. 123 and supersedes APB Opinion No. 25.
Under SFAS No. 123(R), companies are required to
measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize
the costs in the financial statements over the period during
which employees are required to provide services. Share-based
compensation arrangements include stock options, restricted
share plans, performance-based awards, share appreciation rights
and employee share purchase plans. Public companies will be
required to apply SFAS No. 123(R) as of the first
interim or annual reporting period beginning after June 15,
2005. The Company expects to adopt SFAS No. 123(R) in
the third quarter of fiscal 2005. SFAS No. 123(R)
permits public companies to adopt its requirements using one of
two methods. The Company is currently evaluating which method to
adopt. The adoption of SFAS No. 123(R)s fair
value method will have a significant adverse impact on the
Companys results of operations, although it will have no
impact on its overall financial position. The impact of adoption
of SFAS No. 123(R) cannot be predicted at this time
because it will depend on levels of share-based payments granted
in the future. However, had the Company adopted
SFAS No. 123(R) in prior periods, the impact of that
standard would have approximated the impact of
SFAS No. 123 as described under the Accounting
for Stock-Based Compensation section in Note 1.
SFAS No. 123(R) also requires the benefits of tax
deductions in excess of recognized compensation cost to be
reported as a financing cash flow, rather than as an operating
cash flow as required under current literature. This requirement
will reduce net operating cash flows and increase net financing
cash flows in periods after adoption. While the Company cannot
estimate what those amounts will be in the future (because they
depend on, among other things, when employees exercise stock
options), the amount of operating cash flows recognized in prior
periods for such excess tax deductions were zero in fiscal 2004,
2003 and 2002, respectively.
In December 2004, the FASB issued SFAS No. 153,
Exchanges of Nonmonetary Assets an Amendment
of APB Opinion No. 29, which eliminates the exception
for nonmonetary exchanges of similar productive assets and
replaces it with a general exception for exchanges of
nonmonetary assets that do not have commercial substance. A
nonmonetary exchange has commercial substance if the future cash
flows of the entity are expected to change significantly as a
result of the exchange. SFAS No. 153 will be effective
for nonmonetary asset exchanges occurring in fiscal periods
beginning after June 15, 2005. The Company is currently
evaluating SFAS No. 153 and does not expect the
adoption will have a material impact on its results of
operations or financial condition.
In November 2004, the FASB issued SFAS No. 151,
Inventory Costs an Amendment of ARB
No. 43, Chapter 4, which clarifies the
accounting for abnormal amounts of idle facility expense,
freight, handling costs and wasted material (spoilage).
SFAS No. 151 requires that those items be recognized
as current-period charges regardless of whether they meet the
criterion of so abnormal. In addition,
58
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
SFAS No. 151 requires that allocation of fixed
production overheads to the costs of conversion be based on the
normal capacity of the production facilities.
SFAS No. 151 will be effective for inventory costs
incurred in fiscal periods beginning after June 15, 2005.
The Company is currently evaluating SFAS No. 151 and
does not expect the adoption will have a material impact on its
results of operations or financial condition.
In March 2004, the Emerging Issues Task Force (EITF)
reached a consensus on Issue No. 03-01, The Meaning
of Other-Than-Temporary Impairment and Its Application to
Certain Investments. EITF Issue No. 03-01 provides
guidance on recording other-than-temporary impairments of cost
method investments and requires additional disclosures for those
investments. In September 2004, the FASB delayed the accounting
provisions of EITF Issue No. 03-01; however, the disclosure
requirements remain effective for annual periods ended after
June 15, 2005. The Company will evaluate the impact of EITF
Issue No. 03-01 once final guidance is issued.
Note 2 SunPower Corporation
(SunPower)
During the first quarter of fiscal 2003, the Company gained
effective control over SunPower, a company specializing in
high-performance silicon solar cell technology. As a result,
effective the beginning of fiscal 2003, the Company consolidated
the results of SunPower, which had previously been accounted for
under the equity method in fiscal 2002 due to the existence of
substantive participating rights of the minority shareholders.
The total purchase price of $8.8 million paid for the
Companys investment in SunPower was allocated to the
estimated fair value of assets and liabilities as of the date of
acquisition. The following table summarizes the allocation:
|
|
|
|
|
|
|
(In thousands) | |
Net tangible assets
|
|
$ |
4,846 |
|
In-process research and development
|
|
|
2,166 |
|
Purchased technology
|
|
|
1,082 |
|
Other assets
|
|
|
400 |
|
Deferred tax liability
|
|
|
(524 |
) |
Minority interest
|
|
|
(2,083 |
) |
Goodwill
|
|
|
2,883 |
|
|
|
|
|
Total purchase consideration
|
|
$ |
8,770 |
|
|
|
|
|
Minority interest in the net losses of SunPower of zero and
$1.0 million was included in other income and (expense),
net for fiscal 2004 and 2003, respectively. The minority
shareholders investment in SunPower, which was included in
other long-term liabilities, had been reduced to zero at the end
of the second quarter of fiscal 2003. Losses attributable to the
minority shareholders subsequent to the second quarter of fiscal
2003 were borne solely by the Company.
The Company and its chief executive officer owned preferred
stock of SunPower, which was convertible into SunPowers
common stock. During the second quarter of fiscal 2004, the
Company entered into a reorganization agreement with SunPower to
purchase all of the outstanding shares of SunPowers common
stock in exchange for shares of the Companys common stock.
Holders of SunPowers preferred stock, including the
Company and its chief executive officer, were entitled to
participate in this arrangement by converting their preferred
stock into common stock. As of the end of the third quarter of
fiscal 2004, the Company and its chief executive officer owned
approximately 56% and 6%, respectively, of SunPower on an
as-converted basis.
59
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
On November 9, 2004, the Company completed the acquisition
of all of the outstanding minority interest of SunPower. Except
for the Company, all SunPowers preferred holders,
including the Companys chief executive officer, converted
their shares into SunPowers common stock. Pursuant to the
terms of the acquisition, each outstanding share of
SunPowers common stock was exchanged for 0.17 share
of the Companys common stock. The exchange resulted in the
issuance of 2.5 million shares of the Companys common
stock valued at $24.7 million. The value was derived using
an average closing price of the Companys common stock of
$9.71. SunPower is a reportable business segment.
As a result of the acquisition, the Companys chief
executive officer converted his preferred shares into
approximately 1,383,000 shares of SunPowers common
stock, which was then exchanged for 235,000 shares of the
Companys common stock.
The following table summarizes the purchase consideration:
|
|
|
|
|
|
|
(In thousands) | |
Value of common stock issued
|
|
$ |
24,662 |
|
Acquisition costs
|
|
|
550 |
|
Less: Conversion of SunPowers debt to equity
|
|
|
(2,025 |
) |
|
|
|
|
Total purchase consideration
|
|
$ |
23,187 |
|
|
|
|
|
The allocation of the purchase consideration was as follows:
|
|
|
|
|
|
|
|
(In thousands) | |
Acquired identifiable intangible assets:
|
|
|
|
|
|
Purchased technology
|
|
$ |
17,311 |
|
|
Patents
|
|
|
3,811 |
|
|
Trademarks
|
|
|
1,603 |
|
|
Distribution agreement
|
|
|
427 |
|
|
Other
|
|
|
35 |
|
|
|
|
|
Total purchase consideration
|
|
$ |
23,187 |
|
|
|
|
|
|
|
|
Acquired Identifiable Intangible Assets: |
The fair value attributed to purchased technology was determined
using the income approach method, which was based on a
discounted forecast of the estimated net future cash flows to be
generated from the technology using discount rates of 20% and
27%. The fair value of purchased technology is being amortized
over 3 to 6 years on a straight-line basis.
The fair value of patents was determined using the royalty
savings approach method, which calculated the present value of
the royalty savings related to the intangible assets using a
royalty rate of 4% and a discount rate of 27%. The fair value of
patents is being amortized over 6 years on a straight-line
basis.
The fair value of trademarks was determined using the royalty
savings approach method, which calculated the present value of
the royalty savings related to the intangible assets using a
royalty rate of 0.5% and a discount rate of 27%. The fair value
of trademarks is being amortized over 6 years on a
straight-line basis.
The fair value attributed to distribution agreement was
determined using the income approach method, which was based on
a discounted forecast of the estimated net future cash flows to
be generated from the
60
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
agreement using a discount rate of 25%. The fair value of the
distribution agreement is being amortized over 2 years on a
straight-line basis.
|
|
|
In-Process Research and Development: |
No in-process research and development projects existed as of
the acquisition date. The A-300 solar cell project was
considered purchased technology because the technology has been
validated, and the manufacturing process was being completed to
ramp up volume production in fiscal 2005. Furthermore, no
development work had begun yet on the next generation solar cell.
|
|
|
Pro Forma Financial Information: |
Pro forma results of operations have not been presented because
the historical results of operations of SunPower have been
consolidated into the Companys results effective the
beginning of fiscal 2003.
Note 3 Business Combinations
The Company completed three acquisitions in fiscal 2004 and one
in fiscal 2002. No acquisitions were made during fiscal 2003.
Details of the acquisitions are provided below.
2004 Acquisitions
SunPower:
Refer to Note 2 above.
FillFactory N.V. (FillFactory):
On August 4, 2004, the Company completed the acquisition of
FillFactory, a company based in Belgium specializing in active
pixel complimentary metal oxide semiconductor (CMOS)
image sensor technology. The fair value of assets acquired and
liabilities assumed were recorded in the Companys
consolidated balance sheet as of August 4, 2004, the
effective date of the acquisition, and the results of operations
were included in the Companys consolidated results of
operations subsequent to August 4, 2004. There were no
significant differences between the accounting policies of the
Company and FillFactory. FillFactory is part of the
Companys Memory business segment and impacts various
market segments.
Under the terms of the acquisition, the Company acquired 100% of
the outstanding capital stock of FillFactory in exchange for an
aggregate of $100.0 million in cash. The following table
summarizes the total purchase consideration:
|
|
|
|
|
|
|
(In thousands) | |
Cash
|
|
$ |
100,000 |
|
Acquisition costs
|
|
|
1,353 |
|
|
|
|
|
Total purchase consideration
|
|
$ |
101,353 |
|
|
|
|
|
61
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The allocation of the purchase consideration was as follows:
|
|
|
|
|
|
|
|
(In thousands) | |
Net tangible assets
|
|
$ |
8,857 |
|
Acquired identifiable intangible assets:
|
|
|
|
|
|
Purchased technology
|
|
|
5,600 |
|
|
Patents
|
|
|
6,400 |
|
|
Customer contracts
|
|
|
7,500 |
|
|
Trademarks
|
|
|
1,300 |
|
In-process research and development
|
|
|
15,600 |
|
Deferred tax liabilities
|
|
|
(7,071 |
) |
Goodwill
|
|
|
63,167 |
|
|
|
|
|
Total purchase consideration
|
|
$ |
101,353 |
|
|
|
|
|
Net tangible assets acquired consisted of the following:
|
|
|
|
|
|
|
|
(In thousands) | |
Cash and cash equivalents
|
|
$ |
8,343 |
|
Trade accounts receivable, net
|
|
|
4,990 |
|
Inventories
|
|
|
2,735 |
|
Property and equipment
|
|
|
893 |
|
Other assets
|
|
|
768 |
|
|
|
|
|
|
Total assets acquired
|
|
|
17,729 |
|
|
|
|
|
Accounts payable
|
|
|
(4,292 |
) |
Other accrued expenses and liabilities
|
|
|
(4,580 |
) |
|
|
|
|
|
Total liabilities assumed
|
|
|
(8,872 |
) |
|
|
|
|
Net tangible assets acquired
|
|
$ |
8,857 |
|
|
|
|
|
|
|
|
Acquired Identifiable Intangible Assets: |
The fair value attributed to purchased technology was determined
using the income approach method, which was based on a
discounted forecast of the estimated net future cash flows to be
generated from the technology using a discount rate of 20%. The
fair value of purchased technology is being amortized over
4 years on a straight-line basis.
The fair value of patents was determined using the royalty
savings approach method, which calculated the present value of
the royalty savings related to the intangible assets using a
royalty rate of 5% and a discount rate of 40%. The fair value of
patents is being amortized over 4 years on a straight-line
basis.
The fair value attributed to customer contracts was determined
using the income approach method, which was based on a
discounted forecast of the estimated net future cash flows to be
generated from the contracts using discount rates of 17% to 23%.
The fair value of customer contracts is being amortized over
4 years on a straight-line basis.
The fair value attributed to trademarks was determined using the
royalty savings approach method, which calculated the present
value of the royalty savings related to the intangible assets
using a royalty rate of 0.5% and a discount rate of 28%. The
fair value of trademarks is being amortized over 4 years on
a straight-line basis.
62
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
In-Process Research and Development: |
The Company identified in-process research and development
projects in areas for which technological feasibility had not
been established and no alternative future use existed. These
in-process research and development projects include the
development of new image sensors in FillFactorys custom
and standard product applications. Specifically, the custom
products include industrial, automotive, medical and high-end
photography, and the standard products include high-end
photography, digital still cameras and wireless terminal
cameras. In assessing the projects, the Company considered key
characteristics of the technology as well as its future
prospects, the rate technology changes in the industry, product
life cycles, and various projects stage of development.
The Company allocated $15.6 million of the purchase price
to the in-process research and development projects and wrote
off the amount in the third quarter of fiscal 2004.
The value of in-process research and development was determined
using the income approach method, which calculated the sum of
the discounted future cash flows attributable to the projects
once commercially viable using discount rates ranging from 28%
to 50%, which was derived from a weighted-average cost of
capital analysis and adjusted to reflect the stage of completion
of the projects and the level of risks associated with the
projects. The percentage of completion for each project was
determined by identifying the research and development expenses
invested in the project as a ratio of the total estimated
development costs required to bring the project to technical and
commercial feasibility. The following table summarizes certain
information of each significant project as of the acquisition
date:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Stage |
|
Total Estimated |
|
Estimated |
Projects |
|
of Completion |
|
Costs to Complete |
|
Completion Dates |
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
|
Industrial
|
|
|
54% |
|
|
$ |
6,495 |
|
|
|
05/02/2005 |
|
Digital still and wireless terminal cameras
|
|
|
11% |
|
|
|
3,609 |
|
|
|
06/01/2005 |
|
Medical
|
|
|
46% |
|
|
|
2,395 |
|
|
|
06/01/2005 |
|
Automotive
|
|
|
50% |
|
|
|
971 |
|
|
|
01/01/2006 |
|
High-end photography
|
|
|
31% |
|
|
|
659 |
|
|
|
04/28/2005 |
|
FillFactory offers a variety of high-performance custom and
standard products for some of the industrys most advanced
digital photography, high-speed imaging, machine vision and
automotive applications. Through this acquisition, the
Companys goals are to increase its sales into the cellular
phone markets and to augment its penetration of additional
market segments, including digital still cameras and automotive
sensors. These factors primarily contributed to a purchase price
which resulted in goodwill. In accordance with
SFAS No. 142, goodwill is not amortized but will be
tested for impairment at least annually. Goodwill from the
FillFactory acquisition is not expected to be deductible for tax
purposes.
|
|
|
Pro Forma Financial Information: |
The following unaudited pro forma financial information presents
the combined results of operations of the Company and
FillFactory as if the acquisition had occurred as of the
beginning of the periods presented. The unaudited pro forma
financial information is not intended to represent or be
indicative of the consolidated results of operations or
financial condition of the Company that would have been reported
had the acquisition been completed as of the beginning of the
periods presented, and should not be taken as representative of
the
63
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
future consolidated results of operations or financial condition
of the Company. Pro forma results were as follows:
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands, except per | |
|
|
share amounts) | |
Revenues
|
|
$ |
963,737 |
|
|
$ |
856,427 |
|
Net income (loss)
|
|
$ |
21,751 |
|
|
$ |
(11,753 |
) |
Basic net income (loss) per share
|
|
$ |
0.17 |
|
|
$ |
(0.10 |
) |
Diluted net income (loss) per share
|
|
$ |
0.15 |
|
|
$ |
(0.10 |
) |
Cascade Semiconductor Corporation (Cascade):
On January 6, 2004, the Company acquired 100% of the
outstanding common and preferred stock of Cascade, a company
specializing in one-transistor pseudo static random access
memory products for wireless applications, including mobile
phones. Cascade is part of the Companys Memory business
segment and Wireless Terminals market segment.
The fair value of assets acquired and liabilities assumed were
included in the Companys consolidated balance sheet as of
January 6, 2004, and the results of operations were
included in the Companys consolidated results of
operations subsequent to January 6, 2004. There were no
significant differences between the accounting policies of the
Company and Cascade.
Purchase consideration of $9.6 million consisted of:
(1) 290,000 shares of common stock valued at
$6.0 million issued upon closing, and (2) an
additional $3.0 million in share consideration to former
stockholders as a result of the achievement of the milestone in
the first quarter of fiscal 2004, of which 164,000 shares
of common stock valued at $1.5 million were issued in the
fourth quarter of fiscal 2004 and 147,000 shares of common
stock valued at $1.5 million were issued in the first
quarter of fiscal 2005. In addition, purchase consideration
included $0.6 million in acquisition and related expenses.
The allocation of the purchase consideration was as follows:
|
|
|
|
|
|
|
|
(In thousands) | |
Current assets
|
|
$ |
7,960 |
|
Current liabilities
|
|
|
(4,719 |
) |
|
|
|
|
Net tangible assets acquired
|
|
|
3,241 |
|
Acquired identifiable intangible assets:
|
|
|
|
|
|
Purchased technology
|
|
|
6,289 |
|
|
Non-compete agreements
|
|
|
65 |
|
|
|
|
|
Total purchase consideration
|
|
$ |
9,595 |
|
|
|
|
|
|
|
|
Contingent Consideration: |
In addition to the purchase consideration, the terms of the
acquisition also included contingent consideration of
approximately $9.4 million representing contingent payable
to employees based on either revenue milestone achievement and
employment conditions, or employment conditions alone, through
January 2007. Where the contingency is based on milestone
achievements and employment conditions, no
64
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
charge is recognized until it is probable that the milestone
conditions will be reached at which point any contingent
consideration will be recognized over the employment-vesting
period. Employment-only contingent consideration is recognized
over the employment-vesting period. During fiscal 2004, the
Company recorded total charges of $4.8 million related to
the achievement of revenue milestones and vesting of employment
service periods. The $4.8 million charge consisted of the
following: (1) 155,000 shares valued at
$1.6 million (issued in the fourth quarter of fiscal 2004)
and 145,000 shares valued at $1.6 million (issued in
the first quarter of fiscal 2005), and (2) an additional
$1.6 million to be paid in cash or shares at the
Companys option. As of January 2, 2005,
$3.2 million of the charge was accrued in accrued
compensation and employee benefits in the Consolidated Balance
Sheet.
|
|
|
Acquired Identifiable Intangible Assets: |
The fair value attributed to purchased technology and
non-compete agreements was determined using the income approach
method, which was based on a discounted forecast of the
estimated net future cash flows to be generated from the
intangible assets using a discount rate of 20%. The fair value
of purchased technology and non-compete agreements is being
amortized over 2 years on a straight-line basis.
|
|
|
Pro Forma Financial Information: |
Pro forma results of operations have not been presented because
the historical results of operations of Cascade were not
material to the Companys consolidated results of
operations.
2002 Acquisition
Sahasra Networks, Inc. (Sahasra)
On February 28, 2002, the Company acquired 100% of the
outstanding capital stock of Sahasra, a company specializing in
the software-based method of making large-entry, next generation
network search engines, for $3.2 million in cash and the
Companys common stock. Sahasra is part of the Non-memory
business segment and the WAN/ SAN market segment. The
acquisition resulted in identifiable intangible assets of
$2.7 million and a charge for in-process research and
development of $0.5 million. There were no significant
differences between the accounting policies of the Company and
Sahasra.
The agreement with Sahasra included provisions for additional
contingent cash payments to employees and third parties of up to
$2.3 million through December 2005 based on the amount of
revenues generated by certain products in future periods. Cash
payments to third parties based solely on product revenues will
be recorded as an increase in the purchase price, if paid. Cash
payments to employees for achievement of revenue targets require
that payees remain employed by the Company and are accounted for
as compensation for services and expensed in the appropriate
periods. No payments have been recorded in any periods presented
as achievement of product revenue targets have not been met.
In addition, the agreement included provisions for the
contingent issuance to employees of up to 259,000 shares of
the Companys common stock based on the achievement of
certain product development milestones. Issuance of shares to
employees upon successful completion of product milestones
requires that payees remained employed by the Company and are
accounted for as compensation for services and expensed in the
appropriate periods. During fiscal 2004, 2003 and 2002, the
Company recorded charges in research and development expenses of
$0.2 million, $1.8 million and $0.7 million,
respectively, related to the achievement of product milestones,
of which $2.0 million were accrued as of January 2,
2005. During fiscal 2004, the Company issued 42,000 shares
valued at $0.7 million.
Pro forma results of operations have not been presented because
the historical results of operations of Sahasra were not
material to Cypresss consolidated results of operations.
65
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Note 4 Goodwill and Purchased Intangible
Assets
Goodwill
SFAS No. 142 requires the Company to perform an
impairment test annually and in interim periods if certain
events or circumstances occur indicating that the carrying value
of goodwill may be impaired. The impairment test is a two-step
process. The Company performed its annual goodwill impairment
assessment in the fourth quarters of fiscal 2004, 2003 and 2002.
There were no impairment charges recorded in fiscal 2004 and
2003. An impairment charge related to goodwill was recorded in
fiscal 2002 (see Note 9).
The following table presents the changes in the carrying amount
of goodwill allocated to the reportable segments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Memory | |
|
Non-Memory | |
|
SunPower | |
|
Total | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Balance at December 29, 2002
|
|
$ |
|
|
|
$ |
321,669 |
|
|
$ |
|
|
|
$ |
321,669 |
|
Goodwill acquired
|
|
|
|
|
|
|
|
|
|
|
2,883 |
|
|
|
2,883 |
|
Other adjustment
|
|
|
|
|
|
|
(2,344 |
) |
|
|
|
|
|
|
(2,344 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 28, 2003
|
|
|
|
|
|
|
319,325 |
|
|
|
2,883 |
|
|
|
322,208 |
|
Goodwill acquired
|
|
|
63,167 |
|
|
|
|
|
|
|
|
|
|
|
63,167 |
|
Other adjustment
|
|
|
|
|
|
|
(3,091 |
) |
|
|
|
|
|
|
(3,091 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 2, 2005
|
|
$ |
63,167 |
|
|
$ |
316,234 |
|
|
$ |
2,883 |
|
|
$ |
382,284 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill acquired of $63.2 million in fiscal 2004 was
related to FillFactory (see Note 3). The other adjustment
of $3.1 million in fiscal 2004 resulted from the subsequent
cancellation of shares previously issued under the terms of the
agreement for one of the Companys acquisitions.
Goodwill acquired of $2.9 million in fiscal 2003 was
related to SunPower (see Note 2). The other adjustment of
$2.3 million in fiscal 2003 represented other miscellaneous
adjustments to goodwill primarily as a result of the
Companys prior acquisition escrow closings.
Purchased Intangible Assets
The following table presents details of the Companys total
purchased intangible assets with finite lives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated | |
|
|
As of January 2, 2005 |
|
Gross | |
|
Amortization | |
|
Net | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Purchased technology
|
|
$ |
221,856 |
|
|
$ |
(178,748 |
) |
|
$ |
43,108 |
|
Non-compete agreements
|
|
|
18,715 |
|
|
|
(18,596 |
) |
|
|
119 |
|
Patents, customer contracts, licenses and trademarks
|
|
|
27,318 |
|
|
|
(7,156 |
) |
|
|
20,162 |
|
Other
|
|
|
5,062 |
|
|
|
(3,732 |
) |
|
|
1,330 |
|
|
|
|
|
|
|
|
|
|
|
Total purchased intangible assets
|
|
$ |
272,951 |
|
|
$ |
(208,232 |
) |
|
$ |
64,719 |
|
|
|
|
|
|
|
|
|
|
|
66
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated | |
|
|
As of December 28, 2003 |
|
Gross | |
|
Amortization | |
|
Net | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Purchased technology
|
|
$ |
192,656 |
|
|
$ |
(148,234 |
) |
|
$ |
44,422 |
|
Non-compete agreements
|
|
|
18,650 |
|
|
|
(14,436 |
) |
|
|
4,214 |
|
Patents, customer contracts, licenses and trademarks
|
|
|
6,704 |
|
|
|
(3,788 |
) |
|
|
2,916 |
|
Other
|
|
|
4,600 |
|
|
|
(2,877 |
) |
|
|
1,723 |
|
|
|
|
|
|
|
|
|
|
|
Total purchased intangible assets
|
|
$ |
222,610 |
|
|
$ |
(169,335 |
) |
|
$ |
53,275 |
|
|
|
|
|
|
|
|
|
|
|
Amortization expense of purchased intangible assets was
$38.9 million, $37.7 million and $41.9 million
for fiscal 2004, 2003 and 2002, respectively.
The estimated future amortization expense of purchased
intangible assets as of January 2, 2005 was as follows:
|
|
|
|
|
|
|
(In thousands) | |
Fiscal year:
|
|
|
|
|
2005
|
|
$ |
25,922 |
|
2006
|
|
|
13,403 |
|
2007
|
|
|
10,868 |
|
2008
|
|
|
7,821 |
|
2009
|
|
|
4,802 |
|
2010 and thereafter
|
|
|
1,903 |
|
|
|
|
|
Total
|
|
$ |
64,719 |
|
|
|
|
|
Note 5 Financial Instruments
Available-For-Sale Investments
Available-for-sale securities were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross | |
|
Gross | |
|
|
|
|
|
|
Unrealized | |
|
Unrealized | |
|
Fair Market | |
As of January 2, 2005 |
|
Cost | |
|
Gains | |
|
Losses | |
|
Value | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal agency notes
|
|
$ |
4,121 |
|
|
$ |
1 |
|
|
$ |
(17 |
) |
|
$ |
4,105 |
|
|
Money market funds
|
|
|
44,673 |
|
|
|
|
|
|
|
|
|
|
|
44,673 |
|
|
Certificate of deposits
|
|
|
7,048 |
|
|
|
|
|
|
|
|
|
|
|
7,048 |
|
|
Corporate notes/bonds
|
|
|
2,503 |
|
|
|
|
|
|
|
|
|
|
|
2,503 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash equivalents
|
|
$ |
58,345 |
|
|
$ |
1 |
|
|
$ |
(17 |
) |
|
$ |
58,329 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate notes/bonds
|
|
$ |
104,695 |
|
|
$ |
20 |
|
|
$ |
(839 |
) |
|
$ |
103,876 |
|
|
Federal agency notes
|
|
|
68,286 |
|
|
|
19 |
|
|
|
(411 |
) |
|
|
67,894 |
|
|
Auction rate securities
|
|
|
6,508 |
|
|
|
|
|
|
|
|
|
|
|
6,508 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total short-term investments
|
|
$ |
179,489 |
|
|
$ |
39 |
|
|
$ |
(1,250 |
) |
|
$ |
178,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale securities
|
|
$ |
237,834 |
|
|
$ |
40 |
|
|
$ |
(1,267 |
) |
|
$ |
236,607 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
67
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross | |
|
Gross | |
|
|
|
|
|
|
Unrealized | |
|
Unrealized | |
|
Fair Market | |
December 28, 2003 |
|
Cost | |
|
Gains | |
|
Losses | |
|
Value | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Cash equivalents:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper
|
|
$ |
18,995 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
18,995 |
|
|
Federal agency notes
|
|
|
20,095 |
|
|
|
|
|
|
|
(2 |
) |
|
|
20,093 |
|
|
Money market funds
|
|
|
105,267 |
|
|
|
|
|
|
|
|
|
|
|
105,267 |
|
|
Corporate notes/bonds
|
|
|
3,996 |
|
|
|
|
|
|
|
|
|
|
|
3,996 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash equivalents
|
|
$ |
148,353 |
|
|
$ |
|
|
|
$ |
(2 |
) |
|
$ |
148,351 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate notes/bonds
|
|
$ |
12,708 |
|
|
$ |
37 |
|
|
$ |
(13 |
) |
|
$ |
12,732 |
|
|
Federal agency notes
|
|
|
2,175 |
|
|
|
2 |
|
|
|
|
|
|
|
2,177 |
|
|
Auction rate securities
|
|
|
31,684 |
|
|
|
|
|
|
|
|
|
|
|
31,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total short-term investments
|
|
$ |
46,567 |
|
|
$ |
39 |
|
|
$ |
(13 |
) |
|
$ |
46,593 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term marketable securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate notes/bonds
|
|
$ |
66,096 |
|
|
$ |
196 |
|
|
$ |
(112 |
) |
|
$ |
66,180 |
|
|
Federal agency notes
|
|
|
47,415 |
|
|
|
91 |
|
|
|
(45 |
) |
|
|
47,461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total long-term marketable securities(1)
|
|
$ |
113,511 |
|
|
$ |
287 |
|
|
$ |
(157 |
) |
|
$ |
113,641 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale securities
|
|
$ |
308,431 |
|
|
$ |
326 |
|
|
$ |
(172 |
) |
|
$ |
308,585 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Long-term investments of $118.4 million in the Consolidated
Balance Sheet as of December 28, 2003 included long-term
marketable securities of $113.6 million in the table above
and $4.8 million of limited liability partnership
investments as discussed below. |
Prior to fiscal 2004, the Company had classified auction rate
securities as cash equivalents on the Consolidated Balance
Sheets. In fiscal 2004, the Company has classified all auction
rate securities as short-term investments. To conform to the
current year presentation, the Company has reclassified
$31.7 million of auction rate securities from cash
equivalents to short-term investments for fiscal 2003. There was
no impact on the Consolidated Statements of Operations as a
result of the reclassification for fiscal 2003 and 2002. The
impact on the Consolidated Statements of Cash Flows was an
increase of $25.4 million and $6.3 million in cash
used in investing activities for fiscal 2003 and 2002,
respectively.
Prior to fiscal 2004, the Company had classified a portion of
its available-for-sale securities as long-term investments. As
of the end of fiscal 2004, the Company has classified all
available-for-sale securities as either cash equivalents or
short-term investments as the investments are intended to be
available for use in current operations.
As of January 2, 2005, contractual maturities of the
Companys investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Market | |
|
|
Cost | |
|
Value | |
|
|
| |
|
| |
|
|
(In thousands) | |
Maturing in less than 1 year
|
|
$ |
77,965 |
|
|
$ |
77,602 |
|
Maturing in 2 to 3 years
|
|
|
92,397 |
|
|
|
91,564 |
|
Maturing in more than 3 years
|
|
|
9,127 |
|
|
|
9,112 |
|
|
|
|
|
|
|
|
Total
|
|
$ |
179,489 |
|
|
$ |
178,278 |
|
|
|
|
|
|
|
|
68
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Proceeds from sales and maturities of available-for-sale
securities were $104.5 million, $72.1 million and
$197.8 million for fiscal 2004, 2003 and 2002,
respectively. Realized gains were zero, $0.6 million and
$1.8 million for fiscal 2004, 2003 and 2002, respectively.
Limited Liability Partnership Investments
During the fourth quarter of fiscal 2004, the Company sold its
ownership interest in two limited liability partnership
investments for $6.2 million. The proceeds were classified
as receivables in other current assets in the Consolidated
Balance Sheet as of January 2, 2005.
The Company was a limited partner in the two partnerships and as
such, did not participate in the management or control of the
partnerships. The partnerships invest primarily in securities
traded on a national securities exchange and the general partner
in the partnership controls the operating and financial policies
of the partnership. The partnerships account for those
investments using mark-to-market accounting in accordance with
generally accepted accounting principles. The Companys
investments in the partnerships were not significant to its
operations and economically represented investments primarily in
equity securities by the Company.
At December 28, 2003, the Companys investments in
each of the partnerships represented an ownership interest of
approximately 9.5% and 13.2% and amounted to $4.8 million
in total. While the Companys investment percentage in the
partnerships was not significant, generally accepted accounting
principles require that the Company account for the investment
using the equity method of accounting when the investment
represents more than 3% of the partnerships, regardless of the
limited partner influence over the partnerships operating
and financial policies. The Company classified the investments
of $4.8 million in the partnerships in long-term
investments in the Consolidated Balance Sheet as of
December 28, 2003.
Note 6 Development Stage Companies
Investments
The Company has invested in several privately-held companies,
all of which can be considered in the startup or development
stages. As of January 2, 2005 and December 28, 2003,
the carrying values of these investments were $8.8 million
and $4.3 million, respectively, and were included in other
assets in the Consolidated Balance Sheets.
As the Companys equity investments do not permit the
Company to exert significant influence or control over the
entity in which the Company is investing, these amounts
represent the cost of the investments, less any adjustments the
Company makes when it determines that an investments net
realizable value is less than its carrying cost.
The process of assessing whether a particular equity
investments net realizable value is less than its carrying
cost requires a significant amount of judgment. In making this
judgment, the Company carefully considers the investees
cash position, projected cash flows (both short- and long-term),
financing needs, most recent valuation data, the current
investing environment, management/ownership changes, and
competition. This evaluation process is based on information
that the Company requests from these privately-held companies.
This information is not subject to the same disclosure and audit
requirements as the reports required of U.S. public
companies, and as such, the reliability and accuracy of the data
may vary. Based on the Companys evaluation, the Company
recorded impairment charges of $1.1 million in fiscal 2004,
$1.8 million in fiscal 2003 and $18.3 million in
fiscal 2002, as the Company determined that the decline in
values was other-than-temporary (see Note 16).
69
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Other Transactions
During fiscal 2001, the Company entered into an agreement with a
development stage company to provide certain manufacturing
services in exchange for cash payment. The amount is recognized
as revenues in the period earned. During fiscal 2002 and fiscal
2003, the Company recognized revenues of $7.7 million and
$5.0 million, respectively. During fiscal 2004, the Company
elected to receive preferred stock of the development stage
company instead of cash for each of the four quarters and
recognized $5.0 million in revenues. The preferred stock
was valued based on: (1) a valuation prepared by the
Company and reviewed by an independent valuation firm in the
first and second quarters, and (2) the value of cash
investments by outside investors in the third and fourth
quarters.
Note 7 Balance Sheet Components
Accounts Receivable, Net
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Accounts receivable, gross
|
|
$ |
110,883 |
|
|
$ |
125,065 |
|
Allowance for doubtful accounts and customer returns
|
|
|
(3,595 |
) |
|
|
(3,309 |
) |
|
|
|
|
|
|
|
Total accounts receivable, net
|
|
$ |
107,288 |
|
|
$ |
121,756 |
|
|
|
|
|
|
|
|
Inventories
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Raw materials
|
|
$ |
8,048 |
|
|
$ |
3,007 |
|
Work-in-process
|
|
|
63,888 |
|
|
|
43,669 |
|
Finished goods
|
|
|
27,773 |
|
|
|
25,409 |
|
|
|
|
|
|
|
|
Total inventories
|
|
$ |
99,709 |
|
|
$ |
72,085 |
|
|
|
|
|
|
|
|
Other Current Assets
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Employee stock purchase assistance plan, net
|
|
$ |
45,639 |
|
|
$ |
64,311 |
|
Deferred tax assets
|
|
|
29,702 |
|
|
|
35,109 |
|
Prepaid expenses
|
|
|
18,410 |
|
|
|
22,818 |
|
Other
|
|
|
18,235 |
|
|
|
11,887 |
|
|
|
|
|
|
|
|
Total other current assets
|
|
$ |
111,986 |
|
|
$ |
134,125 |
|
|
|
|
|
|
|
|
70
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Property, Plant and Equipment, Net
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Land
|
|
$ |
16,967 |
|
|
$ |
17,613 |
|
Equipment
|
|
|
1,130,877 |
|
|
|
1,034,218 |
|
Buildings and leasehold improvements
|
|
|
214,488 |
|
|
|
201,381 |
|
Furniture and fixtures
|
|
|
11,148 |
|
|
|
11,077 |
|
|
|
|
|
|
|
|
Total property, plant and equipment, gross
|
|
|
1,373,480 |
|
|
|
1,264,289 |
|
Accumulated depreciation and amortization
|
|
|
(928,829 |
) |
|
|
(821,402 |
) |
|
|
|
|
|
|
|
Total property, plant and equipment, net
|
|
$ |
444,651 |
|
|
$ |
442,887 |
|
|
|
|
|
|
|
|
Other Assets
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Restricted cash
|
|
$ |
62,743 |
|
|
$ |
62,814 |
|
Key employee deferred compensation plan
|
|
|
22,000 |
|
|
|
18,700 |
|
Other
|
|
|
32,717 |
|
|
|
30,781 |
|
|
|
|
|
|
|
|
Total other assets
|
|
$ |
117,460 |
|
|
$ |
112,295 |
|
|
|
|
|
|
|
|
Other Current Liabilities
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Customer advances
|
|
$ |
6,151 |
|
|
$ |
25,081 |
|
Accrued interest payable
|
|
|
462 |
|
|
|
1,783 |
|
Sales representative commissions
|
|
|
4,210 |
|
|
|
4,786 |
|
Accrued royalties
|
|
|
2,618 |
|
|
|
3,426 |
|
Current portion of long-term debt
|
|
|
7,234 |
|
|
|
7,017 |
|
Key employee deferred compensation plan
|
|
|
25,547 |
|
|
|
23,828 |
|
Other
|
|
|
29,073 |
|
|
|
21,673 |
|
|
|
|
|
|
|
|
Total other current liabilities
|
|
$ |
75,295 |
|
|
$ |
87,594 |
|
|
|
|
|
|
|
|
71
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Deferred Income Taxes and Other Tax Liabilities
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Deferred income taxes
|
|
$ |
33,514 |
|
|
$ |
35,109 |
|
Non-current tax liabilities
|
|
|
34,963 |
|
|
|
66,145 |
|
|
|
|
|
|
|
|
Total deferred income taxes and other tax liabilities
|
|
$ |
68,477 |
|
|
$ |
101,254 |
|
|
|
|
|
|
|
|
Note 8 Amortization and Impairment of
Intangible Assets
The following table summarizes the components:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Amortization of intangible assets
|
|
$ |
38,898 |
|
|
$ |
37,716 |
|
|
$ |
41,945 |
|
Impairment of intangible assets
|
|
|
|
|
|
|
|
|
|
|
20,303 |
|
|
|
|
|
|
|
|
|
|
|
Total amortization and impairment of intangible assets
|
|
$ |
38,898 |
|
|
$ |
37,716 |
|
|
$ |
62,248 |
|
|
|
|
|
|
|
|
|
|
|
Amortization of Intangible Assets:
Intangible assets with finite useful lives are amortized using
the straight-line method over their useful lives ranging
primarily from 2 to 6 years (see Note 4).
Impairment of Intangible Assets:
During the third quarter of fiscal 2002, Silicon Light Machines
(SLM), a subsidiary of the Company, continued to
experience a severe economic downturn in the optical market in
which SLM participates. In accordance with
SFAS No. 144, the Company performed an impairment
review on all of SLMs intangible assets and recorded an
impairment charge of $20.3 million related to purchased
technology. No impairment existed in other intangible assets
related to SLM. The fair value of purchased technology was
determined using the income approach method, which was based on
a discounted forecast of the estimated net future cash flows to
be generated from the intangible assets using a discount rate of
25%. The carrying amount of purchased technology was
$25.5 million and the fair value was determined to be
$5.2 million, resulting in an impairment loss of
$20.3 million.
The Company noted no impairment indicators related to its
intangible assets in fiscal 2004 and 2003.
Note 9 Impairment of Goodwill
During the fourth quarter of fiscal 2002, as part of the
Companys annual impairment review of the carrying value of
its goodwill under SFAS No. 142, the Company recorded
a goodwill impairment charge of $14.4 million related to
SLM. No impairment existed in goodwill associated with other
reporting units. The fair value of goodwill associated with SLM
was determined based on the income approach method, which
estimated the fair value based on the future discounted cash
flows using a discount rate of 20%. The carrying amount of
goodwill was $14.4 million and the fair value was deemed to
be zero, resulting in an impairment charge of
$14.4 million. Goodwill related to SLM was part of the
Non-Memory segment.
72
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Note 10 Other Charges (Credits)
2003:
During fiscal 1995, in connection with the construction of a
facility, the Company entered into a tax abatement agreement
with a development agency, which called for job creation and
capital investment by the Company in return for a reduction in
certain local taxes payable. The Company was not able to fulfill
certain terms of the agreement. Accordingly, at the time it
became probable that certain terms of the agreement would not be
met, the Company recorded an accrual of $1.5 million,
representing amounts payable under the agreement. The Company
never received any claim for repayment from the development
agency. At the end of fiscal 2003, the Company determined that
given the passage of time, there was a remote likelihood that
the development agency would seek reimbursement of the amounts
payable. As a result, the Company reversed the accrual of
$1.5 million and recorded the amount as a credit in the
Consolidated Statement of Operations.
During fiscal 1999, the Company decided to halt the construction
of its facility and recorded an accrual of $2.0 million,
representing primarily the cancellation penalties payable to
suppliers. Subsequently, no claims were made against the Company
by the suppliers. During fiscal 2003, the Company determined
that the passage of time had made the likelihood of it being
obligated to make these payments remote. As a result, the
Company reversed the accrual of $2.0 million and recorded
the amount as a credit in the Consolidated Statement of
Operations.
2002:
Other charges of $6.1 million were related to certain
abandoned fixed assets.
Note 11 Restructuring
Overview
The semiconductor industry has historically been characterized
by wide fluctuations in demand for, and supply of,
semiconductors. In some cases, industry downturns have lasted
more than a year. Prior experience has shown that restructuring
of operations, resulting in significant restructuring charges,
may become necessary if an industry downturn persists. As of
January 2, 2005, the Company had two active restructuring
plans one initiated in the fourth quarter of fiscal
2002 (Fiscal 2002 Restructuring Plan) and one
initiated in the third quarter of fiscal 2001 (Fiscal 2001
Restructuring Plan).
The Company recorded initial restructuring charges under the
Fiscal 2001 Restructuring Plan and the Fiscal 2002 Restructuring
Plan based on assumptions that it deemed appropriate for the
economic environment that existed at the time these estimates
were made. As the semiconductor industry the Company operates in
is subject to rapid change, cyclical patterns and high
volatility, the Company has taken additional actions and made
appropriate adjustments for property and equipment, leased
facilities and personnel costs under both the Fiscal 2001
Restructuring Plan and the Fiscal 2002 Restructuring Plan.
Following is a detailed discussion of the two restructuring
plans:
Fiscal 2002 Restructuring Plan
On October 17, 2002, the Company implemented the Fiscal
2002 Restructuring Plan that included the reorganization of the
Companys manufacturing facilities and the reduction of
operating expenses, including research and development and
selling, general and administrative, due to the continued
softness in demand. The actions were aimed to reduce the
Companys cost structure, including a reduction in
workforce, closure of sales offices and design centers, and
removal of excess equipment from service due to the reduction of
wafer
73
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
fabrication capacity. The following table summarizes the
restructuring reserve activities since the inception of the
Fiscal 2002 Restructuring Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property & | |
|
Leased | |
|
|
|
|
|
|
Equipment(1) | |
|
Facilities | |
|
Personnel | |
|
Total | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Initial provision
|
|
$ |
35,959 |
|
|
$ |
1,211 |
|
|
$ |
8,188 |
|
|
$ |
45,358 |
|
Non-cash charges
|
|
|
(39 |
) |
|
|
|
|
|
|
(40 |
) |
|
|
(79 |
) |
Cash charges
|
|
|
(50 |
) |
|
|
(524 |
) |
|
|
(5,276 |
) |
|
|
(5,850 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 29, 2002
|
|
|
35,870 |
|
|
|
687 |
|
|
|
2,872 |
|
|
|
39,429 |
|
Provision (benefit)
|
|
|
(494 |
) |
|
|
565 |
|
|
|
4,920 |
|
|
|
4,991 |
|
Non-cash charges
|
|
|
(30,868 |
) |
|
|
114 |
|
|
|
|
|
|
|
(30,754 |
) |
Cash charges
|
|
|
(849 |
) |
|
|
(238 |
) |
|
|
(7,238 |
) |
|
|
(8,325 |
) |
Assets placed back into service
|
|
|
(3,659 |
) |
|
|
|
|
|
|
|
|
|
|
(3,659 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 28, 2003
|
|
|
|
|
|
|
1,128 |
|
|
|
554 |
|
|
|
1,682 |
|
Provision (benefit)
|
|
|
|
|
|
|
297 |
|
|
|
(203 |
) |
|
|
94 |
|
Non-cash charges
|
|
|
|
|
|
|
22 |
|
|
|
|
|
|
|
22 |
|
Cash charges
|
|
|
|
|
|
|
(357 |
) |
|
|
(351 |
) |
|
|
(708 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 2, 2005
|
|
$ |
|
|
|
$ |
1,090 |
|
|
$ |
|
|
|
$ |
1,090 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
These amounts were netted against property and equipment in the
Consolidated Balance Sheets. |
As of December 28, 2003, the Fiscal 2002 Restructuring Plan
has been substantially completed with reserves remaining only
for restructured leased facilities and employee benefits. As of
January 2, 2005, reserves remained for leased facilities,
which will decrease over time as the Company continues to make
lease payments.
Property and Equipment:
The Company and the semiconductor industry experienced robust
growth in 2000 and such growth had been projected to continue in
2001 and beyond. Consequently, the Company invested heavily in
growing the production capacity to meet the projected expanded
growth. When it became evident that the industry was
experiencing a decline instead of growing, the Company took the
restructuring actions in the fourth quarter of fiscal 2002,
including a decision to sell the excess equipment. The decision
to sell the excess capacity was based on the Companys
belief that by the time industry rebounds, the excess equipment
would be obsolete due to constant technological innovations
taking place in the industry.
The Company recorded initial charges of $36.0 million
related to property and equipment that were removed from
operations and reclassified as assets held for sale. These
assets included primarily production equipment. The assets were
purchased based on industry forecast of growth in demand that
subsequently did not materialize. Prior to the Companys
restructuring announcement, the Company did not determine the
assets were impaired as assets to be held and used, as there was
no indication of impairment. The charges for assets held for
sale were recorded as a contra account netted against property
and equipment in the Consolidated Balance Sheets, and not as a
liability within the restructuring reserves. This contra account
was an adjustment made to reflect the property and equipment at
a new cost basis.
During fiscal 2003, the Company recorded an adjustment of
$3.7 million related to placing back into service assets
that had previously been recorded as assets held for sale (see
discussion below). In addition,
74
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
during the fiscal 2003, the Company recorded an adjustment of
$0.5 million associated with the release of excess reserve.
As of the end of fiscal 2004, all property and equipment had
been disposed of, scrapped or placed back into service.
Leased Facilities:
The Company recorded initial restructuring charges totaling
$1.2 million primarily related to leased sales offices and
design centers in Europe and the United States. The Company
estimated the costs of exiting such leases based on the
contractual terms of the agreements and real estate market
condition. During fiscal 2003, the Company recorded a provision
of $0.6 million primarily related to an additional closure
of a design center in the United Kingdom. During fiscal 2004,
the Company recorded a provision of $0.3 million primarily
due to changes in real estate market condition resulting in an
increase to the accrual.
As of January 2, 2005, amounts related to the lease expense
will be paid over the respective lease terms through fiscal 2007.
Personnel:
The Company accrued initial restructuring charges totaling
$8.2 million primarily related to severance and benefits
associated with the reduction of global workforce. During fiscal
2003, the Company recorded a provision of $4.9 million
primarily related to severance and benefits associated with the
additional reduction of global workforce. During fiscal 2004,
the Company recorded a benefit of $0.2 million to the
accrual balance as the actual payments for such charges were
lower than originally estimated. In aggregate, the Company
terminated a total of 507 employees, of which 229 employees were
engaged in manufacturing, 184 employees in research and
development, and 94 employees in selling general and
administrative functions. Geographically, the terminations
included 464 employees located in the U.S., 25 employees in the
Philippines, and 18 in other countries.
As of the end of fiscal 2004, all liabilities related to
severance and benefits have been paid.
Fiscal 2001 Restructuring Plan
On July 16, 2001, the Company implemented the Fiscal 2001
Restructuring Plan that involved the re-organization of its
manufacturing facilities, reducing its workforce and combining
facilities. The restructuring was precipitated by the worldwide
economic slowdown, particularly in the business areas in which
the Company operates. The intended effect of the plan was to
size the manufacturing operations and facilities to meet future
demand and reduce expenses in all operations areas, including a
reduction in workforce, closure of offices, and removal of
excess equipment from service due to the reduction of wafer
fabrication capacity.
75
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table summarizes the restructuring reserve
activities since the inception of the Fiscal 2001 Restructuring
Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property & | |
|
Leased | |
|
|
|
|
|
|
Equipment(1) | |
|
Facilities | |
|
Personnel | |
|
Total | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Initial provision
|
|
$ |
113,350 |
|
|
$ |
4,079 |
|
|
$ |
14,684 |
|
|
$ |
132,113 |
|
Non-cash charges
|
|
|
(7,269 |
) |
|
|
|
|
|
|
(9,056 |
) |
|
|
(16,325 |
) |
Cash charges
|
|
|
(1,619 |
) |
|
|
(213 |
) |
|
|
(4,243 |
) |
|
|
(6,075 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 30, 2001
|
|
|
104,462 |
|
|
|
3,866 |
|
|
|
1,385 |
|
|
|
109,713 |
|
Provision (benefit)
|
|
|
3,378 |
|
|
|
2,761 |
|
|
|
4,145 |
|
|
|
10,284 |
|
Non-cash charges
|
|
|
(30,198 |
) |
|
|
|
|
|
|
(924 |
) |
|
|
(31,122 |
) |
Cash charges
|
|
|
(1,201 |
) |
|
|
(1,962 |
) |
|
|
(3,972 |
) |
|
|
(7,135 |
) |
Assets placed back into service
|
|
|
(22,762 |
) |
|
|
|
|
|
|
|
|
|
|
(22,762 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 29, 2002
|
|
|
53,679 |
|
|
|
4,665 |
|
|
|
634 |
|
|
|
58,978 |
|
Provision (benefit)
|
|
|
(8,404 |
) |
|
|
645 |
|
|
|
|
|
|
|
(7,759 |
) |
Non-cash charges
|
|
|
(42,071 |
) |
|
|
|
|
|
|
21 |
|
|
|
(42,050 |
) |
Cash charges
|
|
|
(1,640 |
) |
|
|
(2,564 |
) |
|
|
(655 |
) |
|
|
(4,859 |
) |
Assets placed back into service
|
|
|
(1,564 |
) |
|
|
|
|
|
|
|
|
|
|
(1,564 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 28, 2003
|
|
|
|
|
|
|
2,746 |
|
|
|
|
|
|
|
2,746 |
|
Cash charges
|
|
|
|
|
|
|
(1,332 |
) |
|
|
|
|
|
|
(1,332 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 2, 2005
|
|
$ |
|
|
|
$ |
1,414 |
|
|
$ |
|
|
|
$ |
1,414 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
These amounts were netted against property and equipment in the
Consolidated Balance Sheets. |
As of December 28, 2003, the Fiscal 2001 Restructuring Plan
has been substantially completed with reserves remaining only
for restructured leased facilities. As of January 2, 2005,
reserves remained for leased facilities, which will decrease
over time as the Company continues to make lease payments.
Property and Equipment:
The Company and the semiconductor industry experienced robust
growth in 2000 and such growth had been projected to continue in
2001 and beyond. Consequently, the Company invested heavily in
growing the production capacity to meet the projected expanded
growth. When it became evident that the industry was
experiencing a decline instead of growing, the Company took the
restructuring actions in the fourth quarter of fiscal 2001,
including a decision to sell the excess equipment. The decision
to sell the excess capacity was based on the Companys
belief that by the time industry rebounds, the excess equipment
would be obsolete due to constant technological innovations
taking place in the industry.
The Company recorded initial charges of $113.4 million
related to property and equipment that were removed from
operations and reclassified as assets held for sale, and
subsequently, during fiscal 2002, the Company identified
additional property and equipment to be removed from operations
and recorded a provision of $3.4 million. These assets
included primarily production equipment. The assets were
purchased based on industry forecast of growth in demand that
subsequently did not materialize. Prior to the Companys
restructuring announcement, the Company did not determine the
assets were impaired as assets to be held and used, as there was
no indication of impairment. The charges for assets held for
sale were recorded as a contra account netted against property
and equipment in the Consolidated Balance Sheets, and not as a
liability
76
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
within the restructuring reserves. This contra account was an
adjustment made to reflect the property and equipment at a new
cost basis.
During fiscal 2002 and 2003, the Company recorded adjustments of
$22.8 million and $1.6 million, respectively, related
to placing back into service assets that had previously been
recorded as assets held for sale (see discussion below). In
addition, the Company recorded an adjustment of
$8.4 million associated with the release of excess reserve.
As of the end of fiscal 2004, all property and equipment had
been disposed of, scrapped or placed back into service.
Leased Facilities:
The Company recorded initial restructuring charges totaling
$4.1 million primarily related to leases assumed from
acquisitions. The Company estimated the costs of exiting such
leases based on the contractual terms of the agreements and real
estate market condition. During fiscal 2002, the Company
recorded a provision of $2.8 million primarily related to
additional closures of domestic sales offices and an additional
lease assumed from an acquisition. During fiscal 2003, the
Company recorded a provision of $0.6 million primarily due
to changes in real estate market condition resulting in an
increase to the accrual.
As of January 2, 2005, amounts related to the lease expense
will be paid over the respective lease terms through fiscal 2006.
Personnel:
The Company accrued initial restructuring charges totaling
$14.7 million primarily related to severance and benefits
associated with the reduction of global workforce. During fiscal
2002, the Company recorded a provision of $4.8 million
primarily related to severance and benefits associated with the
additional reduction of global workforce, partially offset by a
$0.7 million adjustment to the accrual as the actual
payments were lower than originally estimated. In aggregate, the
Company terminated a total of 851 employees, of which 680
employees were engaged in manufacturing, 76 employees in
research and development, and 95 employees in selling general
and administrative functions. Geographically, the terminations
included 369 employees located in the U.S., 453 employees in the
Philippines, and 29 in other countries.
As of the end of fiscal 2004, all liabilities related to
severance and benefits have been paid.
Assets Placed Back in Service
As discussed in both the Fiscal 2002 Restructuring Plan and the
Fiscal 2001 Restructuring Plan, the Company and the
semiconductor industry experienced robust growth in 2000 and
such growth had been projected to continue in 2001 and beyond.
Consequently, the Company invested heavily in growing the
production capacity to meet the projected expanded growth. When
it became evident that the industry was experiencing a decline
instead of growing, the Company took the restructuring actions,
including a decision to sell the excess equipment. The decision
to sell the excess capacity was based on the Companys then
belief that by the time industry rebounds, the excess equipment
would be obsolete due to constant technological innovations
taking place in the industry.
However, the Company was not successful in selling the equipment
as the used semiconductor equipment market was flooded by
several other companies trying to sell their excess equipment as
well, which resulted in supply exceeding demand. In the
meantime, the semiconductor industry began to turn around and
the Company realized that it could still use some of the excess
equipment held for sale. As a result of the decision, the
Company placed certain previously restructured assets back into
service during both fiscal 2003 and 2002.
77
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
For restructuring actions taken prior to December 15, 2001,
the Company placed the assets back in service in accordance with
SFAS No. 121, Accounting for the Impairment of
Long-Lived Assets and for Long-Lived Assets to be Disposed
of. The assets were placed back in service at their prior
cost basis, adjusted for depreciation expense that would have
been recorded during the period the assets were removed from
service. For restructuring actions taken subsequent to
December 15, 2001, the Company placed the assets back in
service in accordance with SFAS No. 144. The Company
recorded the assets back into service at the lower of their fair
value at the time of bringing the assets back in service or
original net book value, less depreciation for the period they
were held for sale. The fair value of the assets was determined
based upon estimated market prices for the equipment obtained
from independent third parties.
For the Fiscal 2002 Restructuring Plan, the Company placed back
into service assets of $3.7 million (adjusted for
depreciation of $0.9 million) during fiscal 2003.
For the Fiscal 2001 Restructuring Plan, the Company placed back
into service assets of $1.6 million (adjusted for
depreciation of $0.4 million) during fiscal 2003, and
$22.8 million (adjusted for depreciation of
$5.6 million) during fiscal 2002.
78
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Reconciliation
The following table provides a reconciliation of activities
presented in the rollforward tables above to the restructuring
charges (credits) recognized in the Consolidated Statements
of Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Fiscal 2002 Restructuring Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
Charges included in the rollforward table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision
|
|
$ |
94 |
|
|
$ |
4,991 |
|
|
$ |
45,358 |
|
|
Assets placed back into service
|
|
|
|
|
|
|
(3,659 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total charges included in the rollforward table
|
|
$ |
94 |
|
|
$ |
1,332 |
|
|
$ |
45,358 |
|
|
|
|
|
|
|
|
|
|
|
Other charges not included in the rollforward table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation adjustment for assets placed back into service
|
|
$ |
|
|
|
$ |
915 |
|
|
$ |
|
|
|
Disposal costs
|
|
|
(199 |
) |
|
|
|
|
|
|
(170 |
) |
|
|
|
|
|
|
|
|
|
|
Total other charges not included in the rollforward table
|
|
$ |
(199 |
) |
|
$ |
915 |
|
|
$ |
(170 |
) |
|
|
|
|
|
|
|
|
|
|
Fiscal 2001 Restructuring Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
Charges included in the rollforward table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision (benefit)
|
|
$ |
|
|
|
$ |
(7,759 |
) |
|
$ |
10,284 |
|
|
Assets placed back into service
|
|
|
|
|
|
|
(1,564 |
) |
|
|
(22,762 |
) |
|
|
|
|
|
|
|
|
|
|
Total charges included in the rollforward table
|
|
$ |
|
|
|
$ |
(9,323 |
) |
|
$ |
(12,478 |
) |
|
|
|
|
|
|
|
|
|
|
Other charges not included in the rollforward table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation adjustment for assets placed back into service
|
|
$ |
|
|
|
$ |
391 |
|
|
$ |
5,581 |
|
|
Disposal costs
|
|
|
(59 |
) |
|
|
|
|
|
|
(40 |
) |
|
|
|
|
|
|
|
|
|
|
Total other charges not included in the rollforward table
|
|
$ |
(59 |
) |
|
$ |
391 |
|
|
$ |
5,541 |
|
|
|
|
|
|
|
|
|
|
|
Total restructuring charges (credits)
|
|
$ |
(164 |
) |
|
$ |
(6,685 |
) |
|
$ |
38,251 |
|
|
|
|
|
|
|
|
|
|
|
Note 12 Debt and Other Long-Term
Liabilities
Convertible Subordinated Notes
The following table summarizes the Companys convertible
subordinated notes:
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
1.25% convertible subordinated notes
(1.25% Notes)
|
|
$ |
599,998 |
|
|
$ |
600,000 |
|
3.75% convertible subordinated notes
(3.75% Notes)
|
|
|
|
|
|
|
68,652 |
|
|
|
|
|
|
|
|
Total convertible subordinated notes
|
|
$ |
599,998 |
|
|
$ |
668,652 |
|
|
|
|
|
|
|
|
During the second quarter of fiscal 2003, the Company issued
$600.0 million in principal amount of its 1.25% Notes
with interest payable on June 15 and December 15 beginning
December 15, 2003. The
79
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
1.25% Notes are due in June 2008. Each note, which may be
converted at anytime by the holders prior to maturity, is
convertible into 55.172 shares of the Companys common
stock, subject to certain adjustments, plus a cash payment of
$300.0. The Company, at its option, may satisfy the $300.0 cash
payment by issuing common stock if the stock price exceeds
$11.65. The 1.25% Notes are callable by the Company at
anytime on or after June 20, 2006. At anytime prior to
June 20, 2006, the Company may, at its option, elect to
terminate the holders conversion rights if the closing
price of the Companys common stock exceeds $21.75, subject
to certain adjustments, for 20 days out of a 30 consecutive
trading day period. If the Company issues a notice of
termination of conversion rights prior to June 20, 2006,
the Company will pay additional interest in an amount equal to
three years of interest, less any interest actually paid prior
to the conversion date, to holders who convert their
1.25% Notes.
During the fourth quarter of fiscal 2004, the Company redeemed
all of its outstanding 3.75% Notes at total costs of
$69.8 million, which included outstanding principal of
$68.7 million and accrued interest of $1.1 million.
Line of Credit
In September 2003, the Company entered into a
$50.0 million, 24-month revolving line of credit with a
major financial institution. In December 2004, this line of
credit was extended to December 2006 and the total amount was
increased to $70.0 million. As of January 2, 2005,
$4.0 million was outstanding and included in other current
liabilities in the Consolidated Balance Sheet. In addition, as
of January 2, 2005, a standby letter of credit of
$0.5 million was outstanding. Loans made under the line of
credit bear interest based upon the Wall Street Journal Prime
Rate or LIBOR plus a spread at the Companys election. The
line of credit agreement includes a variety of covenants
including restrictions on the incurrence of indebtedness,
incurrence of loans, the payment of dividends or distribution on
its capital stock, and transfers of assets and financial
covenants with respects to tangible net worth and a quick ratio.
As of January 2, 2005, the Company was in compliance with
all of the financial covenants. The Companys obligations
under the line of credit are guaranteed and secured by the
common stock of certain of the Companys subsidiaries. The
Company intends to use the line of credit on an as-needed basis
to fund working capital and capital expenditures.
Other Long-Term Liabilities
Other long-term liabilities consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Collateralized debt instruments
|
|
$ |
13,924 |
|
|
$ |
20,675 |
|
Synthetic lease guarantee (Note 21)
|
|
|
3,825 |
|
|
|
2,000 |
|
Notes payable to minority shareholders of SunPower
|
|
|
|
|
|
|
1,950 |
|
Other long-term liabilities
|
|
|
36 |
|
|
|
116 |
|
Less: current portion of collateralized debt instruments
|
|
|
(7,234 |
) |
|
|
(7,017 |
) |
|
|
|
|
|
|
|
Total other long-term liabilities
|
|
$ |
10,551 |
|
|
$ |
17,724 |
|
|
|
|
|
|
|
|
Collateralized Debt Instruments:
During fiscal 2003, the Company entered into long-term loan
agreements primarily with two lenders with an aggregate
principal amount equal to $24.7 million. These agreements
are collateralized by specific equipment located at the
Companys U.S. manufacturing facilities. Principal
amounts are to be repaid in monthly installments inclusive of
accrued interest, over a three to four-year period. The
applicable interest
80
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
rates are variable based on changes to LIBOR rates. Both loans
are subject to financial covenants. As of January 2, 2005,
the aggregate principal outstanding was $13.9 million and
the Company was in compliance with the covenants.
Maturities related to the collateralized debt instruments are as
follows:
|
|
|
|
|
|
|
(In thousands) | |
Fiscal year:
|
|
|
|
|
2005
|
|
$ |
7,234 |
|
2006
|
|
|
5,255 |
|
2007
|
|
|
1,435 |
|
|
|
|
|
Total
|
|
$ |
13,924 |
|
|
|
|
|
Fair Value of Debt Instruments
The estimated fair values of the Companys debt instruments
have generally been determined using available market
information. However, considerable judgment is required in
interpreting market data to develop the estimates of fair
values. Accordingly, the estimates presented are not necessarily
indicative of the amounts that the Company could realize in a
current market exchange. The use of different market assumptions
and/or estimation methodologies could have a material effect on
the estimated fair value amounts.
The Company determines the fair value of the convertible
subordinated notes based on quoted market prices and the fair
value of non-traded collateralized debt instruments using a
discounted cash flow analysis. The discounted cash flow analysis
is based on estimated interest rates for similar types of
currently available borrowing arrangements with similar
remaining maturities. The carrying amounts and estimated fair
values are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, 2005 | |
|
December 28, 2003 | |
|
|
| |
|
| |
|
|
Carrying | |
|
Estimated | |
|
Carrying | |
|
Estimated | |
|
|
Amount | |
|
Fair Value | |
|
Amount | |
|
Fair Value | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Convertible subordinated notes
|
|
$ |
599,998 |
|
|
$ |
626,626 |
|
|
$ |
668,652 |
|
|
$ |
942,200 |
|
Collateralized debt instruments
|
|
|
13,924 |
|
|
|
13,924 |
|
|
|
20,675 |
|
|
|
20,675 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
613,922 |
|
|
$ |
640,550 |
|
|
$ |
689,327 |
|
|
$ |
962,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 13 Foreign Currency Derivatives
The Company purchases capital equipment using foreign currencies
and has non-U.S. subsidiaries that operate and sell the
Companys products in various global markets. As a result,
the Company is exposed to risks associated with changes in
foreign currency exchange rates. It is the Companys policy
to use various hedge instruments to manage the exposures
associated with forecasted purchases of equipment, net asset or
liability positions of its subsidiaries and forecasted revenues
and expenses. The Company does not enter into derivative
financial instruments for speculative or trading purposes.
As of January 2, 2005, the Companys hedge instruments
consisted entirely of forward contracts. The Company calculates
the fair value of its forward contracts based on forward rates
from published sources.
Under SFAS No. 133, Accounting for Derivative
Instruments and Hedging Activities, the Company accounts
for its hedges of forecasted foreign currency revenues and
selected equipment purchases as cash flow hedges or fair value
hedges, such that changes in fair value of the effective portion
of hedge contracts are
81
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
recorded in accumulated other comprehensive income (loss) in
stockholders equity in the Consolidated Balance Sheets.
Amounts deferred in accumulated other comprehensive income
(loss) will be reclassified into the Consolidated Statement of
Operations in the periods in which the revenue or depreciation
expense impact earnings. The effective portion of unrealized
gains (losses) on cash flow hedges and fair value hedges
recorded in accumulated other comprehensive income (loss), net
of tax, was $(2.7) million, $(0.3) million and
$1.3 million for fiscal 2004, 2003 and 2002, respectively.
Cash flow hedges are tested for effectiveness each period on a
spot to spot basis using dollar-offset method and both the
excluded time value and any ineffectiveness are recorded in
other income and (expense), net. The changes in excluded time
value were zero, $0.8 million and $1.0 million for
fiscal 2004, 2003 and 2002, respectively. No ineffectiveness was
recorded for fiscal 2004, 2003 and 2002. As of January 2,
2005, the Company had outstanding cash flow hedge forward
contracts with an aggregate notional value of $34.0 million
related to forecasted Euro revenue transactions. The maturity
dates of these contracts range from March 2005 to February 2006.
The Company records its hedges of foreign currency denominated
monetary assets and liabilities at fair value with the related
gains or losses recorded in other income and (expense), net. The
gains and losses on these contracts are substantially offset by
transaction gains and losses on the underlying balances being
hedged. As of January 2, 2005 and December 28, 2003,
the Company held forward contracts with an aggregate notional
value of $0.7 million and $2.1 million, respectively,
to hedge the risks associated with Yen foreign currency
denominated assets and liabilities. Aggregate net foreign
exchange gains on these hedging transactions and foreign
currency remeasurement gains of $1.1 million,
$0.5 million and $0.9 million were included in other
income and (expense), net in the Consolidated Statements of
Operations for fiscal 2004, 2003 and 2002, respectively.
Note 14 Accumulated Other Comprehensive
Income (Loss)
The components of accumulated other comprehensive income (loss),
net of tax, were as follows:
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Accumulated net unrealized gains (losses) on available-for-sale
investments
|
|
$ |
(736 |
) |
|
$ |
92 |
|
Accumulated net unrealized gains (losses) on derivatives
|
|
|
(1,388 |
) |
|
|
1,301 |
|
|
|
|
|
|
|
|
Total accumulated other comprehensive income (loss)
|
|
$ |
(2,124 |
) |
|
$ |
1,393 |
|
|
|
|
|
|
|
|
Comprehensive income (loss) is defined as the change in equity
during a period from non-owner sources. The Companys
comprehensive income (loss) is comprised of net income (loss)
and changes in unrealized gains (losses), net of tax, on
available-for-sale investments and derivatives. Comprehensive
income (loss) is presented in the Consolidated Statements of
Stockholders Equity.
Note 15 Employee Stock Purchase Assistance
Plan
On May 3, 2001, the Companys stockholders approved
the adoption of the 2001 employee stock purchase assistance plan
(the SPAP). The SPAP became effective on May 3,
2001 and will terminate on the earlier of May 3, 2011, or
such time as determined by the Board of Directors. The SPAP
allowed for loans to employees to purchase shares of the
Companys common stock on the open market. Employees of the
Company and its subsidiaries, including executive officers but
excluding the chief executive officer and the Board of
Directors, were allowed to participate in the SPAP. The loans
were granted to executive officers prior to Section 402 of
the Sarbanes-Oxley Act of 2002, effective July 30, 2002,
which prohibits loans to executive officers of public
corporations. Loans to executive officers represented
approximately 4.3% of the total original
82
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
loans granted. Each loan was evidenced by a full recourse
promissory note executed by the employee in favor of the Company
and was secured by a pledge of the shares of the Companys
common stock purchased with the proceeds of the loan. If a
participant sells the shares of the Companys common stock
purchased with the proceeds from the loan, the proceeds of the
sale must first be used to repay the interest and then the
principal on the loan before being received by the participant.
The loans are callable and currently bear interest at a minimum
rate of 4.0% per annum compounded annually, except for
loans to executive officers that are also named corporate
officers, whose loans bear interest at the rate of 5.0% per
annum, compounded annually.
As the loans are at interest rates below the estimated market
rate, the Company recorded compensation expense to reflect the
difference between the rate charged and an estimated market rate
for each loan outstanding. For fiscal 2004, 2003 and 2002,
compensation expense was $1.9 million, $4.2 million
and $3.9 million, respectively. In addition, the Company
records interest income on the outstanding loan balances.
Accrued interest outstanding totaled $7.0 million and
$7.3 million as of January 2, 2005 and
December 28, 2003, respectively. Loans outstanding
(including accrued interest) under the SPAP, net of loss
reserve, were $45.6 million and $64.3 million as of
January 2, 2005 and December 28, 2003, respectively.
This balance was classified as current assets in the
Consolidated Balance Sheets. The Company has established an
allowance for uncollectible accounts representing an amount for
estimated uncollectible balances, with changes in the allowance
for uncollectible accounts recognized in selling, general and
administrative expenses in the Consolidated Statements of
Operations. In determining the allowance for uncollectible
accounts, management considered various factors, including a
review of borrower demographics (including geographic location
and job grade), loan quality and an independent fair value
analysis of the loans and the underlying collateral. To date,
there have been immaterial write-offs. The allowance for
uncollectible accounts was $8.5 million and
$16.2 million as of January 2, 2005 and
December 28, 2003, respectively.
In the first quarter of fiscal 2004, the Company instituted a
program directed at minimizing losses resulting from these
employee loans. Under this program, employees other than
executive officers were required to execute either a sell limit
order or a stop loss order on the collateral stock once the
common stock price exceeds the employees break-even point.
Executive officers were precluded from participating in the stop
loss program as a result of Section 402 of the
Sarbanes-Oxley Act of 2002, which prohibits material
modifications to any term of a loan to an executive officer. If
the common stock price declines to the stop loss price, the
collateral stock is sold and the proceeds utilized to repay the
employees outstanding loan to the Company. The employee
loans remain callable and the Company is willing to pursue every
available avenue, including those covered under the Uniform
Commercial Code, to recover these loans by pursuing
employees personal assets should the employees not repay
these loans.
83
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
Note 16 |
Other Income and (Expense), Net |
The following table summarizes the components of other income
and (expenses), net:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Amortization of bond issuance costs
|
|
$ |
(4,071 |
) |
|
$ |
(3,686 |
) |
|
$ |
(2,834 |
) |
Equity in net income (loss) of partnership investment
|
|
|
1,424 |
|
|
|
1,540 |
|
|
|
(844 |
) |
Gain (loss) on repurchase of convertible subordinated notes
|
|
|
|
|
|
|
(7,524 |
) |
|
|
5,946 |
|
Gain on sale of investment in NVE Corporation
|
|
|
|
|
|
|
17,126 |
|
|
|
|
|
Investment impairment and other charges
|
|
|
(1,123 |
) |
|
|
(1,792 |
) |
|
|
(18,992 |
) |
Foreign exchange gains, net
|
|
|
1,122 |
|
|
|
473 |
|
|
|
915 |
|
Gain (loss) on investments held in trust for employee elected
deferred compensation
|
|
|
1,218 |
|
|
|
1,912 |
|
|
|
(1,905 |
) |
Minority interest
|
|
|
144 |
|
|
|
1,045 |
|
|
|
|
|
Other
|
|
|
1,030 |
|
|
|
(710 |
) |
|
|
(1,122 |
) |
|
|
|
|
|
|
|
|
|
|
Total other income and (expense), net
|
|
$ |
(256 |
) |
|
$ |
8,384 |
|
|
$ |
(18,836 |
) |
|
|
|
|
|
|
|
|
|
|
During fiscal 2003, the Company sold its investment in NVE
Corporation, a publicly-traded company, and recognized total
gains of $17.1 million from the transactions. The sales
consisted of 0.7 million shares of NVE Corporations
common stock in the open market. The fair market value of the
investment was based on the market prices of NVE
Corporations common stock on the dates of sales, ranging
from $31.5 to $34.7 per share. Gains on the sales were
determined as the difference between the total proceeds of
$23.3 million less the carrying value of the investment of
$6.2 million.
As of January 2, 2005, the Company held warrants to
purchase 400,000 shares of NVE Corporations
common stock at $15.0 per share, which do not allow for net
exercise. If the Company exercises the warrants, the Company
will not be allowed to sell the underlying shares in a public
market transaction for 12 months. The warrants will expire
in April 2005 if not exercised.
Investment impairment and other charges for fiscal 2002 were
primarily attributable to the $18.1 million write-downs of
the Companys investments in privately-held development
stage companies. The Companys ability to recover its
investments is primarily dependent on how successfully these
companies are able to execute to their business plans and how
well their products are accepted, as well as their ability to
obtain venture capital funding to continue operations. The
Company periodically reviews its investments for impairment and
in the event the carrying value of an investment exceeds its
fair value and the decline is determined to be
other-than-temporary, an impairment charge is recorded and a new
cost basis for the investment is established. This impairment
analysis includes assessment of each investees financial
condition, the business prospects for its products and
technology, its projected results and cash flows, the likelihood
of obtaining subsequent rounds of financing, and the impact of
any relevant contractual equity preferences held by the Company
or other investors.
During the periods from fiscal 1999 to 2001, the Company made
investments in several privately-held development stage
companies whose valuations subsequently proved to be high. As
the equity markets continued to decline significantly, these
development stage companies were either unable to raise
additional funding and therefore forced to cease operations, or
were able to obtain additional funding but at a valuation lower
than the carrying amount of the Companys investments. As
the carrying amount of these investments exceeded their fair
value and the Company determined that the decline in values was
other-than-temporary,
84
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
the Company recorded impairment charges of $18.1 million,
which represented the total amount of the write-downs to the
fair value of the Companys remaining investment in each
respective investee. For those investees who ceased operations,
the fair value of the Companys investment was zero, and
for those investees who have obtained additional funding at a
lower valuation than the carrying amount of the Companys
investments, the fair value was based on the new share price of
the additional funding.
Note 17 Net Income (Loss) Per Share
The following table sets forth the computation of basic and
diluted net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands, except per-share amounts) | |
Basic net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
24,698 |
|
|
$ |
(5,331 |
) |
|
$ |
(249,098 |
) |
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares
|
|
|
124,580 |
|
|
|
121,509 |
|
|
|
123,112 |
|
|
|
|
|
|
|
|
|
|
|
Basic net income (loss) per share
|
|
$ |
0.20 |
|
|
$ |
(0.04 |
) |
|
$ |
(2.02 |
) |
|
|
|
|
|
|
|
|
|
|
Diluted net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
24,698 |
|
|
$ |
(5,331 |
) |
|
$ |
(249,098 |
) |
Other
|
|
|
(2,056 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) for diluted computation
|
|
$ |
22,642 |
|
|
$ |
5,331 |
|
|
$ |
(249,098 |
) |
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares
|
|
|
124,580 |
|
|
|
121,509 |
|
|
|
123,112 |
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options
|
|
|
9,792 |
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
220 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares for diluted computation
|
|
|
134,592 |
|
|
|
121,509 |
|
|
|
123,112 |
|
|
|
|
|
|
|
|
|
|
|
Diluted net income (loss) per share
|
|
$ |
0.17 |
|
|
$ |
(0.04 |
) |
|
$ |
(2.02 |
) |
|
|
|
|
|
|
|
|
|
|
Stock Options:
For fiscal 2004, approximately 21.1 million of the
Companys stock options were excluded from the calculation
of diluted net income per share because the exercise prices of
the stock options were greater than or equal to the average
share price for the period, and therefore, their inclusion would
have been anti-dilutive. For fiscal 2003 and 2002, all
outstanding options, approximately 43.8 million and
42.4 million shares, respectively, were excluded from the
calculation of diluted net loss per share as the Company was in
a net loss position and their inclusion would have been
anti-dilutive.
Convertible Subordinated Notes:
For fiscal 2004, 2003 and 2002, 34.1 million,
34.2 million and 9.1 million shares, respectively, of
the Companys common stock issuable upon the assumed
conversion of the Companys subordinated convertible notes
were excluded from the calculation of diluted net income (loss)
per share as the effect was anti-dilutive.
85
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Other:
The Company maintains a key employee deferred compensation plan
(Note 19). For fiscal 2004, net income for diluted
computation was adjusted for the compensation credit recorded
under the deferred compensation plan, and the weighted-average
common shares for diluted computation included the effect of the
shares that would be issuable upon settlement of the deferred
compensation plan. For fiscal 2003 and 2002, no adjustments
related to the deferred compensation plan were included as their
inclusion would have been anti-dilutive.
Note 18 Equity
Option Contracts
As of January 2, 2005, the Company had outstanding a series
of equity options on its common stock with an initial cost of
$26.0 million that were originally entered into in fiscal
2001. These options were included in stockholders equity
in the Consolidated Balance Sheets. The contracts require
physical settlement. The expiration date of the contracts will
be April 2005. Upon expiration of the options, if the
Companys stock price is above the threshold price of
$21.0 per share, the Company will receive a settlement
value totaling $30.3 million in cash. If the Companys
stock price is below the threshold price of $21.0 per
share, the Company will receive 1.4 million shares of its
common stock. Alternatively, the contracts may be renewed and
extended. During fiscal 2004 and 2003, the Company received
total premiums of $1.8 million and $0.7 million,
respectively, upon extensions of the contracts. The amounts were
recorded as a credit to additional paid-in capital in the
Consolidated Balance Sheets.
In conjunction with the issuance of the 1.25% Notes, the
Company purchased a call spread option on its common stock (the
Call Spread Option) maturing on July 15, 2004
for $49.3 million in cash. The Call Spread Option has been
accounted for as an equity transaction in accordance with EITF
No. 00-19, Accounting for Derivative Financial
Instruments Indexed to, and Potentially Settled in, a
Companys Own Stock. The Call Spread Option covered
32.0 million shares of the Companys common stock. The
Call Spread Option was designed to mitigate dilution from
conversion of the 1.25% Notes. The Call Spread Option was
restructured in May 2004 into a single contract of two equal
parts maturing on August 16, 2004 and September 30,
2004, respectively. As of each of the maturity dates, the Call
Spread Option was out of the money and expired. The expiration
of the Call Spread Option had no impact on the Companys
cash balances or operating results.
Deferred Stock-Based Compensation
The Company recorded provisions for deferred stock-based
compensation related to acquisitions in fiscal 2002 and none in
fiscal 2004 or 2003. Deferred stock-based compensation is
amortized over the vesting period of the individual stock
options or restricted stock, generally a period of four to five
years. Amortization of deferred stock-based compensation totaled
approximately $2.3 million, $10.2 million and
$32.5 million for fiscal 2004, 2003 and 2002, respectively.
86
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table presents details of the amortization of
deferred stock-based compensation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Cost of revenues
|
|
$ |
|
|
|
$ |
506 |
|
|
$ |
1,509 |
|
Research and development
|
|
|
2,289 |
|
|
|
9,228 |
|
|
|
27,137 |
|
Selling, general and administrative
|
|
|
5 |
|
|
|
440 |
|
|
|
3,811 |
|
|
|
|
|
|
|
|
|
|
|
Total deferred stock-based compensation expense
|
|
$ |
2,294 |
|
|
$ |
10,174 |
|
|
$ |
32,457 |
|
|
|
|
|
|
|
|
|
|
|
Repurchase Program
On October 14, 2002, the Companys Board of Directors
authorized a discretionary repurchase program to acquire shares
of the Companys common stock in the open market at any
time. The total amount that can be repurchased under the program
is limited to $15.0 million. The program does not have an
expiration date. As of January 2, 2005, the Company has not
repurchased any shares under the program.
Note 19 Common Stock Option and Other
Employee Benefit Plans
Cypress Stock Option Plans
The Company has the following two stock option plans:
1999 Stock Option Plan (the 1999 Plan):
During fiscal 1999, the Company adopted the 1999 Plan. Under the
terms of the 1999 Plan, which is a non-shareholder approved
plan, options may be granted to qualified employees, including
those of acquired companies and consultants of the Company or
its subsidiaries, but options may not be granted to executive
officers or directors. Options become exercisable over a vesting
period as determined by the Board of Directors and expire over
terms not exceeding ten years from the date of grant. The 1999
Plan allows for the granting of options at exercise prices less
than fair market value of the common stock at grant date.
Pursuant to the Companys proposal to amend the 1994 Stock
Option Plan adopted by its shareholders at the 2004 Annual
Meeting of Shareholders, the Company cancelled 20.0 million
shares it had previously authorized under the 1999 Plan.
1994 Stock Option Plan (the 1994 Plan):
In fiscal 1994, the Company adopted the 1994 Plan, which is a
shareholder-approved plan. The 1994 Plan replaced the
Companys 1985 Incentive Stock Option Plan and the
1988 Directors Stock Option Plan with respect to future
option grants. The 1994 Plan was scheduled to expire in April
2004 but was extended to April 2014 by a favorable vote of the
Companys shareholders at the 2004 Annual Meeting of
Shareholders. Under the terms of the amended 1994 Plan, options
may be granted to qualified employees, consultants, officers and
directors of the Company or its subsidiaries. Options become
exercisable over a vesting period as determined by the Board of
Directors and expire over terms not exceeding ten years from the
date of grant. The option price for shares granted under the
amended 1994 Plan is generally equal to the fair market value of
the common stock at the date of grant but can never be at less
than 85% of fair market value on the date of grant. The 4.5%
annual increase formerly provided by the 1994 Plan was
eliminated with the passing of the amended 1994 Plan. In
addition, the shareholders authorized an additional
15.0 million shares for grants under the amended 1994 Plan.
87
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Shares Under Stock Option Plans
The following table summarizes the Companys stock option
activity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, 2005 | |
|
December 28, 2003 | |
|
December 29, 2002 | |
|
|
| |
|
| |
|
| |
|
|
|
|
Weighted- | |
|
|
|
Weighted- | |
|
|
|
Weighted- | |
|
|
|
|
Average | |
|
|
|
Average | |
|
|
|
Average | |
|
|
|
|
Exercise | |
|
|
|
Exercise | |
|
|
|
Exercise | |
|
|
Shares | |
|
Price | |
|
Shares | |
|
Price | |
|
Shares | |
|
Price | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands, except per-share amounts) | |
Options outstanding, beginning of year
|
|
|
43,786 |
|
|
$ |
13.98 |
|
|
|
42,400 |
|
|
$ |
14.07 |
|
|
|
36,946 |
|
|
$ |
15.08 |
|
Options granted
|
|
|
4,013 |
|
|
|
15.61 |
|
|
|
10,601 |
|
|
|
12.46 |
|
|
|
9,785 |
|
|
|
10.27 |
|
Options exercised
|
|
|
(1,994 |
) |
|
|
9.06 |
|
|
|
(3,395 |
) |
|
|
7.78 |
|
|
|
(1,631 |
) |
|
|
6.84 |
|
Options cancelled
|
|
|
(2,710 |
) |
|
|
16.32 |
|
|
|
(5,820 |
) |
|
|
15.51 |
|
|
|
(2,700 |
) |
|
|
17.25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding, end of year
|
|
|
43,095 |
|
|
|
14.22 |
|
|
|
43,786 |
|
|
|
13.98 |
|
|
|
42,400 |
|
|
|
14.07 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercisable, end of year
|
|
|
25,330 |
|
|
|
14.64 |
|
|
|
21,759 |
|
|
|
14.41 |
|
|
|
19,701 |
|
|
|
13.96 |
|
In connection with the acquisitions of various companies, the
Company has assumed the stock option plans of each acquired
company and the related options are included in the preceding
table. In the second quarter of fiscal 2003, the Companys
Board of Directors approved an increase of 20.0 million
shares for issuance under the 1999 Plan, which was subsequently
cancelled in the second quarter of fiscal 2004 pursuant to the
approval of the amended 1994 Plan at the 2004 Annual Meeting of
Shareholders. At January 2, 2005, approximately
22.6 million options were available for grant.
Information regarding options outstanding as of January 2,
2005 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding | |
|
Exercisable | |
|
|
|
|
| |
|
| |
|
|
|
|
|
|
Weighted- | |
|
|
|
Weighted- | |
|
|
|
|
|
|
Average | |
|
|
|
Average | |
|
|
|
|
|
|
Exercise | |
|
|
|
Exercise | |
|
Remaining | |
Range of Exercise Prices |
|
Shares | |
|
Price | |
|
Shares | |
|
Price | |
|
Life | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
|
|
|
(In thousands) | |
|
|
|
(In Years) | |
$ 0.01 5.42
|
|
|
1,788 |
|
|
$ |
3.93 |
|
|
|
1,403 |
|
|
$ |
3.81 |
|
|
|
6.3 |
|
5.43 10.84
|
|
|
17,408 |
|
|
|
8.01 |
|
|
|
9,418 |
|
|
|
8.36 |
|
|
|
6.5 |
|
10.85 16.26
|
|
|
3,275 |
|
|
|
12.77 |
|
|
|
1,920 |
|
|
|
12.89 |
|
|
|
6.0 |
|
16.27 21.68
|
|
|
14,763 |
|
|
|
18.89 |
|
|
|
8,123 |
|
|
|
18.47 |
|
|
|
7.1 |
|
21.69 27.09
|
|
|
5,283 |
|
|
|
23.48 |
|
|
|
3,961 |
|
|
|
23.56 |
|
|
|
6.4 |
|
27.10 32.51
|
|
|
91 |
|
|
|
30.48 |
|
|
|
86 |
|
|
|
30.40 |
|
|
|
5.2 |
|
32.52 37.93
|
|
|
339 |
|
|
|
35.79 |
|
|
|
287 |
|
|
|
35.77 |
|
|
|
5.6 |
|
37.94 43.35
|
|
|
64 |
|
|
|
40.84 |
|
|
|
62 |
|
|
|
40.84 |
|
|
|
5.2 |
|
43.36 48.77
|
|
|
57 |
|
|
|
45.17 |
|
|
|
48 |
|
|
|
45.17 |
|
|
|
5.5 |
|
48.78 54.19
|
|
|
27 |
|
|
|
49.82 |
|
|
|
22 |
|
|
|
49.85 |
|
|
|
5.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43,095 |
|
|
|
14.22 |
|
|
|
25,330 |
|
|
|
14.64 |
|
|
|
6.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary Stock Option and Restricted Stock Purchase
Plans
During fiscal 2001, Silicon Magnetic Systems (SMS)
and SLM each adopted a stock option plan. SMS made available for
grant 25.0 million shares under the terms of its plan. The
plan allows for early exercise of stock options. SLM made
available for grant 11.0 million shares under the terms of
its plan. The
88
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
plans allow the subsidiaries to grant options to qualified
employees and consultants. Options become exercisable over a
five-year period and expire over terms not exceeding ten years
from the date of grant.
SunPower has two stock option plans, the 1988 Incentive Stock
Plan (the 1988 Plan) and the 1996 Incentive Stock
Plan (the 1996 Plan). Under the terms of the plans,
SunPower may issue incentive or non-statutory stock options or
stock purchase rights to employees and consultants. The maximum
number of shares of common stock authorized for issuance was
0.9 million shares under the 1988 Plan and
14.3 million shares under the 1996 Plan. Options become
vested over a five-year period and expire over terms not
exceeding 10 years from date of grant.
Cypress MicroSystems (CMS) adopted the 1999 Stock
Plan. Under the terms of the plan, CMS may issue non-statutory
stock options to employees and consultants. Options granted
under this plan become exercisable over a five-year period over
terms not exceeding 10 years from date of grant. The
exercise price for options granted under the plans has been the
estimated fair value of the common stock at the date of grant.
In addition, the 1999 Stock Plan allows eligible employees of
CMS to purchase restricted CMS common stock. The restricted
shares have a vesting period of five years. The total maximum
number of shares of common stock authorized for issuance was
26.2 million. As of the end of fiscal 2004,
21.8 million restricted shares were issued and outstanding.
The purchase price of the restricted shares has a range of $0.01
to $0.10 per share.
The following table summarizes stock option activity for the
subsidiary stock option plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMS(1) | |
|
SMS | |
|
SLM | |
|
SunPower(2) | |
|
|
| |
|
| |
|
| |
|
| |
|
|
|
|
Exercise | |
|
|
|
Exercise | |
|
|
|
Exercise | |
|
|
|
Exercise | |
|
|
Shares | |
|
Price | |
|
Shares | |
|
Price | |
|
Shares | |
|
Price | |
|
Shares | |
|
Price | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands, except per-share amounts) | |
Options outstanding, December 30, 2001
|
|
|
|
|
|
|
|
|
|
|
19,550 |
|
|
$ |
0.058 |
|
|
|
3,263 |
|
|
$ |
0.65 |
|
|
|
|
|
|
|
|
|
Options granted
|
|
|
|
|
|
|
|
|
|
|
8,488 |
|
|
|
0.062 |
|
|
|
4,756 |
|
|
|
0.50 |
|
|
|
|
|
|
|
|
|
Options exercised
|
|
|
|
|
|
|
|
|
|
|
(17,155 |
) |
|
|
0.058 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options cancelled
|
|
|
|
|
|
|
|
|
|
|
(3,900 |
) |
|
|
0.058 |
|
|
|
(1,295 |
) |
|
|
0.54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding, December 29, 2002
|
|
|
|
|
|
|
|
|
|
|
6,983 |
|
|
|
0.059 |
|
|
|
6,724 |
|
|
|
0.56 |
|
|
|
1,034 |
|
|
$ |
0.29 |
|
Options granted
|
|
|
|
|
|
|
|
|
|
|
4,350 |
|
|
|
0.073 |
|
|
|
1,397 |
|
|
|
0.15 |
|
|
|
2,720 |
|
|
|
0.25 |
|
Options exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(41 |
) |
|
|
0.20 |
|
Options cancelled
|
|
|
|
|
|
|
|
|
|
|
(1,689 |
) |
|
|
0.068 |
|
|
|
(465 |
) |
|
|
0.53 |
|
|
|
(223 |
) |
|
|
0.28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding, December 28, 2003
|
|
|
|
|
|
$ |
|
|
|
|
9,644 |
|
|
|
0.064 |
|
|
|
7,656 |
|
|
|
0.49 |
|
|
|
3,490 |
|
|
|
0.25 |
|
Options granted
|
|
|
1,517 |
|
|
|
0.10 |
|
|
|
850 |
|
|
|
0.083 |
|
|
|
4,747 |
|
|
|
0.18 |
|
|
|
5,699 |
|
|
|
1.61 |
|
|
|
|
748 |
|
|
|
0.12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercised
|
|
|
(9 |
) |
|
|
0.10 |
|
|
|
|
|
|
|
|
|
|
|
(18 |
) |
|
|
0.43 |
|
|
|
(559 |
) |
|
|
0.27 |
|
Options cancelled
|
|
|
(109 |
) |
|
|
0.10 |
|
|
|
(480 |
) |
|
|
0.080 |
|
|
|
(3,016 |
) |
|
|
0.26 |
|
|
|
(60 |
) |
|
|
0.58 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding, January 2, 2005
|
|
|
2,147 |
|
|
|
0.11 |
|
|
|
10,014 |
|
|
|
0.065 |
|
|
|
9,369 |
|
|
|
0.41 |
|
|
|
8,570 |
|
|
|
1.15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercisable at January 2, 2005
|
|
|
232 |
|
|
|
0.10 |
|
|
|
4,671 |
|
|
|
0.062 |
|
|
|
3,651 |
|
|
|
0.54 |
|
|
|
1,324 |
|
|
|
0.48 |
|
|
|
(1) |
CMS began granting options in fiscal 2004. |
|
(2) |
The Company began consolidating the results of SunPower in
fiscal 2003. |
89
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Equity Compensation Plan Information
The following table summarizes information with respect to
shares of the Companys common stock that may be issued
under the Companys existing equity compensation plans.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities Remaining | |
|
|
|
|
|
|
Available for Future Issuance | |
|
|
Number of Securities | |
|
Weighted-Average | |
|
Under Equity Compensation | |
|
|
to be Issued Upon Exercise | |
|
Exercise Price of | |
|
Plans (Excluding Securities | |
|
|
of Outstanding Options | |
|
Outstanding Options | |
|
Reflected in Column (a)) | |
Plan Category |
|
(a) | |
|
(b) | |
|
(c) | |
|
|
| |
|
| |
|
| |
|
|
(In thousands, except per-share amounts) | |
Equity compensation plans approved by shareholders
|
|
|
35,011 |
|
|
$ |
14.55 |
|
|
|
23,143 |
(1) |
Equity compensation plans not approved by shareholders
|
|
|
7,014 |
|
|
|
13.91 |
|
|
|
3,106 |
(2) |
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
42,025 |
(3) |
|
|
14.44 |
|
|
|
26,249 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Includes 19.5 million shares available for future issuance
under the Companys amended 1994 Plan, generally used for
grants to all employees including officers and directors. In
addition, the amount includes 3.6 million shares available
under the Companys employee stock purchase plan. |
|
(2) |
Includes shares available under the Companys 1999 Plan
used for grants to employees other than officers and directors. |
|
(3) |
Total number does not include 1.1 million shares issuable
under outstanding options, with a weighted-average exercise
price of $5.31, originally granted under plans assumed by the
Company in connection with acquisitions. The Company does not
intend to grant any further options under these plans. |
Employee Stock Purchase Plan (ESPP)
The ESPP allows eligible employees of the Company and its
subsidiaries to purchase shares of the Companys common
stock through payroll deductions. During fiscal 2004, the
Company amended its ESPP. The amendment to the ESPP consisted of
reducing the term of each offering period from consecutive
24-month offering periods composed of four six-month exercise
periods to consecutive 18-month offering periods composed of
three 6-month exercise periods. The shares can be purchased at
the lower of 85% of the fair market value of the common stock at
the date of commencement of the offering period or at the last
day of each six-month exercise period. Purchases are limited to
10% of an employees eligible compensation, subject to a
maximum annual employee contribution limit of $25,000. Of the
20.6 million shares authorized under the ESPP,
17.0 million shares have been issued through fiscal 2004,
including 3.0 million shares at a weighted-average price of
$5.10 per share in fiscal 2004, 2.6 million shares at
a weighted-average price of $4.86 per share in fiscal 2003
and 1.0 million shares at a weighted-average price of
$14.54 per share in fiscal 2002. The plan provides for an
annual increase in shares available for issuance equal to 1.5%
of the number of outstanding common stock on the last day of the
preceding fiscal year.
90
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Pro Forma Net Income (Loss) and Net Income (Loss) Per
Share
As discussed in Note 1, the Company accounts for
stock-based employee compensation using the intrinsic value
method of APB No. 25. The assumptions used for valuing the
Companys stock option plans under SFAS No. 123
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
Expected life
|
|
|
4.4 years |
|
|
|
4.4 years |
|
|
|
4 years |
|
Risk-free interest rate
|
|
|
3.14 |
% |
|
|
2.78 |
% |
|
|
3.38 |
% |
Volatility
|
|
|
0.75 |
|
|
|
0.78 |
|
|
|
0.72 |
|
Dividend yield
|
|
|
0.00 |
% |
|
|
0.00 |
% |
|
|
0.00 |
% |
The weighted-average estimated fair value at the date of grant,
as defined by SFAS No. 123, for options granted in
fiscal 2004, 2003 and 2002 was $9.04, $7.54 and $6.15 per
share, respectively. The estimated grant-date fair value was
calculated using the Black-Scholes model. The Black-Scholes
model, as well as other currently accepted option valuation
models, was developed to estimate the fair value of freely
tradable, fully transferable options without vesting
restrictions, which significantly differ from the Companys
stock option awards. These models also require highly subjective
assumptions, including future stock price volatility and
expected time until exercise, which greatly affect the
calculated grant date fair value.
In addition, the assumptions used in valuing shares under the
Companys ESPP were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
Expected life
|
|
|
6 months |
|
|
|
6 months |
|
|
|
6 months |
|
Risk-free interest rate
|
|
|
0.97 |
% |
|
|
1.40 |
% |
|
|
2.33 |
% |
Volatility
|
|
|
0.53 |
|
|
|
0.61 |
|
|
|
0.58 |
|
Dividend yield
|
|
|
0.00 |
% |
|
|
0.00 |
% |
|
|
0.00 |
% |
The weighted-average estimated grant-date fair value, as defined
by SFAS No. 123, for rights to purchase common stock
under the ESPP granted in fiscal 2004, 2003 and 2002 were
$10.12, $2.28 and $5.67 per share, respectively.
Other Employee Benefit Plans
Other employee benefit plans include the following:
401(k) Plan:
The 401(k) Plan provides participating employees with an
opportunity to accumulate funds for retirement. The Company does
not make contributions to the plan.
Pension Plans:
The Company has two pension plans, covering employees in the
Philippines and Belgium. As of and for the year ended
January 2, 2005, the aggregate costs and outstanding
liability of these pension plans were not material to the
Companys consolidated operating results or financial
position.
New Product Bonus Plan:
Under the New Product Bonus Plan, all qualified employees are
provided bonus payments based on achieving certain levels of new
product revenues, meeting design deadlines and attaining certain
levels of profitability by the Company. Bonus payments under
this plan totaled $3.4 million, $3.3 million and zero
in fiscal 2004, 2003 and 2002, respectively.
91
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Key Employee Bonus Plan:
The Key Employee Bonus Plan provides for bonus payments to
selected employees upon achievement of certain Companys
and individual performance targets. Bonus payment under this
plan totaled $4.2 million, $4.8 million and zero in
fiscal 2004, 2003 and 2002, respectively.
Deferred Compensation Plan:
In fiscal 1995, the Company adopted a deferred compensation
plan, which provides certain key employees with the option to
defer the receipt of compensation in order to accumulate funds
for retirement. Amounts deferred by the key employees are
invested primarily in mutual funds and individual company
stocks. During fiscal 2002, the Board of Directors amended the
plan to allow the plan to invest in the Companys common
stock. In fiscal 2003, the Board of Directors amended the plan
to prohibit the plan from investing in the Companys common
stock. The Company does not make contributions to the deferred
compensation plan other than the amounts withheld from key
employee compensation. Participant deferrals and investment
gains and losses remain an asset of the Company and are subject
to claims of general creditors. As of January 2, 2005, the
deferred compensation plan assets of $22.0 million and
liabilities of $25.5 million were recorded in other assets
and other current liabilities, respectively, in the Consolidated
Balance Sheets.
The Company accounts for the deferred compensation plan in
accordance with EITF No. 97-14, Accounting for
Deferred Compensation Arrangements Where Amounts Earned Are Held
in a Rabbi Trust and Invested. In accordance with EITF
No. 97-14, the liability associated with the other
diversified assets and the investment in the Companys
common stock is being marked to market, with the offset being
recorded as compensation expense to the extent there is an
increase in the value or a reduction of operating expense to the
extent there is a decrease in the value. The other diversified
assets are marked to market with the offset being recorded as
other income and (expense), net. No entries are recorded for the
amounts invested in the Companys common stock since this
is accounted for in treasury stock.
The net favorable impact on the Consolidated Statement of
Operations as a result of all changes recorded for the deferred
compensation plan was $1.6 million during fiscal 2004.
However, changes recorded for the increased market value of the
Companys common stock during fiscal 2003 unfavorably
impacted the Consolidated Statement of Operations by
approximately $4.0 million. The net impact was
insignificant in fiscal 2002.
During fiscal 2003, the Company took two actions to minimize the
impact on the operating results as a result of changes to the
market value of the Companys common stock held in the
deferred compensation plan. First, a restriction on the purchase
of additional shares of the Companys common stock by plan
participants was implemented during the third quarter of fiscal
2003. Secondly, during the fourth quarter of fiscal 2003, the
Company entered into an arrangement with a financial
institution, wherein the Company purchased a forward contract to
hedge the impact of market changes of the Companys common
stock currently held by the plan. The Company paid the financial
institution $5.0 million for the right to receive in cash
at the end of the contract period the fair value of
222,000 shares of the Companys common stock, which
approximated the share count of the Companys common stock
held by the participants. The forward contract is carried at
fair value with any changes recorded as compensation expense
(benefit). The forward contract is recorded in other current
assets on the Consolidated Balance Sheet. The fair-value income
statement impact of the forward contract is designed to
approximately offset the change in the liability to deferred
compensation participants. During fiscal 2004 and 2003, the
Company recorded a mark-to-market expense of $2.1 million
and $0.3 million related to the forward contract.
92
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Note 20 Income Taxes
The geographic distribution of loss before income taxes and the
components of benefit from (provision for) income taxes are
summarized below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Geographic distribution of loss before income taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. loss
|
|
$ |
(15,487 |
) |
|
$ |
(29,942 |
) |
|
$ |
(209,698 |
) |
|
Foreign income (loss)
|
|
|
13,610 |
|
|
|
27,433 |
|
|
|
(36,562 |
) |
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
$ |
(1,877 |
) |
|
$ |
(2,509 |
) |
|
$ |
(246,260 |
) |
|
|
|
|
|
|
|
|
|
|
Benefit from (provision for) income taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current tax benefit (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$ |
28,432 |
|
|
$ |
(264 |
) |
|
$ |
|
|
|
|
State
|
|
|
(200 |
) |
|
|
201 |
|
|
|
(37 |
) |
|
|
Foreign
|
|
|
(2,424 |
) |
|
|
(2,759 |
) |
|
|
(2,801 |
) |
|
|
|
|
|
|
|
|
|
|
|
Total Current
|
|
$ |
25,808 |
|
|
$ |
(2,822 |
) |
|
$ |
(2,838 |
) |
|
|
|
|
|
|
|
|
|
|
|
Deferred tax benefit (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
|
|
$ |
767 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred
|
|
$ |
767 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
Benefit from (provision for) income taxes
|
|
$ |
26,575 |
|
|
$ |
(2,822 |
) |
|
$ |
(2,838 |
) |
|
|
|
|
|
|
|
|
|
|
Benefit from (provision for) income taxes differs from the
amounts obtained by applying the statutory U.S. federal
income tax rate to income before taxes as shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Tax at U.S. statutory rate of 35%
|
|
$ |
657 |
|
|
$ |
878 |
|
|
$ |
86,247 |
|
Foreign income at other than U.S. rates
|
|
|
2,039 |
|
|
|
6,748 |
|
|
|
(1,596 |
) |
State income taxes, net of federal benefit
|
|
|
(130 |
) |
|
|
130 |
|
|
|
(37 |
) |
Non-deductible restructuring
|
|
|
|
|
|
|
|
|
|
|
(17,119 |
) |
Non-deductible acquisition costs and charges
|
|
|
(3,293 |
) |
|
|
(4,636 |
) |
|
|
(21,289 |
) |
Future benefits not recognized
|
|
|
(2,372 |
) |
|
|
(5,784 |
) |
|
|
(48,842 |
) |
Reversal of previously accrued taxes
|
|
|
29,922 |
|
|
|
|
|
|
|
|
|
Other, net
|
|
|
(248 |
) |
|
|
(158 |
) |
|
|
(202 |
) |
|
|
|
|
|
|
|
|
|
|
Benefit from (provision for) income taxes
|
|
$ |
26,575 |
|
|
$ |
(2,822 |
) |
|
$ |
(2,838 |
) |
|
|
|
|
|
|
|
|
|
|
The calculation of tax liabilities involves dealing with
uncertainties in the application of complex global tax
regulations. The Company regularly assesses its tax positions in
light of legislative, bilateral tax treaty, regulatory and
judicial developments in many countries in which the Company and
its affiliates do business.
The Company and its affiliates file tax returns in each
jurisdiction in which they are registered to do business. In the
U.S. and many of the state jurisdictions, and in many foreign
countries in which the Company
93
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
files tax returns, a statute of limitations period exists. After
a statute of limitations period expires, the respective tax
authorities may no longer assess additional income tax for the
expired period. Similarly, the Company is no longer eligible to
file claims for refund for any tax that it may have overpaid.
During the third quarter of fiscal 2004, the statute of
limitations expired for several tax jurisdictions. The
expiration of the statute of limitations led to
managements assessment that the previously accrued income
taxes were no longer necessary. Accordingly, during fiscal 2004,
the Company recorded a benefit of $29.9 million for the
reversal of previously accrued income taxes.
The components of deferred tax assets and liabilities were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Deferred tax assets:
|
|
|
|
|
|
|
|
|
|
Credits and loss carryover
|
|
$ |
177,520 |
|
|
$ |
169,088 |
|
|
Reserves and accruals
|
|
|
92,734 |
|
|
|
77,754 |
|
|
Deferred income
|
|
|
1,965 |
|
|
|
4,302 |
|
|
|
|
|
|
|
|
Total deferred tax assets
|
|
|
272,219 |
|
|
|
251,144 |
|
Less valuation allowance
|
|
|
(194,725 |
) |
|
|
(171,027 |
) |
|
|
|
|
|
|
|
Deferred tax assets, net
|
|
$ |
77,494 |
|
|
$ |
80,117 |
|
|
|
|
|
|
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
|
Depreciation
|
|
$ |
(60,231 |
) |
|
$ |
(62,400 |
) |
|
Intangibles arising from acquisitions
|
|
|
(21,843 |
) |
|
|
(17,717 |
) |
|
|
|
|
|
|
|
Total deferred tax liabilities
|
|
$ |
(82,074 |
) |
|
$ |
(80,117 |
) |
|
|
|
|
|
|
|
Net deferred tax liabilities
|
|
$ |
(4,580 |
) |
|
$ |
|
|
|
|
|
|
|
|
|
At January 2, 2005, the net deferred tax assets were fully
reserved due to uncertainty of realization in accordance with
the accounting procedures as established by
SFAS No. 109, Accounting for Income Taxes.
In compliance with SFAS No. 109, current and long-term
net deferred taxes have been netted to the extent they are in
the same tax jurisdiction.
At January 2, 2005, deferred tax assets of approximately
$30.0 million pertained to certain net operating loss
carryforwards resulting from the exercise of employee stock
options. When recognized, the tax benefit of these loss
carryforwards will be accounted for as a credit to additional
paid-in capital rather than a reduction of the income tax
provision.
At January 2, 2005, the Company had U.S. federal net
operating loss carryovers of approximately $420.0 million,
which, if not utilized, will expire from 2016 through 2023. The
Company had state net operating loss carryovers of approximately
$31.3 million which, if not utilized, will expire from 2016
through 2023. A portion of these net operating loss carryovers
relates to recent acquisitions and are subject to certain
limitations under the U.S. Internal Revenue Code. Tax
benefits related to pre-acquisition losses of acquired entities
aggregating $105.6 million will be utilized first to reduce
any associated intangibles and goodwill. In addition, the
Company had U.S. federal and state tax credit carryforwards
of approximately $29.5 million, which, if not utilized,
will expire in 2023.
U.S. income taxes and foreign withholding taxes have not
been provided on a cumulative total of $305.8 million of
undistributed earnings for certain non-U.S. subsidiaries.
The Company is currently studying the impact of the one-time
favorable foreign dividend provision recently enacted as part of
the American Jobs
94
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Creation Act of 2004, and intends to complete its analysis by
the end of fiscal 2005. At January 2, 2005, and based on
the tax laws in effect at that time, it was the Companys
intention to continue to indefinitely reinvest its undistributed
foreign earnings and, accordingly, no deferred tax liability has
been recorded on these undistributed foreign earnings.
The Companys global operations involve manufacturing,
research and development, and selling activities. The
Companys operations outside the U.S. are in certain
countries that impose a statutory tax rate both higher and lower
than the U.S. The Company is subject to tax holidays in the
Philippines and India where it manufactures and designs certain
of its products, respectively. These tax holidays are scheduled
to expire at varying times within the next one and four years,
respectively. Overall, the Company expects its foreign earnings
to be taxed at rates lower than the statutory tax rate in the
U.S.
The tax returns of the Company and its subsidiaries could be
subject to examination by various tax authorities in the many
countries in which the Company operates. As of January 2,
2005, the Company had no material audits in progress.
Note 21 Commitments and Contingencies
Guarantees and Product Warranties
The Company applies the disclosure provisions of FASB
Interpretation No. 45, Guarantors Accounting
and Disclosure Requirements for Guarantees, including Indirect
Guarantees of Indebtedness of Others, to its agreements
that contain guarantee or indemnification clauses. These
disclosure provisions expand those required by
SFAS No. 5, Accounting for Contingencies,
by requiring that guarantors disclose certain types of
guarantees, even if the likelihood of requiring the
guarantors performance is remote. As of January 2,
2005, Cypress has accrued its estimate of liability incurred
under these indemnification arrangements and guarantees, as
applicable. The Company maintains self-insurance for certain
liabilities of its officers and directors.
Indemnification Obligations:
The Company is a party to a variety of agreements pursuant to
which it may be obligated to indemnify the other party with
respect to certain matters. Typically, these obligations arise
in the context of contracts entered into by the Company, under
which the Company customarily agrees to hold the other party
harmless against losses arising from a breach of representations
and covenants related to such matters as title to assets sold,
certain intellectual property rights, specified environmental
matters and certain income taxes. In these circumstances,
payment by the Company is customarily conditioned on the other
party making a claim pursuant to the procedures specified in the
particular contract, which procedures typically allow the
Company to challenge the other partys claims. Further, the
Companys obligations under these agreements may be limited
in terms of time and/or amount, and in some instances, the
Company may have recourse against third parties for certain
payments made by it under these agreements.
It is not possible to predict the maximum potential amount of
future payments under these or similar agreements due to the
conditional nature of the Companys obligations and the
unique facts and circumstances involved in each particular
agreement. Historically, payments made by the Company under
these agreements did not have a material effect on its business,
financial condition or results of operations. The Company
believes that if it were to incur a loss in any of these
matters, such loss would not have a material effect on its
business, financial condition, cash flows or results of
operations.
Product Warranties:
The Company estimates its warranty costs based on historical
warranty claim experience and applies this estimate to the
revenue stream for products under warranty. The Companys
product warranty claims are
95
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
settled through the returns of defective products and the
reshipment of replaced products. Warranty returns are included
in the allowance for sales returns, which is based on historical
returns. The allowance for sales returns is reviewed quarterly
to verify that it properly reflects the remaining obligations
based on the anticipated returns over the balance of the
obligation period. Adjustments are made when actual return claim
experience differs from estimates. As of January 2, 2005
and December 28, 2003, allowance for sales returns were
$2.7 million and $2.4 million, respectively.
For products sold in the automotive sector, the Company may face
product liability claims that are disproportionately higher than
the value of the products involved. These costs might include,
but are not limited to, labor and other costs of replacing
defective parts, lost profits and other damages. If the Company
is required to pay for damages resulting from quality or
performance issues in the Companys automotive products,
the Companys results of operations and business could be
adversely affected. The Companys revenue for products sold
in the automotive sector was $8.4 million in fiscal 2004.
The following table summarizes the Companys sales returns
reserve activities:
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Beginning balance
|
|
$ |
2,364 |
|
|
$ |
1,839 |
|
Settlements made
|
|
|
(10,858 |
) |
|
|
(8,021 |
) |
Provisions made
|
|
|
11,211 |
|
|
|
8,546 |
|
|
|
|
|
|
|
|
Ending balance
|
|
$ |
2,717 |
|
|
$ |
2,364 |
|
|
|
|
|
|
|
|
Operating Lease Commitments
The Company leases most of its manufacturing facilities and
office facilities, and certain land and equipment under
non-cancelable operating lease agreements that expire at various
dates through fiscal 2073. Some leases include renewal options,
which would permit extensions of the expiration dates at rates
approximating fair market rental values.
As of January 2, 2005, the Company had a land lease
expiring in fiscal 2073. The lease does not transfer ownership
of the land to the Company at the end of the lease term, and the
lease does not contain a bargain purchase option. In accordance
with SFAS No. 13, Accounting for Leases,
the Company classified the land lease as an operating lease.
As of January 2, 2005, future minimum lease payments under
non-cancelable operating leases, including the synthetic leases,
were as follows:
|
|
|
|
|
|
|
(In thousands) | |
Fiscal year:
|
|
|
|
|
2005
|
|
$ |
13,006 |
|
2006
|
|
|
8,339 |
|
2007
|
|
|
7,294 |
|
2008
|
|
|
4,558 |
|
2009
|
|
|
2,714 |
|
2010 and thereafter
|
|
|
2,437 |
|
|
|
|
|
Total
|
|
$ |
38,348 |
|
|
|
|
|
96
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Included in the table above are leases that the Company has
fully reserved as part of the Fiscal 2002 Restructuring Plan and
Fiscal 2001 Restructuring Plan (see Note 11).
Rental expenses totaled approximately $11.7 million,
$15.9 million and $18.2 million in fiscal 2004, 2003
and 2002, respectively. In addition, some of these leases
require the Company to pay taxes, insurance, maintenance and
other expenses with respect to the properties.
Contingent Milestones/ Revenue-Based Compensation
Contingent milestone/ revenue-based compensation charges tied to
continued employment related to acquisitions were
$6.8 million, $3.7 million and $11.4 million for
fiscal 2004, 2003 and 2002, respectively. The components of the
charges were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Cost of revenues
|
|
$ |
30 |
|
|
$ |
188 |
|
|
$ |
123 |
|
Research and development
|
|
|
6,569 |
|
|
|
3,388 |
|
|
|
11,189 |
|
Selling, general and administrative
|
|
|
166 |
|
|
|
87 |
|
|
|
129 |
|
|
|
|
|
|
|
|
|
|
|
Total deferred stock compensation expense
|
|
$ |
6,765 |
|
|
$ |
3,663 |
|
|
$ |
11,441 |
|
|
|
|
|
|
|
|
|
|
|
The aggregate amount of unpaid contingent cash compensation that
could be paid under all acquisition agreements assuming all
milestones are met was $8.6 million as of January 2,
2005. Included in the aggregate unpaid contingent cash
compensation was a $6.2 million contingency relating to an
acquisition that could be paid, at the Companys
discretion, in equivalent common stock instead of cash. In
addition, the Company could be required to pay amounts in the
Companys common stock with the maximum equivalent share
payout based in dollar amounts being $1.6 million and the
maximum share based payout being 0.2 million shares.
Synthetic Lease Transactions
On June 27, 2003, the Company entered into an operating
lease agreement, commonly known as a synthetic lease, for
manufacturing and office facilities located in Minnesota and
California. This transaction, which qualifies for operating
lease accounting treatment, replaced the three existing
synthetic leases associated with these two facilities. There was
no impact to the Companys results of operations as a
result of terminating the former leases and entering into the
new lease. Lease obligations related to the replaced synthetic
leases, totaling $61.4 million, were extinguished with
existing restricted cash collateral, and a new synthetic lease
obligation of $62.7 million with new restricted cash
collateral was established as of the second quarter of fiscal
2003. The new synthetic lease requires the Company to purchase
the properties or to arrange for the properties to be acquired
by a third party at lease expiration, which is June 2008. If the
Company had exercised its right to purchase all the properties
subject to the new synthetic lease at January 2, 2005, the
Company would have been required to make a payment and record
assets totaling $62.7 million (the Termination
Value). If the Company exercised its option to sell the
properties to a third party, the proceeds from such a sale could
be less than the properties Termination Value, and the
Company would be required to pay the difference up to the
guaranteed residual value of $54.5 million (the
Guaranteed Residual Value).
In accordance with FASB Interpretation No. 45, the Company
determined that the fair value associated with the Guaranteed
Residual Value embedded in the synthetic operating lease was
$2.0 million, which was recorded in other assets and other
long-term liabilities in the Consolidated Balance Sheet as of
January 2, 2005.
97
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company is required to evaluate periodically the expected
fair value of the properties at the end of the lease term. In
the event the Company determines that it is estimable and
probable that the expected fair value of the properties at the
end of the lease term will be less than the Termination Value,
the Company will ratably accrue the loss over the remaining
lease term. During fiscal 2004, the Company performed the
analysis and recorded a loss contingency of approximately
$1.8 million in other long-term liabilities relating to the
potential decline in the fair value of the facilities in
California. The loss accrual was determined by management with
the assistance of a market analysis performed by an independent
appraisal firm.
The synthetic lease agreements require periodic payments that
vary based on the LIBOR rate, plus a spread. The total amount of
such payments were $1.3 million, $1.7 million and
$2.2 million in fiscal 2004, 2003 and 2002, respectively.
The Company is required to maintain restricted cash or
investments to serve as collateral for this lease. As of
January 2, 2005, the amount of restricted cash recorded was
$62.7 million and was classified in other assets in the
Consolidated Balance Sheet. As of January 2, 2005, the
Company was in compliance with the financial covenants.
Litigation and Asserted Claims
In January 1998, an attorney representing the estate of
Mr. Jerome Lemelson contacted the Company and charged that
the Company infringed certain patents owned by Mr. Lemelson
and/or a partnership controlled by Mr. Lemelsons
estate. On February 26, 1999, the Lemelson Partnership sued
the Company and 87 other companies in the United States District
Court for the District of Arizona for infringement of 16
patents. In May 2000, the Court stayed litigation on 14 of the
16 patents in view of concurrent litigation in the United States
District Court, District of Nevada, on the same 14 patents. On
January 23, 2004, the Nevada Court held in favor of
plaintiffs, that all asserted claims of the 14 patents are
unenforceable, invalid, and not infringed. The Nevada ruling is
now being appealed, and the 14 patents remain stayed as to the
Company during the appeal. In October 2001, the Lemelson
Partnership amended its Arizona complaint to add allegations
that two more patents were infringed. Therefore, there are
currently four patents that are not stayed in this litigation.
The case is in the claim construction (i.e., patent
claim interpretation) phase on the four non-stayed patents. The
claim construction hearing concluded on December 10, 2004,
and the Company is awaiting the Judges order. The Company
has reviewed and investigated the allegations in both
Lemelsons original and amended complaints. The Company
believes that it has meritorious defenses to these allegations
and will vigorously defend itself in this matter. However,
because of the nature and inherent uncertainties of litigation,
should the outcome of this action be unfavorable, the
Companys business, financial condition, results of
operations or cash flows could be materially and adversely
affected.
The Company is currently a party to various other legal
proceedings, claims, disputes and litigation arising in the
ordinary course of business, including those noted above. The
Company currently believes that the ultimate outcome of these
proceedings, individually and in the aggregate, will not have a
material adverse effect on its financial position, results of
operation or cash flows. However, because of the nature and
inherent uncertainties of litigation, should the outcome of
these actions be unfavorable, the Companys business,
financial condition, results of operations or cash flows could
be materially and adversely affected.
Purchase Commitment
The Company purchases services, software, manufacturing
equipment and facilities from a variety of vendors. During the
normal course of business, in order to manage manufacturing lead
times and help assure adequate supply, the Company enters into
agreements with contract manufacturing and suppliers that either
allow them to procure goods and services based upon criteria, as
defined by the Company, or that establish parameters defining
the Companys requirements. In certain instances, these
agreements allow the Company the option to cancel, reschedule or
adjust the Companys requirements based on its business
needs prior to
98
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
firm orders being placed. Consequently, only a portion of the
Companys recorded purchase commitments arising from these
agreements are firm, noncancelable and unconditional
commitments. As of January 2, 2005, the Company estimated
its obligations under such agreements to be approximately
$48.6 million. These commitments included purchases of
$44.2 million to be made in fiscal 2005 and the remainder
is committed through fiscal 2007.
Note 22 Segment, Geographical and Customer
Information
The Company reports two sets of segment information:
(1) business segments and (2) market segments:
Business Segments
The business segment data is the primary set of information
reviewed by the Companys chief operating decision maker
(CODM) to assess financial performance and allocate
resources. The Companys business segments include four
product divisions and four subsidiaries. Under
SFAS No. 131, Disclosures about Segments of an
Enterprise and Related Information, two or more operating
segments may be aggregated into a single operating segment for
financial reporting purposes if: (1) aggregation is
consistent with the objective and basic principles of
SFAS No. 131, (2) the segments have similar
economic characteristics, and (3) the segments are similar
in each of the following areas:
|
|
|
|
|
the nature of products and services; |
|
|
|
the nature of the production processes; |
|
|
|
the type or class of customer for their products and services;
and |
|
|
|
the methods used to distribute their products or provide their
services. |
Using the SFAS No. 131 aggregation criteria, the
Company aggregates its eight business segments into three
reportable business segments as follows:
|
|
|
|
|
|
|
|
|
|
|
Memory: |
|
consists of the Companys Memory Products Division; |
|
|
|
|
Non-Memory: |
|
consists of the Companys Data Communications Division,
Time Technology Division, Personal Communications Division, and
the subsidiaries SLM, CMS and SMS; and |
|
|
|
|
SunPower: |
|
consists of the SunPower subsidiary. |
The tables below set forth information about the reportable
business segments. The Company does not allocate restructuring
and acquisition-related costs, interest and other income and
expense, and income taxes to its reportable business segments.
In addition, the Company does not allocate assets to the
reportable business segments as the Company does not manage its
business this way.
Net Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Memory
|
|
$ |
400,818 |
|
|
$ |
334,779 |
|
|
$ |
303,388 |
|
Non-Memory
|
|
|
536,915 |
|
|
|
497,305 |
|
|
|
471,358 |
|
SunPower
|
|
|
10,705 |
|
|
|
4,672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net revenues
|
|
$ |
948,438 |
|
|
$ |
836,756 |
|
|
$ |
774,746 |
|
|
|
|
|
|
|
|
|
|
|
99
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Loss Before Income Taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Memory
|
|
$ |
4,577 |
|
|
$ |
(8,304 |
) |
|
$ |
(23,061 |
) |
Non-Memory
|
|
|
74,129 |
|
|
|
40,482 |
|
|
|
(85,156 |
) |
SunPower
|
|
|
(25,754 |
) |
|
|
(12,952 |
) |
|
|
|
|
Unallocated items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring and acquisition-related costs
|
|
|
(54,334 |
) |
|
|
(27,530 |
) |
|
|
(123,127 |
) |
|
Interest income
|
|
|
11,115 |
|
|
|
13,024 |
|
|
|
23,117 |
|
|
Interest expense
|
|
|
(11,354 |
) |
|
|
(15,613 |
) |
|
|
(19,197 |
) |
|
Other income and (expense), net
|
|
|
(256 |
) |
|
|
8,384 |
|
|
|
(18,836 |
) |
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
$ |
(1,877 |
) |
|
$ |
(2,509 |
) |
|
$ |
(246,260 |
) |
|
|
|
|
|
|
|
|
|
|
Depreciation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Memory
|
|
$ |
54,659 |
|
|
$ |
52,401 |
|
|
$ |
54,507 |
|
Non-Memory
|
|
|
73,244 |
|
|
|
74,070 |
|
|
|
78,011 |
|
SunPower
|
|
|
2,237 |
|
|
|
1,337 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total depreciation
|
|
$ |
130,140 |
|
|
$ |
127,808 |
|
|
$ |
132,518 |
|
|
|
|
|
|
|
|
|
|
|
In January 2005, the Company reorganized its operating structure
which resulted in changes in its operating segments. The segment
information presented herein is based on the Companys
operating structure in existence in fiscal 2004. The Company
will report segment information based on the new operating
structure beginning in the first quarter of fiscal 2005.
Market Segments
In addition to the reportable business segments, the Company
reports its product offerings by market segments in order to
provide enhanced focus on serving end markets. The market focus
is expected to provide systems knowledge, cross-product-line
product portfolio definition, early engagement with strategic
accounts and added management of research and development
spending. The WAN/ SAN segment helps to provide product
definition in the networking arena. The WIN/ WIT segment helps
focus the Companys efforts in the wireless space. The
Computation and Consumer segment includes products used in
computers, peripherals and other applications. The Cypress
Subsidiaries segment includes the operations of the
Companys subsidiaries: SLM, CMS, SMS and SunPower.
100
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The tables below set forth information about the market
segments. Similar to the reportable business segments, the
Company does not allocate restructuring and acquisition-related
costs, interest and other income and expense, and income taxes
to its market segments. In addition, the Company does not
allocate assets to the market segments as the Company does not
manage its business this way.
Net Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
WAN/ SAN
|
|
$ |
304,412 |
|
|
$ |
268,978 |
|
|
$ |
253,205 |
|
WIN/ WIT
|
|
|
313,209 |
|
|
|
249,150 |
|
|
|
246,800 |
|
Computation and Consumer
|
|
|
283,124 |
|
|
|
284,572 |
|
|
|
254,615 |
|
Cypress Subsidiaries
|
|
|
47,693 |
|
|
|
34,056 |
|
|
|
20,126 |
|
|
|
|
|
|
|
|
|
|
|
Total net revenues
|
|
$ |
948,438 |
|
|
$ |
836,756 |
|
|
$ |
774,746 |
|
|
|
|
|
|
|
|
|
|
|
Loss Before Income Taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
WAN/ SAN
|
|
$ |
11,821 |
|
|
$ |
(4,389 |
) |
|
$ |
(49,500 |
) |
WIN/ WIT
|
|
|
37,623 |
|
|
|
9,911 |
|
|
|
(26,693 |
) |
Computation and Consumer
|
|
|
34,139 |
|
|
|
38,390 |
|
|
|
(7,246 |
) |
Cypress Subsidiaries
|
|
|
(30,631 |
) |
|
|
(24,686 |
) |
|
|
(24,778 |
) |
Unallocated items:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring and acquisition-related costs
|
|
|
(54,334 |
) |
|
|
(27,530 |
) |
|
|
(123,127 |
) |
|
Interest income
|
|
|
11,115 |
|
|
|
13,024 |
|
|
|
23,117 |
|
|
Interest expense
|
|
|
(11,354 |
) |
|
|
(15,613 |
) |
|
|
(19,197 |
) |
|
Other income and (expense), net
|
|
|
(256 |
) |
|
|
8,384 |
|
|
|
(18,836 |
) |
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
$ |
(1,877 |
) |
|
$ |
(2,509 |
) |
|
$ |
(246,260 |
) |
|
|
|
|
|
|
|
|
|
|
Geographical Information
Revenues are attributed to countries based on the customer
location. Revenues by geographic locations were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
December 29, | |
|
|
2005 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
United States
|
|
$ |
325,112 |
|
|
$ |
305,930 |
|
|
$ |
329,598 |
|
Europe
|
|
|
146,742 |
|
|
|
150,621 |
|
|
|
117,172 |
|
Japan
|
|
|
114,261 |
|
|
|
88,492 |
|
|
|
90,272 |
|
Other
|
|
|
362,323 |
|
|
|
291,713 |
|
|
|
237,704 |
|
|
|
|
|
|
|
|
|
|
|
Total net revenues
|
|
$ |
948,438 |
|
|
$ |
836,756 |
|
|
$ |
774,746 |
|
|
|
|
|
|
|
|
|
|
|
101
CYPRESS SEMICONDUCTOR CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Long-lived assets (property, plant and equipment, net) by
geographic locations were as follows:
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
| |
|
|
January 2, | |
|
December 28, | |
|
|
2005 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In thousands) | |
United States
|
|
$ |
402,558 |
|
|
$ |
396,737 |
|
Philippines
|
|
|
38,099 |
|
|
|
43,547 |
|
Other foreign countries
|
|
|
3,994 |
|
|
|
2,603 |
|
|
|
|
|
|
|
|
Total long-lived assets
|
|
$ |
444,651 |
|
|
$ |
442,887 |
|
|
|
|
|
|
|
|
International revenues accounted for 66% of total revenues in
fiscal 2004, compared with 63% in fiscal 2003 and 57% in fiscal
2002.
Customer Information
Sales to U.S. and non-U.S. based distributors accounted for 50%
of our total revenues in fiscal 2004, compared with 48% in
fiscal 2003 and 46% in fiscal 2002.
Sales to Arrow Electronics, a distributor, accounted for
approximately 15% of total revenues in fiscal 2004. No
individual customer accounted for greater than 10% of total
revenues in fiscal 2003. Sales to Motorola, Inc. accounted for
approximately 10% of total revenues in fiscal 2002.
Note 23 Subsequent Events
Restructuring Plan
Due to the continued economic slowdown, on January 13,
2005, management announced a restructuring plan aimed to reduce
its costs structure and improve its end-market orientation. The
restructuring plan will include closure of a facility in Texas,
a reorganization of several of the Companys product
divisions and a reduction in workforce of approximately 200
employees worldwide. The Company expects to record restructuring
charges in the first and second quarters of fiscal 2005 relating
to this plan.
Acquisition
On February 14, 2005, the Company completed the acquisition
of SMaL Camera Technologies, Inc. (SCT), a designer
of digital imaging solutions for a variety of business and
consumer applications, such as digital still cameras, automotive
vision systems, and mobile phone cameras. Under the terms of the
acquisition, the Company acquired all of the outstanding capital
stock of SCT in exchange for $42.5 million in cash. In
addition, options held by SCT employees to purchase SCTs
common stock have been converted into options to purchase an
aggregate of approximately 338,000 shares of the
Companys common stock. The acquisition also includes a
performance-based employee bonus plan, under which the Company
may be required to pay additional cash based on the satisfaction
of certain conditions subsequent to the acquisition.
Divestiture of Business
On February 14, 2005, the Company announced its plan to
sell SMS, a subsidiary specializing in the magnetic random
access memory (MRAM) technology. The Company expects
to complete the sale in the first half of fiscal 2005.
102
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of Cypress
Semiconductor Corporation:
We have completed an integrated audit of Cypress Semiconductor
Corporations fiscal 2004 consolidated financial statements
and of its internal control over financial reporting as of
January 2, 2005 and audits of its fiscal 2003 and 2002
consolidated financial statements in accordance with the
standards of the Public Company Accounting Oversight Board
(United States). Our opinions, based on our audits, are
presented below.
|
|
|
Consolidated financial statements and financial statement
schedule |
In our opinion, the consolidated financial statements listed in
the index appearing under Item 15(a)(1) present fairly, in
all material respects, the financial position of Cypress
Semiconductor Corporation and its subsidiaries at
January 2, 2005 and December 28, 2003, and the results
of their operations and their cash flows for each of the three
years in the period ended January 2, 2005 in conformity
with accounting principles generally accepted in the United
States of America. In addition, in our opinion, the financial
statement schedule listed in the index appearing under
Item 15(a)(2) presents fairly, in all material respects,
the information set forth therein when read in conjunction with
the related consolidated financial statements. These financial
statements and financial statement schedule are the
responsibility of the Companys management. Our
responsibility is to express an opinion on these financial
statements and financial statement schedule based on our audits.
We conducted our audits of these statements in accordance with
the standards of the Public Company Accounting Oversight Board
(United States). Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. An
audit of financial statements includes examining, on a test
basis, evidence supporting the amounts and disclosures in the
financial statements, assessing the accounting principles used
and significant estimates made by management, and evaluating the
overall financial statement presentation. We believe that our
audits provide a reasonable basis for our opinion.
|
|
|
Internal control over financial reporting |
Also, in our opinion, managements assessment, included in
Managements Report on Internal Control Over Financial
Reporting appearing under Item 9A, that the Company
maintained effective internal control over financial reporting
as of January 2, 2005 based on criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organization of the Treadway
Commission (COSO), is fairly stated, in all material respects,
based on those criteria. Furthermore, in our opinion, the
Company maintained, in all material respects, effective internal
control over financial reporting as of January 2, 2005,
based on criteria established in Internal Control
Integrated Framework issued by the COSO. The Companys
management is responsible for maintaining effective internal
control over financial reporting and for its assessment of the
effectiveness of internal control over financial reporting. Our
responsibility is to express opinions on managements
assessment and on the effectiveness of the Companys
internal control over financial reporting based on our audit. We
conducted our audit of internal control over financial reporting
in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards
require that we plan and perform the audit to obtain reasonable
assurance about whether effective internal control over
financial reporting was maintained in all material respects. An
audit of internal control over financial reporting includes
obtaining an understanding of internal control over financial
reporting, evaluating managements assessment, testing and
evaluating the design and operating effectiveness of internal
control, and performing such other procedures as we consider
necessary in the circumstances. We believe that our audit
provides a reasonable basis for our opinions.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (i) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (ii) provide reasonable assurance that
transactions are recorded as necessary to permit preparation of
financial
103
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (iii) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
As described in Managements Report on Internal
Control Over Financial Reporting, management has excluded
FillFactory NV from its assessment of internal control over
financial reporting as of January 2, 2005 because it was
acquired by the Company in a purchase business combination
during 2004. We have also excluded FillFactory NV from our audit
of internal control over financial reporting. FillFactory NV is
a wholly-owned subsidiary whose total assets and total revenues
represented approximately 1% of the related consolidated
financial statement amounts as of and for the year ended
January 2, 2005.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 17, 2005
104
UNAUDITED QUARTERLY FINANCIAL DATA
(In thousands, except per-share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended | |
|
|
| |
|
|
January 2, | |
|
September 26, | |
|
June 27, | |
|
March 28, | |
|
|
2005 | |
|
2004 | |
|
2004 | |
|
2004 | |
|
|
| |
|
| |
|
| |
|
| |
Revenues
|
|
$ |
210,181 |
|
|
$ |
219,595 |
|
|
$ |
264,269 |
|
|
$ |
254,393 |
|
Gross Margin
|
|
$ |
78,739 |
|
|
$ |
107,194 |
|
|
$ |
139,414 |
|
|
$ |
131,033 |
|
Net income (loss)
|
|
$ |
(28,098 |
) |
|
$ |
4,336 |
|
|
$ |
21,980 |
|
|
$ |
26,480 |
|
Basic net income (loss) per share
|
|
$ |
(0.22 |
) |
|
$ |
0.03 |
|
|
$ |
0.18 |
|
|
$ |
0.22 |
|
Diluted net income (loss) per share
|
|
$ |
(0.22 |
) |
|
$ |
0.02 |
|
|
$ |
0.13 |
|
|
$ |
0.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended | |
|
|
| |
|
|
December 28, | |
|
September 28, | |
|
June 29, | |
|
March 30, | |
|
|
2003 | |
|
2003 | |
|
2003 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
| |
Revenues
|
|
$ |
236,031 |
|
|
$ |
216,642 |
|
|
$ |
203,116 |
|
|
$ |
180,967 |
|
Gross Margin
|
|
$ |
120,802 |
|
|
$ |
105,143 |
|
|
$ |
96,668 |
|
|
$ |
78,394 |
|
Net income (loss)
|
|
$ |
23,163 |
|
|
$ |
17,267 |
|
|
$ |
(12,438 |
) |
|
$ |
(33,323 |
) |
Basic net income (loss) per share
|
|
$ |
0.19 |
|
|
$ |
0.15 |
|
|
$ |
(0.10 |
) |
|
$ |
(0.27 |
) |
Diluted net income (loss) per share
|
|
$ |
0.15 |
|
|
$ |
0.12 |
|
|
$ |
(0.10 |
) |
|
$ |
(0.27 |
) |
105
|
|
ITEM 9. |
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURES |
None.
|
|
ITEM 9A. |
CONTROLS AND PROCEDURES |
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures, as
such term is defined in Rule 13a-15(e) under the Securities
Exchange Act of 1934 (the Exchange Act), that are
designed to ensure that information required to be disclosed by
us in reports that we file or submit under the Exchange Act is
recorded, processed, summarized, and reported within the time
periods specified in Securities and Exchange Commission rules
and forms, and that such information is accumulated and
communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, as appropriate, to allow
timely decisions regarding required disclosure. In designing and
evaluating our disclosure controls and procedures, management
recognized that disclosure controls and procedures, no matter
how well conceived and operated, can provide only reasonable,
not absolute, assurance that the objectives of the disclosure
controls and procedures are met. Additionally, in designing
disclosure controls and procedures, our management necessarily
was required to apply its judgment in evaluating the
cost-benefit relationship of possible disclosure controls and
procedures.
Based on their evaluation as of the end of the period covered by
this Annual Report on Form 10-K, our Chief Executive
Officer and Chief Financial Officer have concluded that our
disclosure controls and procedures were effective.
Managements Report on Internal Control over Financial
Reporting
Our management is responsible for establishing and maintaining
adequate internal control over financial reporting as defined in
Rule 13a-15(f) of the Securities Exchange Act of 1934.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
Our management assessed the effectiveness of our internal
control over financial reporting as of January 2, 2005. In
making this assessment, we used the criteria set forth by the
Committee of Sponsoring Organizations of the Treadway Commission
(COSO) in Internal Control Integrated
Framework. Based on our assessment using those criteria, we
concluded that our internal control over financial reporting was
effective as of January 2, 2005.
Our managements assessment of the effectiveness of our
internal control over financial reporting as of January 2,
2005 excluded FillFactory NV (FillFactory) because
it was acquired by us in a purchase business combination during
fiscal 2004. FillFactory is a wholly-owned subsidiary whose
total assets and total revenues represented approximately 1% of
the related consolidated financial statement amounts as of and
for the fiscal year ended January 2, 2005.
Our managements assessment of the effectiveness of our
internal control over financial reporting as of January 2,
2005 has been audited by PricewaterhouseCoopers LLP, an
independent registered public accounting firm, as stated in
their report which appears herein of this Annual Report on
Form 10-K.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial
reporting that occurred during the fourth fiscal quarter that
has materially affected, or is reasonably likely to materially
affect, our internal control over financial reporting.
106
|
|
ITEM 9B. |
OTHER INFORMATION |
None.
PART III
Certain information required by Part III is omitted from
this Annual Report on Form 10-K. We will file a definitive
proxy statement pursuant to Regulation 14A (the Proxy
Statement) not later than 120 days after the end of
the fiscal year covered by this Annual Report on Form 10-K,
and certain information included therein is incorporated herein
by reference.
|
|
ITEM 10. |
DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT |
The information required by this item concerning our directors
is incorporated by reference from the information set forth in
the sections entitled Proposal One-Election of
Directors and Section 16(a) Beneficial
Ownership Reporting Compliance in our Proxy Statement. The
information required by this item concerning our executive
officers is incorporated by reference to the information set
forth in the section entitled Executive Officers of the
Registrant under Item 1, Part I of this Annual
Report on Form 10-K.
We have adopted a code of ethics that applies to all of our
directors, officers (including our chief executive officer,
chief financial officer, controller and any person performing
similar functions) and employees. We have made the code of
ethics available, free of charge, on our website at
www.cypress.com.
The information required by this item concerning our audit
committee financial expert is incorporated by reference from the
information set forth in the section titled Board
Structure and Compensation in our Proxy Statement.
|
|
ITEM 11. |
EXECUTIVE COMPENSATION |
The information required by this item concerning executive
compensation is incorporated by reference from the information
set forth in the section entitled Executive
Compensation in our Proxy Statement. The information
required by this item concerning compensation of directors is
incorporated by reference from the information set forth in the
section entitled Compensation of Directors in our
Proxy Statement.
|
|
ITEM 12. |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT AND RELATED STOCKHOLDER MATTERS |
The information required by this item regarding security
ownership of certain beneficial owners, directors and executive
officers is incorporated by reference from the information set
forth in the section titled Security Ownership of Certain
Beneficial Owners and Management in our Proxy Statement.
See Note 19 of Notes to Consolidated Financial Statements
included in Item 8, Part II of this Annual Report on
Form 10-K for equity compensation plan information.
|
|
ITEM 13. |
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS |
Information required by this item regarding transactions with
certain persons is incorporated by reference from the
information set forth in the section Certain Relationships
and Related Transactions in our Proxy Statement.
|
|
ITEM 14. |
PRINCIPAL ACCOUNTANT FEES AND SERVICES |
The information required by this item is incorporated by
reference from the information set forth in the sections titled
Board Structure and Compensation, Report of
the Audit Committee of the Board of Directors and
Ratification of Selection of Independent Registered Public
Accounting Firm in our Proxy Statement.
107
PART IV
|
|
ITEM 15. |
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES |
(a) The following documents are filed as a part of this
Annual Report on Form 10-K:
1. Financial Statements:
|
|
|
|
|
|
|
Page | |
|
|
| |
Consolidated Balance Sheets at January 2, 2005 and
December 28, 2003
|
|
|
49 |
|
Consolidated Statements of Operations for the three years in the
period ended January 2, 2005
|
|
|
50 |
|
Consolidated Statements of Stockholders Equity for the
three years in the period ended January 2, 2005
|
|
|
51 |
|
Consolidated Statements of Cash Flows for the three years in the
period ended January 2, 2005
|
|
|
52 |
|
Notes to Consolidated Financial Statements
|
|
|
53 |
|
Report of Independent Registered Public Accounting Firm
|
|
|
103 |
|
2. Financial Statement Schedules:
|
|
|
|
|
|
|
Page | |
|
|
| |
Schedule II Valuation and Qualifying Accounts
|
|
|
111 |
|
|
|
|
All other schedules are omitted as the required information is
inapplicable or the information is presented in the Consolidated
Financial Statements or Notes to Consolidated Financial
Statements under Item 8 of this Annual Report on
Form 10-K. |
3. Exhibits:
|
|
|
|
|
Exhibit | |
|
|
Number | |
|
Description |
| |
|
|
|
2 |
.1(1) |
|
Agreement and Plan of Reorganization dated as of
January 16, 2001 by and among Cypress Semiconductor
Corporation, Clock Acquisition Corporation, International
Microcircuits, Inc. and with respect to Article VII,
U.S. Bank Trust, N.A., as Escrow Agent, and Kurt R.
Jaggers, as Securityholder Agent. |
|
|
2 |
.2(1) |
|
Agreement and Plan of Reorganization dated as of
January 26, 2001 by and among Cypress Semiconductor
Corporation, Hilo Acquisition Corporation, HiBand
Semiconductors, Inc., certain shareholder parties thereto, and
U.S. Bank Trust, National Association, as Escrow Agent. |
|
|
2 |
.3(2) |
|
Stock Purchase Agreement dated as of May 29, 2001 by and
among Cypress Semiconductor Corporation, ScanLogic Holding
Company, ScanLogic Corporation, certain shareholder parties
thereto, and with respect to Article VII, U.S. Bank
Trust, N.A., as Escrow Agent, and Israel Zilberman, as
Securityholder Agent. |
|
|
2 |
.4(3) |
|
Agreement and Plan of Reorganization dated as of June 2,
2001 by and among Cypress Semiconductor Corporation, Lion
Acquisition Corporation, Lara Networks, Inc., U.S. Bank
Trust National Association, as Escrow Agent (with respect to
Article VII only), and Kenneth P. Lawler, as Securityholder
Agent (with respect to Articles I and VII only). |
|
|
2 |
.5(3) |
|
First Amendment to Agreement and Plan of Reorganization dated as
of July 3, 2001 by and among Cypress Semiconductor
Corporation, Lion Acquisition Corporation, Lara Networks, Inc.,
U.S. Bank Trust, N.A., as Escrow Agent, and Kenneth P.
Lawler, as Securityholder Agent. |
|
|
2 |
.6(3) |
|
Agreement and Plan of Reorganization dated as of August 19,
2001 by and among Cypress Semiconductor Corporation, In-System
Design, Inc., and with respect to Articles VII,
U.S. Bank Trust, N.A., as Escrow Agent, and Lynn Watson, as
Securityholder Agent. |
108
|
|
|
|
|
Exhibit | |
|
|
Number | |
|
Description |
| |
|
|
|
|
2 |
.7(3) |
|
First Amendment to Agreement and Plan of Reorganization dated as
of September 10, 2001 by and among Cypress Semiconductor
Corporation, Idaho Acquisition Corporation, In-System Design,
Inc., U.S. Bank Trust, N.A., as Escrow Agent and Lynn
Watson, as Securityholder Agent. |
|
|
2 |
.8(4) |
|
Agreement and Plan of Reorganization dated as of
November 17, 2001 by and among Cypress Semiconductor
Corporation, Steelers Acquisition Corporation, Silicon Packets,
Inc., and with respect to Article VII only, U.S. Bank
Trust, N.A., as Escrow Agent, and Robert C. Marshall, as
Securityholder Agent. |
|
|
2 |
.9(5) |
|
Stock Purchase Agreement dated as of June 21, 2004 by and
among Cypress Semiconductor Corporation, in the name and on
behalf of Cypress Semiconductor (Belgium) BVBA, FillFactory NV,
certain stockholders of FillFactory NV and with respect to
Article VIII and Article X only: U.S. Bank,
National Association as Escrow Agent, and Luc De Mey and
IT-Partners NV as Stockholder Agents. |
|
|
2 |
.10* |
|
Agreement and Plan of Reorganization dated as of June 30,
2004 by and among Cypress Semiconductor Corporation, SP
Acquisition Corporation and SunPower Corporation. |
|
|
3 |
.1(6) |
|
Second Restated Certificate of Incorporation. |
|
|
3 |
.2(7) |
|
Bylaws, as Amended. |
|
|
4 |
.1(8) |
|
Subordinated Indenture dated as of January 15, 2000 between
Cypress Semiconductor Corporation and State Street Bank and
Trust Company of California, N.A., as Trustee. |
|
|
4 |
.2(9) |
|
Supplemental Trust Indenture dated as of June 15, 2000
between Cypress Semiconductor Corporation and State Street Bank
and Trust Company of California, N.A., as Trustee. |
|
|
4 |
.3(10) |
|
Indenture dated as of June 3, 2003 between Cypress
Semiconductor Corporation and U.S. Bank National
Association, as Trustee. |
|
|
10 |
.1(11) |
|
Form of Indemnification Agreement. |
|
|
10 |
.2(M)(12) |
|
Cypress Semiconductor Corporation 1994 Stock Option Plan. |
|
|
10 |
.3(M)(13) |
|
Cypress Semiconductor Corporation Employee Qualified Stock
Purchase Plan, Amended and Restated Effective as of May 15,
1998. |
|
|
10 |
.4(M)(14) |
|
Cypress Semiconductor Corporation 1998 Key Employee Bonus Plan. |
|
|
10 |
.5(M)(15) |
|
Cypress Semiconductor Corporation 1999 Non-statutory Stock
Option Plan. |
|
|
10 |
.6(M)(16) |
|
Cypress Semiconductor Corporation Non-Qualified Deferred
Compensation Plan I. |
|
|
10 |
.7(M)(16) |
|
Cypress Semiconductor Corporation Non-Qualified Deferred
Compensation Plan II. |
|
|
10 |
.8(17) |
|
Amendment to 1999 Nonstatutory Stock Option Plan. |
|
|
10 |
.9(17) |
|
Lease Agreement dated as of June 27, 2003 between Wachovia
Development Corporation and Cypress Semiconductor Corporation. |
|
|
10 |
.10(17) |
|
Participation Agreement dated as of June 27, 2003 by and
among Cypress Semiconductor Corporation, Wachovia Development
Corporation and Wachovia Bank, National Association. |
|
|
10 |
.11(17) |
|
Call Spread Option Confirmation dated May 29, 2003 among
Cypress Semiconductor Corporation, Credit Suisse First Boston
International, and Credit Suisse First Boston. |
|
|
10 |
.12(18) |
|
Loan and Security Agreement dated as of September 25, 2003
by and between Silicon Valley Bank and Cypress Semiconductor
Corporation. |
|
|
10 |
.13(19) |
|
Amended and Restated Call Spread Option Confirmation dated as of
May 11, 2004 among Cypress Semiconductor Corporation,
Credit Suisse First Boston International, and Credit Suisse
First Boston. |
|
|
10 |
.14* |
|
Amendment No. 1 to Loan and Security Agreement dated as of
December 13, 2004 by and between Silicon Valley Bank and
Cypress Semiconductor Corporation. |
|
|
10 |
.15* |
|
Cypress Semiconductor Corporation Employee Qualified Stock
Purchase Plan, Amended and Restated Effective as of the Offering
Period Commencing December 31, 2004 |
|
|
21 |
.1* |
|
Subsidiaries of Cypress Semiconductor Corporation. |
|
|
23 |
.1* |
|
Consent of Independent Registered Independent Public Accounting
Firm. |
109
|
|
|
|
|
Exhibit | |
|
|
Number | |
|
Description |
| |
|
|
|
|
24 |
.1* |
|
Power of Attorney (reference is made to page 112 of this
Annual Report on Form 10-K). |
|
|
31 |
.1* |
|
Certification of Chief Executive Officer Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
31 |
.2* |
|
Certification of Chief Financial Officer Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
32 |
.1* |
|
Certification of Chief Executive Officer Pursuant to
18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
32 |
.2* |
|
Certification of Chief Financial Officer Pursuant to
18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
(1) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended April 1, 2001. |
|
|
(2) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended July 1, 2001. |
|
|
(3) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended September 30,
2001. |
|
|
(4) |
Previously filed as an exhibit to our annual report on
Form 10-K for the fiscal year ended December 30, 2001. |
|
|
(5) |
Previously filed as an exhibit to our current report on
Form 8-K filed August 13, 2004. |
|
|
(6) |
Previously filed as an exhibit to our annual report on
Form 10-K for the fiscal year ended December 31, 2000. |
|
|
(7) |
Previously filed as an exhibit to our annual report on
form 10-K for the fiscal year ended December 29, 2002. |
|
|
(8) |
Previously filed as an exhibit to our current report on
Form 8-K filed March 17, 2000. |
|
|
(9) |
Previously filed as an exhibit to our current report on
Form 8-K filed July 11, 2000. |
|
|
(10) |
Previously filed as an exhibit to our registration statement on
Form S-3 filed June 30, 2003. |
|
(11) |
Previously filed as an exhibit to our registration statement on
Form S-1, which was declared effective on March 4,
1987. |
|
(12) |
Previously filed as an exhibit to our annual report on
Form 10-K for the fiscal year ended January 2, 2000. |
|
(13) |
Previously filed as an exhibit to our registration statement on
Form S-8 dated December 10, 1998. |
|
(14) |
Previously filed as an exhibit to our annual report on
Form 10-K for the fiscal year ended January 3, 1999. |
|
(15) |
Previously filed as an exhibit to our registration statement on
Form S-8 dated April 20, 1999. |
|
(16) |
Previously filed as an exhibit to our registration statement on
Form S-8 dated September 5, 2002. |
|
(17) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended June 29, 2003 |
|
(18) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended September 28,
2003. |
|
(19) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended June 27, 2004. |
|
(M) |
Management compensatory plan, contract or arrangement. |
|
|
|
|
* |
Filed as an exhibit to this annual report on Form 10-K. |
110
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at | |
|
Additions/Charges | |
|
|
|
|
|
|
Beginning of | |
|
to | |
|
|
|
Balance at End | |
|
|
Period | |
|
Expenses/Revenues | |
|
Deductions | |
|
of Period | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Allowance for doubtful accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended January 2, 2005
|
|
$ |
945 |
|
|
$ |
158 |
|
|
$ |
(225 |
) |
|
$ |
878 |
|
Year ended December 28, 2003
|
|
|
1,674 |
|
|
|
82 |
|
|
|
(811 |
) |
|
|
945 |
|
Year ended December 29, 2002
|
|
|
3,729 |
|
|
|
1,246 |
|
|
|
(3,301 |
) |
|
|
1,674 |
|
Sales returns and allowances:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended January 2, 2005
|
|
$ |
2,364 |
|
|
$ |
11,211 |
|
|
$ |
(10,858 |
) |
|
$ |
2,717 |
|
Year ended December 28, 2003
|
|
|
1,839 |
|
|
|
8,546 |
|
|
|
(8,021 |
) |
|
|
2,364 |
|
Year ended December 29, 2002
|
|
|
3,610 |
|
|
|
12,840 |
|
|
|
(14,611 |
) |
|
|
1,839 |
|
Employee stock purchase assistance plan reserve:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended January 2, 2005
|
|
$ |
16,221 |
|
|
$ |
|
|
|
$ |
(7,752 |
) |
|
$ |
8,469 |
|
Year ended December 29, 2003
|
|
|
15,964 |
|
|
|
257 |
|
|
|
|
|
|
|
16,221 |
|
Year ended December 29, 2002
|
|
|
1,167 |
|
|
|
14,797 |
|
|
|
|
|
|
|
15,964 |
|
111
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant, has duly caused
this report to be signed on its behalf by the undersigned,
thereto duly authorized.
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION |
|
|
|
|
By: |
/s/ Emmanuel Hernandez |
|
|
|
|
|
Emmanuel Hernandez, |
|
Executive Vice President, |
|
Finance and Administration and |
|
Chief Financial Officer |
March 18, 2005
POWER OF ATTORNEY
Know all persons by their presents, that each of the officers
and directors of Cypress Semiconductor Corporation whose
signature appears below hereby constitutes and appoints T.J.
Rodgers and Emmanuel Hernandez and each of them, his true and
lawful attorneys-in-fact and agents, with full power of
substitution, each with power to act alone, to sign and execute
on behalf of the undersigned any amendment or amendments to this
Annual Report on Form 10-K, and to perform any acts
necessary to be done in order to file such amendment, and each
of the undersigned does hereby ratify and confirm all that said
attorneys-in-fact and agents, or their or his substitutes, shall
do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed by the following persons on
behalf of the registrant and in the capacities and on the dates
indicated:
|
|
|
|
|
|
|
Signature |
|
Title |
|
Date |
|
|
|
|
|
|
/s/ T. J. Rodgers
T.
J. Rodgers |
|
President, Chief Executive Officer and Director (Principal
Executive Officer) |
|
March 18, 2005 |
|
/s/ Emmanuel Hernandez
Emmanuel
Hernandez |
|
Executive Vice President, Finance and Administration and Chief
Financial Officer (Principal Financial and Accounting Officer) |
|
March 18, 2005 |
|
/s/ W. Steve Albrecht
W.
Steve Albrecht |
|
Director |
|
March 18, 2005 |
|
/s/ Eric A. Benhamou
Eric
A. Benhamou |
|
Director |
|
March 18, 2005 |
|
/s/ Fred B. Bialek
Fred
B. Bialek |
|
Director |
|
March 18, 2005 |
|
/s/ John C. Lewis
John
C. Lewis |
|
Director |
|
March 18, 2005 |
|
/s/ James R. Long
James
R. Long |
|
Director |
|
March 18, 2005 |
|
/s/ Dan McCranie
Dan
McCranie |
|
Director |
|
March 18, 2005 |
|
/s/ Alan F. Shugart
Alan
F. Shugart |
|
Director |
|
March 18, 2005 |
112
CYPRESS SEMICONDUCTOR
INDEX TO EXHIBITS
|
|
|
|
|
Exhibit | |
|
|
Number | |
|
Description |
| |
|
|
|
2 |
.1(1) |
|
Agreement and Plan of Reorganization dated as of
January 16, 2001 by and among Cypress Semiconductor
Corporation, Clock Acquisition Corporation, International
Microcircuits, Inc. and with respect to Article VII,
U.S. Bank Trust, N.A., as Escrow Agent, and Kurt R.
Jaggers, as Securityholder Agent. |
|
|
2 |
.2(1) |
|
Agreement and Plan of Reorganization dated as of
January 26, 2001 by and among Cypress Semiconductor
Corporation, Hilo Acquisition Corporation, HiBand
Semiconductors, Inc., certain shareholder parties thereto, and
U.S. Bank Trust, National Association, as Escrow Agent. |
|
|
2 |
.3(2) |
|
Stock Purchase Agreement dated as of May 29, 2001 by and
among Cypress Semiconductor Corporation, ScanLogic Holding
Company, ScanLogic Corporation, certain shareholder parties
thereto, and with respect to Article VII, U.S. Bank
Trust, N.A., as Escrow Agent, and Israel Zilberman, as
Securityholder Agent. |
|
|
2 |
.4(3) |
|
Agreement and Plan of Reorganization dated as of June 2,
2001 by and among Cypress Semiconductor Corporation, Lion
Acquisition Corporation, Lara Networks, Inc., U.S. Bank
Trust National Association, as Escrow Agent (with respect to
Article VII only), and Kenneth P. Lawler, as Securityholder
Agent (with respect to Articles I and VII only). |
|
|
2 |
.5(3) |
|
First Amendment to Agreement and Plan of Reorganization dated as
of July 3, 2001 by and among Cypress Semiconductor
Corporation, Lion Acquisition Corporation, Lara Networks, Inc.,
U.S. Bank Trust, N.A., as Escrow Agent, and Kenneth P.
Lawler, as Securityholder Agent. |
|
|
2 |
.6(3) |
|
Agreement and Plan of Reorganization dated as of August 19,
2001 by and among Cypress Semiconductor Corporation, In-System
Design, Inc., and with respect to Articles VII,
U.S. Bank Trust, N.A., as Escrow Agent, and Lynn Watson, as
Securityholder Agent. |
|
|
2 |
.7(3) |
|
First Amendment to Agreement and Plan of Reorganization dated as
of September 10, 2001 by and among Cypress Semiconductor
Corporation, Idaho Acquisition Corporation, In-System Design,
Inc., U.S. Bank Trust, N.A., as Escrow Agent and Lynn
Watson, as Securityholder Agent. |
|
|
2 |
.8(4) |
|
Agreement and Plan of Reorganization dated as of
November 17, 2001 by and among Cypress Semiconductor
Corporation, Steelers Acquisition Corporation, Silicon Packets,
Inc., and with respect to Article VII only, U.S. Bank
Trust, N.A., as Escrow Agent, and Robert C. Marshall, as
Securityholder Agent. |
|
|
2 |
.9(5) |
|
Stock Purchase Agreement dated as of June 21, 2004 by and
among Cypress Semiconductor Corporation, in the name and on
behalf of Cypress Semiconductor (Belgium) BVBA, FillFactory NV,
certain stockholders of FillFactory NV and with respect to
Article VIII and Article X only: U.S. Bank,
National Association as Escrow Agent, and Luc De Mey and
IT-Partners NV as Stockholder Agents. |
|
|
2 |
.10* |
|
Agreement and Plan of Reorganization dated as of June 30,
2004 by and among Cypress Semiconductor Corporation, SP
Acquisition Corporation and SunPower Corporation. |
|
|
3 |
.1(6) |
|
Second Restated Certificate of Incorporation. |
|
|
3 |
.2(7) |
|
Bylaws, as Amended. |
|
|
4 |
.1(8) |
|
Subordinated Indenture dated as of January 15, 2000 between
Cypress Semiconductor Corporation and State Street Bank and
Trust Company of California, N.A., as Trustee. |
|
|
4 |
.2(9) |
|
Supplemental Trust Indenture dated as of June 15, 2000
between Cypress Semiconductor Corporation and State Street Bank
and Trust Company of California, N.A., as Trustee. |
|
|
4 |
.3(10) |
|
Indenture dated as of June 3, 2003 between Cypress
Semiconductor Corporation and U.S. Bank National
Association, as Trustee. |
|
|
10 |
.1(11) |
|
Form of Indemnification Agreement. |
113
|
|
|
|
|
Exhibit | |
|
|
Number | |
|
Description |
| |
|
|
|
|
10 |
.2(M)(12) |
|
Cypress Semiconductor Corporation 1994 Stock Option Plan. |
|
|
10 |
.3(M)(13) |
|
Cypress Semiconductor Corporation Employee Qualified Stock
Purchase Plan, Amended and Restated Effective as of May 15,
1998. |
|
|
10 |
.4(M)(14) |
|
Cypress Semiconductor Corporation 1998 Key Employee Bonus Plan. |
|
|
10 |
.5(M)(15) |
|
Cypress Semiconductor Corporation 1999 Non-statutory Stock
Option Plan. |
|
|
10 |
.6(M)(16) |
|
Cypress Semiconductor Corporation Non-Qualified Deferred
Compensation Plan I. |
|
|
10 |
.7(M)(16) |
|
Cypress Semiconductor Corporation Non-Qualified Deferred
Compensation Plan II. |
|
|
10 |
.8(17) |
|
Amendment to 1999 Nonstatutory Stock Option Plan. |
|
|
10 |
.9(17) |
|
Lease Agreement dated as of June 27, 2003 between Wachovia
Development Corporation and Cypress Semiconductor Corporation. |
|
|
10 |
.10(17) |
|
Participation Agreement dated as of June 27, 2003 by and
among Cypress Semiconductor Corporation, Wachovia Development
Corporation and Wachovia Bank, National Association. |
|
|
10 |
.11(17) |
|
Call Spread Option Confirmation dated May 29, 2003 among
Cypress Semiconductor Corporation, Credit Suisse First Boston
International, and Credit Suisse First Boston. |
|
|
10 |
.12(18) |
|
Loan and Security Agreement dated as of September 25, 2003
by and between Silicon Valley Bank and Cypress Semiconductor
Corporation. |
|
|
10 |
.13(19) |
|
Amended and Restated Call Spread Option Confirmation dated as of
May 11, 2004 among Cypress Semiconductor Corporation,
Credit Suisse First Boston International, and Credit Suisse
First Boston. |
|
|
10 |
.14* |
|
Amendment No. 1 to Loan and Security Agreement dated as of
December 13, 2004 by and between Silicon Valley Bank and
Cypress Semiconductor Corporation. |
|
|
10 |
.15* |
|
Cypress Semiconductor Corporation Employee Qualified Stock
Purchase Plan, Amended and Restated Effective as of the Offering
Period Commencing December 31, 2004 |
|
|
21 |
.1* |
|
Subsidiaries of Cypress Semiconductor Corporation. |
|
|
23 |
.1* |
|
Consent of Independent Registered Independent Public Accounting
Firm. |
|
|
24 |
.1* |
|
Power of Attorney (reference is made to page 112 of this
Annual Report on Form 10-K). |
|
|
31 |
.1* |
|
Certification of Chief Executive Officer Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
31 |
.2* |
|
Certification of Chief Financial Officer Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
32 |
.1* |
|
Certification of Chief Executive Officer Pursuant to
18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
32 |
.2* |
|
Certification of Chief Financial Officer Pursuant to
18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
(1) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended April 1, 2001. |
|
|
(2) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended July 1, 2001. |
|
|
(3) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended September 30,
2001. |
|
|
(4) |
Previously filed as an exhibit to our annual report on
Form 10-K for the fiscal year ended December 30, 2001. |
|
|
(5) |
Previously filed as an exhibit to our current report on
Form 8-K filed August 13, 2004. |
|
|
(6) |
Previously filed as an exhibit to our annual report on
Form 10-K for the fiscal year ended December 31, 2000. |
114
|
|
|
|
(7) |
Previously filed as an exhibit to our annual report on
form 10-K for the fiscal year ended December 29, 2002. |
|
|
(8) |
Previously filed as an exhibit to our current report on
Form 8-K filed March 17, 2000. |
|
|
(9) |
Previously filed as an exhibit to our current report on
Form 8-K filed July 11, 2000. |
|
|
(10) |
Previously filed as an exhibit to our registration statement on
Form S-3 filed June 30, 2003. |
|
(11) |
Previously filed as an exhibit to our registration statement on
Form S-1, which was declared effective on March 4,
1987. |
|
(12) |
Previously filed as an exhibit to our annual report on
Form 10-K for the fiscal year ended January 2, 2000. |
|
(13) |
Previously filed as an exhibit to our registration statement on
Form S-8 dated December 10, 1998. |
|
(14) |
Previously filed as an exhibit to our annual report on
Form 10-K for the fiscal year ended January 3, 1999. |
|
(15) |
Previously filed as an exhibit to our registration statement on
Form S-8 dated April 20, 1999. |
|
(16) |
Previously filed as an exhibit to our registration statement on
Form S-8 dated September 5, 2002. |
|
(17) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended June 29, 2003 |
|
(18) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended September 28,
2003. |
|
(19) |
Previously filed as an exhibit to our quarterly report on
Form 10-Q for the fiscal quarter ended June 27, 2004. |
|
(M) |
Management compensatory plan, contract or arrangement. |
|
|
|
|
* |
Filed as an exhibit to this annual report on Form 10-K. |
115